
<html lang="en"     class="pb-page"  data-request-id="96f8b03c-98c9-4b27-9cfc-a6bed72fcccd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-10;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.6b00465;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H" /></meta><meta name="dc.Creator" content="Jayakanth  Kankanala" /></meta><meta name="dc.Creator" content="Karen A.  Kirby" /></meta><meta name="dc.Creator" content="Feng  Liu" /></meta><meta name="dc.Creator" content="Lena  Miller" /></meta><meta name="dc.Creator" content="Eva  Nagy" /></meta><meta name="dc.Creator" content="Daniel J.  Wilson" /></meta><meta name="dc.Creator" content="Michael A.  Parniak" /></meta><meta name="dc.Creator" content="Stefan G.  Sarafianos" /></meta><meta name="dc.Creator" content="Zhengqiang  Wang" /></meta><meta name="dc.Description" content="Targeting the clinically unvalidated reverse transcriptase (RT) associated ribonuclease H (RNase H) for human immunodeficiency virus (HIV) drug discovery generally entails chemotypes capable of che..." /></meta><meta name="Description" content="Targeting the clinically unvalidated reverse transcriptase (RT) associated ribonuclease H (RNase H) for human immunodeficiency virus (HIV) drug discovery generally entails chemotypes capable of che..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 29, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00465" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00465" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00465" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00465" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00465" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0009.jpeg" /></meta><meta property="og:description" content="Targeting the clinically unvalidated reverse transcriptase (RT) associated ribonuclease H (RNase H) for human immunodeficiency virus (HIV) drug discovery generally entails chemotypes capable of chelating two divalent metal ions in the RNase H active site. The hydroxypyridonecarboxylic acid scaffold has been implicated in inhibiting homologous HIV integrase (IN) and influenza endonuclease via metal chelation. We report herein the design, synthesis, and biological evaluations of a novel variant of the hydroxypyridonecarboxylic acid scaffold featuring a crucial N-1 benzyl or biarylmethyl moiety. Biochemical studies show that most analogues consistently inhibited HIV RT-associated RNase H in the low micromolar range in the absence of significant inhibition of RT polymerase or IN. One compound showed reasonable cell-based antiviral activity (EC50 = 10 μM). Docking and crystallographic studies corroborate favorable binding to the active site of HIV RNase H, providing a basis for the design of more potent analogues." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00465"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00465">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00465&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00465&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00465&amp;href=/doi/10.1021/acs.jmedchem.6b00465" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5051-5062</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00453" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00484" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayakanth++Kankanala">Jayakanth Kankanala</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+A.++Kirby">Karen A. Kirby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Liu">Feng Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lena++Miller">Lena Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Nagy">Eva Nagy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Wilson">Daniel J. Wilson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Parniak">Michael A. Parniak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+G.++Sarafianos">Stefan G. Sarafianos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhengqiang++Wang">Zhengqiang Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Molecular Microbiology and Immunology and Department of Biochemistry, University of Missouri School of Medicine, Christopher S. Bond Life Sciences Center, Columbia, Missouri 65211, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ccbbada2abb4f8fbfe8cb9a1a2e2a9a8b9"><span class="__cf_email__" data-cfemail="d9aeb8b7bea1edeeeb99acb4b7f7bcbdac">[email protected]</span></a>. Phone: +1 (612) 626-7025.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00465&amp;href=/doi/10.1021%2Facs.jmedchem.6b00465" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5051–5062</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 20, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 March 2016</li><li><span class="item_label"><b>Published</b> online</span>29 April 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 May 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00465" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00465</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5051%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJayakanth%2BKankanala%252C%2BKaren%2BA.%2BKirby%252C%2BFeng%2BLiu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D10%26contentID%3Dacs.jmedchem.6b00465%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluations%2Bof%2BHydroxypyridonecarboxylic%2BAcids%2Bas%2BInhibitors%2Bof%2BHIV%2BReverse%2BTranscriptase%2BAssociated%2BRNase%2BH%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5062%26publicationDate%3DMay%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00465"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2202</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00465" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jayakanth&quot;,&quot;last_name&quot;:&quot;Kankanala&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;A. Kirby&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Lena&quot;,&quot;last_name&quot;:&quot;Miller&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Nagy&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Wilson&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Parniak&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;G. Sarafianos&quot;},{&quot;first_name&quot;:&quot;Zhengqiang&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;5051-5062&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00465&quot;},&quot;abstract&quot;:&quot;Targeting the clinically unvalidated reverse transcriptase (RT) associated ribonuclease H (RNase H) for human immunodeficiency virus (HIV) drug discovery generally entails chemotypes capable of chelating two divalent metal ions in the RNase H active site. The hydroxypyridonecarboxylic acid scaffold has been implicated in inhibiting homologous HIV integrase (IN) and influenza endonuclease via metal chelation. We report herein the design, synthesis, and biological evaluations of a novel variant of the hydroxypyridonecarboxylic acid scaffold featuring a crucial N-1 benzyl or biarylmethyl moiety. Biochemical studies show that most analogues consistently inhibited HIV RT-associated RNase H in the low micromolar range in the absence of significant inhibition of RT polymerase or IN. One compound showed reasonable cell-based antiviral activity (EC50 = 10 μM). Docking and crystallographic studies corroborate favorable binding to the active site of HIV RNase H, providing a basis for the design of more potent analogues.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00465&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00465" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00465&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00465" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00465&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00465" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00465&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00465&amp;href=/doi/10.1021/acs.jmedchem.6b00465" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00465" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00465" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00465%26sid%3Dliteratum%253Aachs%26pmid%3D27094954%26genre%3Darticle%26aulast%3DKankanala%26date%3D2016%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluations%2Bof%2BHydroxypyridonecarboxylic%2BAcids%2Bas%2BInhibitors%2Bof%2BHIV%2BReverse%2BTranscriptase%2BAssociated%2BRNase%2BH%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D10%26spage%3D5051%26epage%3D5062%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/jmcmar.2016.59.issue-10/20160526/jmcmar.2016.59.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Targeting the clinically unvalidated reverse transcriptase (RT) associated ribonuclease H (RNase H) for human immunodeficiency virus (HIV) drug discovery generally entails chemotypes capable of chelating two divalent metal ions in the RNase H active site. The hydroxypyridonecarboxylic acid scaffold has been implicated in inhibiting homologous HIV integrase (IN) and influenza endonuclease via metal chelation. We report herein the design, synthesis, and biological evaluations of a novel variant of the hydroxypyridonecarboxylic acid scaffold featuring a crucial <i>N</i>-1 benzyl or biarylmethyl moiety. Biochemical studies show that most analogues consistently inhibited HIV RT-associated RNase H in the low micromolar range in the absence of significant inhibition of RT polymerase or IN. One compound showed reasonable cell-based antiviral activity (EC<sub>50</sub> = 10 μM). Docking and crystallographic studies corroborate favorable binding to the active site of HIV RNase H, providing a basis for the design of more potent analogues.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Current HIV antivirals target three of the four virally encoded enzymes (RT polymerase, IN, and protease), as well as viral entry proteins and cellular co-receptors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These drugs form the basis for current combination drug therapy of HIV infection (HAART)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> by virtue of their distinct mechanisms of action. However, since current HIV therapeutics involve only a few of possible targets, the efficacy of HAART is plagued by the inevitable emergence of HIV mutants resistant to current drugs. Thus, the development of antivirals targeting underexplored and unvalidated processes required for HIV replication may be key to combating current drug-resistant viral strains. One such target is the RT associated RNase H activity.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> RT encodes two distinct enzymatic functions:<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> the polymerase activity that carries out both RNA and DNA dependent DNA polymerization; the RNase H function that selectively degrades RNA from the RNA/DNA heteroduplex intermediate. The well-known drug families of nucleoside RT inhibitors (NRTIs)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and non-nucleoside RT inhibitors (NNRTIs)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> all target the DNA polymerase function of RT; the RNase H function remains a clinically unvalidated target, as none of its inhibitors have advanced to development pipeline.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Nevertheless, the crucial role of RNase H in HIV replication has been well recognized, as research showed that active site mutations associated with reduced RNase H biochemical activity conferred attenuated HIV replication in cell culture.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This suggests that potent and selective RNase H inhibition should lead to effective antiviral activity.</div><div class="NLM_p">The main medicinal chemistry challenge of targeting HIV RNase H is the lack of appropriate chemical scaffolds supporting specific RNase H inhibition and potent antiviral activity. Reported RNase H inhibitors<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> generally target the active site by using a chelating triad (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a, in magenta) for competitive binding to divalent metals, e.g., hydroxyisoquinolinedione (HID, <b>1</b>),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> β-thujaplicinol (<b>2</b>),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and dihydroxycoumarin (<b>3</b>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> More potent and selective RNase H inhibition was achieved with structurally more elaborate chemotypes, such as diketoacid <b>4</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> pyrimidinolcarboxylic acid <b>5</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> hydroxynaphthyridine <b>6</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and pyridopyrimidone <b>7</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> all featuring a hydrophobic aromatic moiety seemingly important for antiviral activity. Compounds <b>6</b> and <b>7</b> are among the very few RNase H inhibitors with reported antiviral activity. Exploiting a chelating core for competitive metal binding is a general medicinal chemistry approach for inhibiting a wide array of enzymes homologous to HIV RNase H.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> For example, the hydroxypyridone carboxylate core (blue, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b) for current study has been implicated in influenza endonuclease inhibitor <b>8</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as well as the FDA-approved HIV IN strand transfer inhibitor (INSTI) dolutegravir (DTG)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><b>9</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b). On the basis of the pharmacophore model of RNase H inhibitors <b>4</b>–<b>7</b>, chemotype <b>10</b> was designed for selectively inhibiting RNase H. We report herein the chemical synthesis, biochemical and antiviral evaluations, molecular modeling, and cocrystal structure of <b>10</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of active site RNase H inhibitors. (a) Major chemotypes reported as HIV RNase H active site inhibitors. All chemotypes contain a chelating triad (magenta). Scaffolds <b>4</b>–<b>7</b> also feature an aryl or biaryl moiety (cyan) connected through a methylene or amino linker. (b) Hydroxypyridone carboxylate (blue) is implicated in influenza endonuclease inhibitor <b>8</b> and HIV INSTI <b>9</b>. Active site RNase H inhibitor chemotype <b>10</b> based on the same chelating core (blue) is designed. An N-1 aryl or biaryl methyl group is included to mimick scaffolds <b>5</b>–<b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The pyridone carboxylate chelating core was constructed using a modification of a previously reported approach.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The synthesis began with a benzyl etherification of the commercially available ethyl chloroacetoacetate (<b>12</b>). The resulting ether intermediate (<b>13</b>) was subjected to a one-carbon homologation to yield enamine <b>14</b>. The subsequent Claisen condensation followed by an immediate cyclization produced the pyrone intermediate <b>15</b>. The conversion of the pyrone ring into pyridone (<b>16</b>) was effected by heating with an aromatic amine (R = aryl), which upon saponification afforded pyridonecarboxylic acid <b>17</b>. At this stage, biaryl N-1 substituents were constructed via a Suzuki coupling reaction with a para-bromopenyl substrate (<b>17</b>, R = 4-bromobenzyl). The final step of the synthesis involved a debenzylation to yield the designed analogues (<b>10a</b>–<b>z</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Hydroxylpyridinonecarboxylic Acids <b>10a</b>–<b>z</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, THF, rt, 16 h, 95% ; (b) DMF DMA, toluene, rt, 30%; (c) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 75%; (d) R-NH<sub>2</sub>, EtOH, 100 °C, 30–40 min, microwave, 40–85%; (e) 2 N NaOH, EtOH, 90 °C, 4–6 h, 65–95%; (f) ArB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME/H<sub>2</sub>O (4:1), 150 °C, 30–40 min, microwave, 60–80%; (g) TFA, 80 °C, 20 min, microwave, 40–87%.</p></p></figure><div class="NLM_p">Additional carboxylate derivatives were prepared to provide preliminary structure–activity relationship (SAR) data (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Direct debenzylation of pyridonecarboxylate <b>16d</b> provided an ester analogue (<b>18</b>), and a carboxamide analogue (<b>20</b>) was prepared from <b>16d</b> via amination and debenzylation. A structurally more elaborate <i>N</i>-benzyl substituted carboxamide (<b>22</b>) was synthesized via a three-step sequence involving saponification, amide coupling, and debenzylation.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Hydroxylpyridinonecarboxylate Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 7 N NH<sub>3</sub>/ MeOH, rt, 48 h, 70%; (b) TFA, 80 °C, 20 min, microwave, 65—78%; (c) 2 N NaOH, EtOH, 90 °C, 4 h, 87%; (d) benzylamine, HATU, DIPEA, DMF, rt, 12 h, 72%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biology</h3><div class="NLM_p">All compounds were evaluated biochemically for inhibition in HIV RT RNase H and polymerase assays. Selected compounds were also tested in an HIV IN strand transfer assay. Antiviral screening was conducted using a HIV-1 single replication cycle assay.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> RNase H Inhibition</h4><div class="NLM_p">Inhibition of RT-associated RNase H inhibitory activity was evaluated in a biochemical assay<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> using three different oligonucleotide duplexes as substrates to probe three distinct modes of RNase H cleavages: HTS-1 for internal cleavages which likely represent the primary mode of RNase H cleavage; HTS-2 for the DNA 3′ end-directed cleavages allowing specific RNA cuts 17—18 nucleotides downstream from the polymerase active site; and HTS-3 for the RNA 5′ end-directed cleavages of recessed RNA templates. Assay results are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Most of the hydroxypyridone carboxylate analogues inhibited the internal cleavage (HTS-1) by RNase H in the low micromolar to submicromolar range (IC<sub>50</sub> = 0.65–18 μM), with some exceptions (<b>10a</b>–<b>c</b>, <b>10n</b>–<b>p</b>). Second, analogues bearing a two-ring (<b>10r</b>–<b>t</b>) or a biaryl (<b>10r</b>–<b>z</b>) substituent at N-1 position demonstrated significantly more potent inhibition (IC<sub>50</sub> = 0.65–7.7 μM) than those with a single-ring substituent (<b>10b</b>–<b>p</b>, IC<sub>50</sub> = 12 to >25 μM), with <b>10q</b> being the sole exception. N-1 unsubstituted (<b>10a</b>) and phenyl substituted (<b>10b</b>) analogues were both inactive. These observations strongly corroborate the pharmacophore model that an aryl or biaryl ring separated from the chelating core with a one-atom linker is required for RNase H inhibition and that the biaryl confers better inhibition than the aryl (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a, <b>5</b>–<b>7</b>). Third the two submicromolar inhibitors, <b>10x</b> and <b>10y</b>, both have H-bond acceptors and/or donors at the terminus of the biaryl substituent, suggesting interaction of the biaryl with the nucleic acid substrate.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Assay Results of N Substituted Pyridonecarboxylic Acid Analogues (<b>10</b>) against HIV RT</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub>: concentration of a compound producing 50% inhibition, expressed as the mean ± standard deviation from at least three independent experiments.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Substrate that measures internal cleavage.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Substrate that measures DNA 3′ end directed cleavage.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Substrate that measures RNA 5′ end directed cleavage.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Reconstituted HIV RNase H domain.</p></div></div><div></div></div><div class="NLM_p">The broadest range of inhibition across all compounds was noted with the HTS-1 substrate, which is not surprising since this substrate was designed to enable highly sensitive detection of inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> No inhibition was observed using the more rigorous substrates HTS-2 or HTS-3 for analogues with a single ring N-1 substituent (<b>10b</b>–<b>p</b>). For analogues with a two-ring N-1 substituent, the same substrate bias was observed with compounds <b>10r</b>–<b>u</b> and <b>10z</b>, whereas others (<b>10v</b>–<b>y</b>) showed nearly equal inhibition with all three substrates.</div><div class="NLM_p">In addition, the biochemical assessment of RNase H inhibition was also carried out with a catalytically active RNase H domain fragment (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, RNase H Ffragment). Nearly all analogues inhibited the RNase H fragment in the low micromolar range. The data with this fragment confirmed that biaryl substitution confers better inhibition than aryl.</div><div class="NLM_p last">Our SAR analysis was expanded by exploring the importance of the carboxylate functional group by synthesizing analogues of <b>10d</b>: the ester <b>18</b>, the carboxamide <b>20</b>, and the 2,4-difluorobenzylcarboxamide <b>22</b>. The biochemical assay results showed that esterification abrogated inhibitory activity (compound <b>18</b>), whereas the inhibitory activity was preserved with carboxamide modification (<b>20</b> and <b>22</b>). Importantly, the 2,4-difluorobenzylcarboxamide <b>22</b> provided significantly better inhibition of RT polymerase and RNase H activities compared to the parent carboxylic acid <b>10d</b>. This same modification may also provide integrase inhibition, leading to multitarget efficacy in a single compound.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Polymerase Inhibition</h4><div class="NLM_p last">All compounds were evaluated for inhibition of RT RNA-dependent DNA polymerase activity. A sharp SAR trend was noted in which the N-1 unsubstituted analogue <b>10a</b> and all one-ring substituted analogues (<b>10b</b>–<b>q</b>) showed no inhibitory activity (at concentrations up to 25 μM) whereas most two-ring substituted analogues (<b>10r</b>–<b>t</b> and <b>10v</b>–<b>y)</b> inhibited RT pol with potencies nearly equal to RNase H inhibition. Although the mechanism of this polymerase inhibition remains unclear, we speculate that these inhibitors may block the polymerase active site metal-binding triad to prevent facile catalysis of nucleotide incorporation.</div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Order-of-Addition RNase H inhibition Assays</h4><div class="NLM_p">To determine whether lead analogues retain inhibitory activity when added after the RNA/DNA substrate, we performed order-of-addition assays to examine the effect of various preincubation conditions on RT-associated RNase H inhibition. We tested six of the most potent inhibitors of RT-associated RNase H using β-thujaplicinol for comparison under conditions similar to those run for the in vitro RNase H inhibition assays in which the RNA/DNA substrate is in excess of the RT (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Generally, the inhibitors are most potent against RNase H activity when they are added to RT before the RNA/DNA substrate (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). When the RT/substrate complex is formed before addition of compound, the inhibitor potency is decreased in all cases, including the previously published β-thujaplicinol.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Under these conditions, analogue <b>10x</b> is the most potent of the inhibitors against cleavage of the preformed RT/substrate complex (>50% inhibition), suggesting it can compete with the substrate for binding to RT.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Order-of-Addition RNase H Inhibition Assay Results</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">% inhibition</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">(1) preincubation (10 min at 37 °C)</th><th class="colsep0 rowsep0" align="center">RT + inhibitor</th><th class="colsep0 rowsep0" align="center">RT + MgCl<sub>2</sub> + inhibitor</th><th class="colsep0 rowsep0" align="center">RT + inhibitor + HTS-1</th><th class="colsep0 rowsep0" align="center">RT + HTS-1</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">(2) reaction initiation (10 min at 37 °C)</th><th class="colsep0 rowsep0" align="center">HTS-1 + MgCl<sub>2</sub></th><th class="colsep0 rowsep0" align="center">HTS-1</th><th class="colsep0 rowsep0" align="center">MgCl<sub>2</sub></th><th class="colsep0 rowsep0" align="center">inhibitor + MgCl<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10q</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">69 ± 5<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">52 ± 17</td><td class="colsep0 rowsep0" align="left">27 ± 4</td><td class="colsep0 rowsep0" align="left">21 ± 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10r</b></td><td class="colsep0 rowsep0" align="left">58 ± 0</td><td class="colsep0 rowsep0" align="left">51 ± 7</td><td class="colsep0 rowsep0" align="left">35 ± 3</td><td class="colsep0 rowsep0" align="left">28 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10t</b></td><td class="colsep0 rowsep0" align="left">75 ± 5</td><td class="colsep0 rowsep0" align="left">84 ± 1</td><td class="colsep0 rowsep0" align="left">38 ± 2</td><td class="colsep0 rowsep0" align="left">18 ± 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10v</b></td><td class="colsep0 rowsep0" align="left">68 ± 9</td><td class="colsep0 rowsep0" align="left">36 ± 12</td><td class="colsep0 rowsep0" align="left">37 ± 7</td><td class="colsep0 rowsep0" align="left">21 ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10x</b></td><td class="colsep0 rowsep0" align="left">95 ± 1</td><td class="colsep0 rowsep0" align="left">68 ± 10</td><td class="colsep0 rowsep0" align="left">66 ± 8</td><td class="colsep0 rowsep0" align="left">50 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10y</b></td><td class="colsep0 rowsep0" align="left">97 ± 1</td><td class="colsep0 rowsep0" align="left">79 ± 9</td><td class="colsep0 rowsep0" align="left">68 ± 6</td><td class="colsep0 rowsep0" align="left">14 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-thujaplicinol</td><td class="colsep0 rowsep0" align="left">100 ± 1</td><td class="colsep0 rowsep0" align="left">99 ± 1</td><td class="colsep0 rowsep0" align="left">79 ± 8</td><td class="colsep0 rowsep0" align="left">12 ± 4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Final reaction conditions: 100 nM HIV RT, 250 nM HTS-1, 6 mM MgCl<sub>2</sub>, 30 μM inhibitor.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Values are reported as the mean ± standard deviation from two independent experiments.</p></div></div></div><div class="NLM_p">When these assays were carried out using RT in excess of the RNA/DNA substrate, which more closely resembles actual conditions in the virion, generally the analogues more efficiently maintain effective inhibition against the preformed RT/substrate complex. Under conditions of excess RT compared to RNA/DNA substrate, <b>10y</b> is the most potent inhibitor of the RT/substrate complex, as it blocks 80% of the RT-asociated RNase H activity (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Order-of-Addition RNase H Inhibition Assay Results in the Presence of Excess RT</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">% inhibition</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">(1) preincubation (10 min at 37 °C)</th><th class="colsep0 rowsep0" align="center">RT + inhibitor</th><th class="colsep0 rowsep0" align="center">RT + HTS-1</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">(2) reaction initiation (2 min at 37 °C)</th><th class="colsep0 rowsep0" align="center">HTS-1 + MgCl<sub>2</sub></th><th class="colsep0 rowsep0" align="center">inhibitor + MgCl<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10q</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">70 ± 9<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">58 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10r</b></td><td class="colsep0 rowsep0" align="left">82 ± 1</td><td class="colsep0 rowsep0" align="left">61 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10t</b></td><td class="colsep0 rowsep0" align="left">42 ± 1</td><td class="colsep0 rowsep0" align="left">15 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10v</b></td><td class="colsep0 rowsep0" align="left">78 ± 2</td><td class="colsep0 rowsep0" align="left">59 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10x</b></td><td class="colsep0 rowsep0" align="left">91 ± 0</td><td class="colsep0 rowsep0" align="left">74 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10y</b></td><td class="colsep0 rowsep0" align="left">92 ± 1</td><td class="colsep0 rowsep0" align="left">80 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-thujaplicinol</td><td class="colsep0 rowsep0" align="left">100 ± 0</td><td class="colsep0 rowsep0" align="left">98 ± 4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Final reaction conditions: 300 nM HIV RT, 50 nM HTS-1, 0.5 mM EDTA, 6 mM MgCl<sub>2</sub>, 30 μM inhibitor.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Values are reported as the mean ± standard deviation from two independent experiments.</p></div></div></div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> HIV Integrase Strand Transfer Inhibition</h4><div class="NLM_p">HIV IN and RNase H share similar active site configurations; thus inhibitors of these enzymatic functions entail overlapping pharmacophore features. Selective inhibition of RNase H over INST is therefore particularly important in RNase H inhibitor discovery. To assess the selectivity profile of the new pyridone chemotype, all analogues were tested for INST activity (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison of Biochemical Inhibition against RT RNase H, RT pol, and INST</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">RT RNase H IC<sub>50</sub> <a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>(μM)</th><th class="colsep0 rowsep0" align="center">RT Pol IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">IN IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">16 ± 4.5</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">17 ± 5.2</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">13 ± 2.1</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10i</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10j</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10k</b></td><td class="colsep0 rowsep0" align="left">18 ± 2.8</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">44.5 ± 18.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10l</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10m</b></td><td class="colsep0 rowsep0" align="left">18 ± 4.5</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10n</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10o</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10p</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10q</b></td><td class="colsep0 rowsep0" align="left">2.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10r</b></td><td class="colsep0 rowsep0" align="left">2.7 ± 0.6</td><td class="colsep0 rowsep0" align="left">8.5 ± 1.5</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10s</b></td><td class="colsep0 rowsep0" align="left">7.0 ± 0.7</td><td class="colsep0 rowsep0" align="left">19 ± 5.5</td><td class="colsep0 rowsep0" align="left">2.26 ± 0.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10t</b></td><td class="colsep0 rowsep0" align="left">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10u</b></td><td class="colsep0 rowsep0" align="left">7.7 ± 2.4</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10v</b></td><td class="colsep0 rowsep0" align="left">2.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10w</b></td><td class="colsep0 rowsep0" align="left">3.2 ± 0.3</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.8</td><td class="colsep0 rowsep0" align="left">7.79 ± 1.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10x</b></td><td class="colsep0 rowsep0" align="left">0.90 ± 0.05</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">16.0 ± 6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10y</b></td><td class="colsep0 rowsep0" align="left">0.65 ± 0.05</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10z</b></td><td class="colsep0 rowsep0" align="left">3.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">35.0 ± 10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">12 ± 1.8</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">7.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data with HTS-1 as substrate.</p></div></div></div><div class="NLM_p last">While most of the compounds showed some INST inhibitory activity, this inhibitory activity was much weaker (14 μM to >100 μM) than that provided against RT RNase H, suggesting that the hydroxypyridone carboxylate core represents an interesting chemotype for future development of specific inhibitors of HIV RNase H.</div></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Antiviral Assay</h4><div class="NLM_p">All compounds were screened in a previously reported single replication cycle antiviral assay<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> to gauge their ability in inhibiting HIV replication in cell culture. Although most compounds did not inhibit HIV-1 replication in this assay, analogue <b>10r</b> inhibited HIV-1 replication in a dose-dependent manner (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, EC<sub>50</sub> = 10 μM) without cytotoxicity at concentrations up to 25 μM (CC<sub>50</sub> > 25 μM). This is an important and exciting observation, as very few RNase H inhibitors to date have been reported to possess antiviral activity in cell-based assays.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dose–response antiviral effect of <b>10r</b> against HIV-1. Experiments were done in triplicate with each data point. The antiviral EC<sub>50</sub> is calculated to be 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Molecular Modeling</h4><div class="NLM_p">Docking analysis was performed with Glide XP (version 6.4)<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> using two metal sites as a constraint. The predicted binding mode of compound <b>10r</b> in the active site of RNase H suggests an interaction between the 4-oxo-1,4-dihydropyridinecarboxylic acid core (chelating triad) and the two active site metal cations (coordinated to essential active site residues D443, E478, D498, and D549). The hydroxyl group at 5-position of <b>10r</b> can form H-bonding interactions with H539 which would stabilize inhibitor positioning near the active site metal-chelating residues D443, E478, D498, and D549, all of which are crucial for RT-RNase H activity. The flexible methylene linker at N1 position of the pyridone core induces a conformational flexibility in the inhibitor that allows π-stacking interaction between the naphthalene ring of the ligand and RNase H residues H539 and A538 and L560. This interaction may limit the conformational flexibility of the loop with H539 and thus impact on efficiency of RNase H catalytic activity. Notably, a similar binding mode was observed for RT complexes with dsDNA or RNA–DNA hybrids as reported by Harrison et.al<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and Sarafianos et.al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The predicted binding mode of <b>10r</b> is shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a within the active site of RNase H. Compound <b>10y</b> was predicted to bind in an identical fashion to that of <b>10r</b>. Compounds <b>10r</b> and <b>10y</b> were observed to overlay with the pyrimidinolcarboxylic acid core (<b>5</b>) and mimic the interactions within the RNaseH to a greater extent as depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Molecular modeling of analogues <b>10r</b> and <b>10y</b> at the RNase H active site and comparison to crystal structure of the HIV RNase H domain in complex with pyrimidinol carboxylic acid. (a) Predicted binding mode of <b>10r</b> within active site of RNase H (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HYF">3HYF</a>). Active site residues are highlighted in green sticks with metal ions as spheres. Some chelating and H-bond interactions are depicted as black dotted lines. (b) Overlay of <b>10r</b> (yellow) on the crystal structure of RNase H with pyrimidinol carboxylic acid (magenta). (c) Overlay of <b>10y</b> (yellow) on the crystal structure of RNase H with pyrimidinolcarboxylic acid (magenta).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Crystal Structure of HIV RT in Complex with <b>10y</b></h4><div class="NLM_p">In order to further understand the molecular details of HIV RT-associated RNase H inhibition by hydroxypyridone carboxylate analogues, we solved the crystal structure of HIV RT in complex with the most potent RNase H inhibitor from the in vitro assays, <b>10y</b>, at 2.9 Å resolution. The asymmetric unit comprises two RT molecules and therefore two distinct RNase H active sites. Analogue <b>10y</b> is only observed at one RT active site in the asymmetric unit, most likely due to partial occlusion of one RNase H active site by the fingers subdomain of the second RT molecule. Unlike other RT/RNase H active-site-directed inhibitor complex structures,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> the RT/<b>10y</b> complex was crystallized without a non-nucleoside RT inhibitor (NNRTI), leaving the positions of the two p66 thumb domains in a closed conformation, similar to other reported unliganded RT structures.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34">(30-34)</a></div><div class="NLM_p">In the occupied RNase H active site, two Mg<sup>2+</sup> ions are bound by conserved active site residues D443, E478, D498, and D549. Analogue <b>10y</b> chelates both Mg<sup>2+</sup> ions through the carboxylate, carbonyl, and hydroxyl groups of the pyrimidone (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) in a manner similar to that of a previously reported RT/pyrimidinol carboxylic acid inhibitor.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><b>10y</b> interacts directly with RT through interactions between the hydroxyl group of the pyridone and H539, and the sulfonamide group of the N-1 substituted biaryl moiety with K540 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). These additional interactions with the RT enzyme likely provide increased stability to the RT/<b>10y</b> complex and may potentially explain the potent RNase H inhibition observed for <b>10y</b> in the in vitro assays (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of HIV RT in complex with analogue <b>10y</b>. Cross-eyed stereoview of <b>10y</b> (cyan) bound at the RNase H active site of HIV RT. The RNase H domain of RT is shown in orange, the p51 in light gray. Conserved active site residues are shown as sticks, and Mg<sup>2+</sup> ions are shown as magenta spheres. Chelating and H-bond interactions are indicated by dashed lines. Cartoon was prepared by PyMOL,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and crystallographic coordinates have been submitted to the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J1E">5J1E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compared to other analgoues, <b>10y</b> was found to be the most potent inhibitor of RT-associated RNase H inihibiton. Structural insights suggest that the length provided by the N-1 substituted biaryl moiety could be important for RNase H inhibition, since many of the shorter phenyl-substituted analogues (<b>10b</b>–<b>q</b>) were less potent. It also appears that charge may also contribute to potent inhibition, as other biaryl-substituted compounds without charged groups (such as <b>10w</b>) were less effective inhibitors of RNase H activity. Furthermore, para substitution of the biaryl moiety relative to the pyridone ring seems to position the biaryl group in a favorable position to have potential interactions with RT, which may not be achievable with ortho-substituted analogues such as <b>10u</b> and may explain this analogue’s decreased potency.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">New hydroxypyridone carboxylate analogues featuring an N-1 benzyl or biarylmethyl moiety were designed and synthesized as potential inhibitors of HIV RT associated RNase H. In vitro biochemical assays showed that analogues with a two-ring substituent at N-1 are significantly more potent than those with a one-ring substituent against all three modes of RNase H cuts as well as the RT polymerase function. While some analogues also inhibited strand transfer activity of HIV IN, this inhibition was substantially less than that for RT RNase H inhibition, suggesting that the pyridone chemotype may represent an interesting scaffold for development of RNase H-specific inhibitors. Importantly, compound <b>10r</b> exhibited significant inhibitory activity in a cell-based antiviral assay with an EC<sub>50</sub> of 10 μM. Molecular docking of <b>10r</b> and the crystal structure of RT/<b>10y</b> corroborate for hydroxypyridone carboxylate analogues a mechanism of active site binding for RNase H inhibition. The mechanism of the observed polymerase inhibition remains unclear. These results indicate that the hydroxypyridone carboxylate chemotype previously implicated in the inhibition of INST and influenza endonuclease can be valuable in the discovery of HIV antivirals targeting the RT-associated RNase H.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry. General Procedures</h3><div class="NLM_p last">All commercial chemicals were used as supplied unless otherwise indicated. Flash chromatography was performed on a Teledyne Combiflash RF-200 with RediSep columns (silica) and indicated mobile phase. All moisture sensitive reactions were performed under an inert atmosphere of ultrapure argon with oven-dried glassware. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian 600 MHz spectrometer. Mass data were acquired on an Agilent TOF II TOS/MS spectrometer capable of ESI and APCI ion sources. Analysis of sample purity was performed on a Varian Prepstar SD-1 HPLC system with a Phenomenex Gemini, 5 μm C18 column (250 mm × 4.6 mm). HPLC conditions: solvent A = H<sub>2</sub>O, solvent B = MeCN; flow rate = 1.0 mL/min; compounds were eluted with a gradient of 5% MeCN/H<sub>2</sub>O for 0–5 min and to 95% MeCN/H<sub>2</sub>O from 5 to 30 min followed by 100% MeCN from 35 to 40 min. Purity was determined by total absorbance at 254 nm. All tested compounds have a purity ≥98%.</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Ethyl-4-(benzyloxy)-3-oxobutanoate (<b>13</b>)</h3><div class="NLM_p last">To a suspension of 60% NaH (66.83 mmol, 2.2 equiv) in THF (20 mL) at 0 °C was added benzyl alcohol (30.37 mmol, 1.05 equiv), and the resulting mixture was stirred at rt for 2 h. To this mixture was then added ethyl 4-chloroacetoacetate (30.37 mmol, 1.0 equiv) dropwise over 30 min, and the resulting clear yellow solution was stirred at rt overnight before it was cooled to 5 °C, acidified to pH = 4 using 5% HCl and extracted with the EtOAc (2 × 25 mL). The combined organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to yield the desired product (<b>13</b>) as orange oil. The crude material was used for next step without further purification. Yield: 95% (6.8 g). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.40–7.28 (m, 5H), 4.59 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 4.14 (s, 2H), 3.54 (s, 2H), 1.25 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-Benzyloxy-2-(1-dimethylaminomethylidene)-3-oxobutyric Acid Ethyl Ester (<b>14</b>)</h3><div class="NLM_p last">To a solution of <b>13</b> (28.36 mmol, 1.0 equiv) in toluene (30 mL) was added DMF DMA (42.54 mmol, 1.5 equiv), and the resulting mixture was stirred at rt for 12 h. The reaction mixture was quenched by adding water and was acidified (pH = 4) using 5% HCl. The aqueous solution was extracted using EtOAc (2 × 20 mL). The combined organics were washed with NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude mixture was purified using CombiFlash with eluent starting from hexane/EtOAc (4:1) to hexane/EtOAc (1:1) to yield the desired product (<b>14</b>) as yellow oil. Yield: 30% (2.45 g). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.67 (s, 1H), 7.38–7.30 (m, 4H), 7.28 (t, <i>J</i> = 6.8 Hz, 1H), 4.45 (s, 2H), 4.30 (s, 2H), 4.06 (q, <i>J</i> = 7.1 Hz, 2H), 3.24 (brs, 3H), 2.73 (brs, 3H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Method for the Synthesis of Pyrone. Ethyl-5-(benzyloxy)-4-oxo-4<i>H</i>-pyran-3-carboxylate (<b>15</b>)</h3><div class="NLM_p last">To a suspension of potassium <i>tert</i>-butoxide (1 M in THF; 15.79 mmol, 2.0 equiv) in THF (14 mL) was added ethyl formate (33.8 mmol, 4.3 equiv), and the mixture was stirred at rt for 30 min before compound <b>13</b> (7.89 mmol, 1.0 equiv) in THF (14 mL) was added dropwise over 10 min. The resulting mixture was stirred at rt for 8 h and quenched by adding 2 N HCl (12 mL). After extraction with the EtOAc (2 × 20 mL), the combined organics were washed with NaHCO<sub>3</sub> (2 × 10 mL), water (30 mL), brine (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to leave brownish yellow oil. This crude product was triturated by adding hexanes to yield the desired product (<b>15</b>) as brown solid. Yield: 75% (1.62 g). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (d, <i>J</i> = 0.8 Hz, 1H), 8.30 (d, <i>J</i> = 0.8 Hz, 1H), 7.49–7.33 (m, 5H), 4.95 (s, 2H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 1.25 (t, <i>J</i> = 7.1, 3H).</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Method for the Synthesis of 4-Oxodihydropyridine Esters (<b>16a</b>–<b>s</b>)</h3><div class="NLM_p last">To a solution of <b>15</b> (1.0 equiv) in EtOH (5 mL) was added amine (2.0 equiv), and the resulting mixture was heated at 100 °C for 40 min under microwave conditions. After the solvent was removed in vacuo the residue was purified using CombiFlash to produce the crude product as colorless oil which was triturated with hexanes/EtOAc to yield the titled compound as colorless solid (<b>16a</b>–<b>s</b>).</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Ethyl-1-benzhydryl-5-(benzyloxy)-4-oxo-1,4-dihydropyridine-3-carboxylate (<b>16a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (d, <i>J</i> = 1.8 Hz, 1H), 7.48–7.40 (m, 6H), 7.36–7.31 (m, 3H), 7.29–7.26 (m, 3H), 7.11 (d, <i>J</i> = 7.0 Hz, 4H), 6.92 (s, 1H), 4.93 (s, 2H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 1.19 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for Saponification: <b>17a</b>–<b>s</b></h3><div class="NLM_p last">To a solution of <b>16</b> (1.0 equiv) in EtOH (5 mL) was added 2 N NaOH (10 mL). The resulting mixture was heated at 90 °C for 6 h and was then cooled to rt and concentrated in vacuo. The resulting solution was acidified (pH = 3) using 2 N HCl. The precipitate was collected via filtration, washed with water, and then dried to obtain the titled compound as colorless solid (<b>17)</b>.</div></div><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-Benzhydryl-5-(benzyloxy)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>17a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 1H), 7.48 (s,1H), 7.42–7.39 (m, 6H), 7.27–7.26 (m, 5H), 7.06 (d, <i>J</i> = 3.9 Hz, 4H), 6.92 (s, 1H), 5.05 (s, 2H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure for Suzuki Coupling (<b>17w</b>–<b>z</b>)</h3><div class="NLM_p last">The mixture of <b>17l</b> (1.0 equiv), boronic acid (1.6 equiv), Pd (PPh<sub>3</sub>)<sub>4</sub> (0.065 equiv), K<sub>2</sub>CO<sub>3</sub> (3.6 equiv) in DME/H<sub>2</sub>O (4:1) was irradiated at 150 °C for 30 min under microwave conditions. The black residue formed was filtered through Celite, and the solvent was concentrated in vacuo. The resulting aqueous solution was acidified (pH = 3) using 2 N HCl. A white precipitate was obtained via filtration, washed with water, and dried under vacuum to furnish the desired compound as colorless solid (<b>17w</b>–<b>z</b>).</div></div><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-((4′-(Aminomethyl)-[1,1′-biphenyl]-4-yl)methyl)-5-(benzyloxy)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>17w</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.79 (s, 1H), 8.18 (s, 1H), 7.67 (d, <i>J</i> = 7.8 Hz, 2H), 7.75–7.60 (m, 4H), 7.52–7.35 (m, 4H), 7.35–7.17 (m, 5H), 5.41 (s, 2H), 5.11 (s, 2H), 4.08 (s, 2H).</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-(Benzyloxy)-1-(4-fluorobenzyl)-4-oxo-1,4-dihydropyridine-3-carboxamide (<b>19</b>)</h3><div class="NLM_p last">To a solution of <b>16d</b> (90 mg) in methanol was added NH<sub>3</sub> in MeOH (7 N, 4 mL), and the resulting solution was stirred at rt for 48 h. A white precipitate was collected via filtration, washed with methanol, and then dried under high vacuum to yield the carboxamide as colorless solid (<b>19</b>). Yield: 70%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.47 (s, 1H), 8.52 (s, 3H), 7.81 (s, 1H), 7.44 (s, 1H), 7.35 (m, 7H), 7.24–7.15 (m, 2H), 5.22 (s, 2H), 5.00 (s, 2H).</div></div><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure for Amide Coupling. 5-(Benzyloxy)-<i>N</i>-(2, 4-difluorobenzyl)-1-(4-fluorobenzyl)-4-oxo-1, 4-dihydropyridine-3-carboxamide (<b>21</b>)</h3><div class="NLM_p last">To a mixture of <b>17d</b> (1.0 equiv) in DMF (5 mL) were added HATU (1.2 equiv), DIPEA (1.2 equiv), amine (1.2 equiv), and the resulting reaction mixture was stirred at rt for 12 h. The reaction was quenched with water and extracted with the EtOAc (2 x20 mL). The combined organics were washed with 1 N HCl (2 × 10 mL), NaHCO<sub>3</sub> (2 × 10 mL), water (30 mL), brine (30 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo to produce the crude product as yellow solid which was purified using CombiFlash with 0–100% EtOAc as an eluent to furnish the titled compound as colorless solid (<b>21</b>). Yield: 72%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (t, <i>J</i> = 5.8 Hz, 1H), 8.57 (d, <i>J</i> = 1.7 Hz, 1H), 7.87 (d, <i>J</i> = 1.7 Hz, 1H), 7.37 (m, 7H), 7.22 (m, 4H), 7.05 (dd, <i>J</i> = 8.4, 6.4 Hz, 1H), 5.26 (s, 2H), 5.02 (s, 2H), 4.51 (d, <i>J</i> = 5.8 Hz, 2H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for O-Debenzylation: <b>10a</b>–<b>z</b>, <b>18</b>, <b>20</b>, <b>22</b></h3><div class="NLM_p last">A mixture of <b>17</b> (1.0 equiv) in TFA (2 mL) was irradiated at 80 °C for 20 min under microwave conditions. The solvent was removed in vacuo to produce the crude product as pale yellow solid which was triturated in methanol and ether to produce the titled compound as colorless solid (<b>10a</b>–<b>z</b>, <b>18</b>, <b>20</b>, <b>22</b>).</div></div><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-Hydroxy-4-oxo-1, 4-dihydropyridine-3-carboxylic Acid (<b>10a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.74 (s, 1H), 9.84 (s, 1H), 8.31 (s, 1H), 7.69 (s, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.8, 166.6, 148.1, 137.0, 122.4, 113.3. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>6</sub>H<sub>4</sub>NO<sub>4</sub> 154.0146 [M – H]<sup>−</sup>, found 154.0148.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-Hydroxy-4-oxo-1-phenyl-1,4-dihydropyridine-3-carboxylic Acid (<b>10b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): 10.22 (s, 1H), 8.46 (d, <i>J</i> = 2.3 Hz, 1H), 8.05 (d, <i>J</i> = 2.3 Hz, 1H), 7.74–7.68 (m, 2H), 7.63–7.52 (m, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.8, 166.0, 148.8, 142.9, 139.6, 130.3, 129.6, 125.8, 123.9, 113.8. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>8</sub>NO<sub>4</sub> 230.0459 [M – H]<sup>−</sup>, found 230.0468.</div></div><div id="sec4_1_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-Benzyl-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.67 (d, <i>J</i> = 2.0 Hz, 1H), 7.83 (d, <i>J</i> = 2.0 Hz, 1H), 7.51–7.31 (m, 5H), 5.35 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 165.0, 148.3, 139.9, 135.4, 128.8, 128.4, 127.9, 125.5, 113.0, 59.8. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>10</sub>NO<sub>4</sub> 244.0615 [M – H]<sup>−</sup>, found 244.0627.</div></div><div id="sec4_1_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(4-Fluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): 10.06 (s, 1H), 8.68 (d, <i>J</i> = 2.0 Hz, 1H), 7.84 (d, <i>J</i> = 2.0 Hz, 1H), 7.51 (dd, <i>J</i> = 8.5, 5.5 Hz, 2H), 7.45 (t, <i>J</i> = 8.8 Hz, 2H), 5.33 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.3, 166.3, 148.9, 140.6, 132.2, 130.7, 116.5, 115.8, 115.6, 113.5, 59.5. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>9</sub>FNO<sub>4</sub> 262.0521 [M – H]<sup>−</sup>, found 262.0531.</div></div><div id="sec4_1_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(1-(4-Fluorophenyl)ethyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10e</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.05 (s, 1H), 8.64 (d, <i>J</i> = 2.2 Hz, 1H), 7.83 (d, <i>J</i> = 2.2 Hz, 1H), 7.61–7.51 (m, 2H), 7.35–7.08 (m, 2H), 5.78 (q, <i>J</i> = 7.1 Hz, 1H), 1.86 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.1, 166.1, 163.0, 148.9, 138.9, 135.3, 129.5, 123.6, 116.1, 113.3, 64.9, 19.3. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>11</sub>FNO<sub>4</sub> 276.0678 [M – H]<sup>−</sup>, found 276.0682.</div></div><div id="sec4_1_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(4-Fluoro-3-methylbenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.66 (d, <i>J</i> = 2.1 Hz, 1H), 7.82 (d, <i>J</i> = 2.1 Hz, 1H), 7.39 (dd, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.34 (m, 1H), 7.21 (m, 1H), 5.29 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.1, 166.2, 161.8, 160.2, 148.7, 140.2, 131.9, 131.6, 128.2, 127.9, 125.2, 113.3, 59.5, 14.2. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>11</sub>FNO<sub>4</sub> 276.0678 [M – H]<sup>−</sup>, found 276.0687.</div></div><div id="sec4_1_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(2,4-Difluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10g</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.11 (s, 1H), 8.60 (d, <i>J</i> = 1.7 Hz, 1H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H), 7.57 (dd, <i>J</i> = 15.2, 8.6 Hz, 1H), 7.41–7.31 (m, 1H), 7.17 (td, <i>J</i> = 8.5, 2.2 Hz, 1H), 5.42 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.2, 166.1, 161.5, 160.1, 148.7, 140.6, 140.4, 132.3, 125.6, 119.2, 113.3, 112.4, 104.6, 54.2. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>8</sub>F<sub>2</sub>NO<sub>4</sub> 280.0427 [M – H]<sup>−</sup>, found 280.0425.</div></div><div id="sec4_1_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(4-Chlorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10h</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): 10.08 (s, 1H), 8.69 (d, <i>J</i> = 1.8 Hz, 1H), 7.83 (d, <i>J</i> = 1.8 Hz, 1H), 7.48 (d, <i>J</i> = 8.5 Hz, 2H), 7.45 (d, <i>J</i> = 8.5 Hz, 2H), 5.34 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.5, 166.5, 149.1, 140.6, 135.1, 133.8, 130.5, 129.4, 126.0, 113.7, 59.6. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>9</sub>ClNO<sub>4</sub> 278.0226 [M – H]<sup>−</sup>, found 278.0222.</div></div><div id="sec4_1_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(3,4-Dichlorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10i</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, dmso): 10.08 (s, 1H), 8.72 (s, 1H), 7.87 (s, 1H), 7.81 (d, <i>J</i> = 8.5 Hz, 2H), 7.68 (s, 1H), 7.43 (d, <i>J</i> = 8.5 Hz, 2H), 5.33 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.6, 166.5, 149.1, 140.9, 140.7, 137.0, 131.9, 131.6, 131.0, 128.9, 126.0, 113.8, 59.1. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>8</sub>Cl<sub>2</sub>NO<sub>4</sub> 311.9836 [M – H]<sup>−</sup>, found 311.9843.</div></div><div id="sec4_1_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(2,4-Dichlorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10j</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): 10.12 (s, 1H), 8.58 (d, <i>J</i> = 2.1 Hz, 1H), 7.74 (d, <i>J</i> = 2.2 Hz, 1H), 7.50 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 5.47 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.7, 166.4, 149.0, 141.2, 134.7, 134.1, 132.7, 131.8, 129.8, 128.6, 126.2, 113.7, 57.8. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>8</sub>Cl<sub>2</sub>NO<sub>4</sub> 311.9836 [M – H]<sup>−</sup>, found 311.9844.</div></div><div id="sec4_1_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(3-Chloro-4-fluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10k</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.07 (s, 1H), 8.72 (s, 1H), 7.87 (s, 1H), 7.80 (d, <i>J</i> = 6.5 Hz, 1H), 7.49–7.45 (m, 2H), 5.31 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 165.9, 158.0, 148.5, 140.1, 133.3, 130.7, 129.2, 125.3, 119.8, 117.4, 113.2, 58.5. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>8</sub>ClFNO<sub>4</sub> 296.0131 [M – H]<sup>−</sup>, found 296.0134.</div></div><div id="sec4_1_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(4-Bromobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10l</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.09 (s, 1H), 8.68 (d, <i>J</i> = 1.5 Hz, 1H), 7.83 (d, <i>J</i> = 1.5 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.38 (d, <i>J</i> = 8.3 Hz, 2H), 5.33 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 165.9, 148.5, 140.9, 131.8, 130.2, 125.5, 121.9, 113.1, 59.1. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>9</sub>BrNO<sub>4</sub> 321.9720 [M – H]<sup>−</sup>, found 321.9727.</div></div><div id="sec4_1_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-Hydroxy-4-oxo-1-(3-(trifluoromethyl)benzyl)-1,4-dihydropyridine-3-carboxylic Acid (<b>10m</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.09 (s, 1H), 8.75 (d, <i>J</i> = 2.1 Hz, 1H), 7.90–7.89 (m, 2H), 7.75 (d, <i>J</i> = 7.7 Hz, 1H), 7.72 (d, <i>J</i> = 7.8 Hz, 1H), 7.65 (t, <i>J</i> = 7.8 Hz, 1H), 5.43 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.0, 165.9, 148.5, 140.2, 136.8, 132.2, 130.0, 129.5, 125.4, 125.0, 124.9, 113.2, 59.1. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>9</sub>F<sub>3</sub>NO<sub>4</sub> 312.0489 [M – H]<sup>−</sup>, found 312.0484.</div></div><div id="sec4_1_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-Hydroxy-4-oxo-1-(pyridin-4-ylmethyl)-1,4-dihydropyridine-3-carboxylic Acid (<b>10n</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): 8.74 (d, <i>J</i> = 4.9 Hz, 2H), 8.60 (d, <i>J</i> = 2.0 Hz, 1H), 7.69 (d, <i>J</i> = 2.0 Hz, 1H), 7.64 (d, <i>J</i> = 4.9 Hz, 2H), 5.57 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>9</sub>N<sub>2</sub>O<sub>4</sub> 245.0568 [M – H]<sup>−</sup>, found 245.0570.</div></div><div id="sec4_1_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-Hydroxy-1-(4-(methylsulfonyl)benzyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10o</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.11 (s, 1H), 8.73 (d, <i>J</i> = 2.1 Hz, 1H), 7.96 (d, <i>J</i> = 8.3 Hz, 2H), 7.86 (d, <i>J</i> = 2.1 Hz, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 2H), 5.48 (s, 2H), 3.21 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.6, 166.5, 141.8, 141.3, 140.9, 129.2, 128.1, 126.1, 113.8, 87.2, 59.9, 44.4. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>12</sub>NO<sub>6</sub>S 322.0391 [M – H]<sup>−</sup>, found 322.0382.</div></div><div id="sec4_1_6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(4-Carboxybenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10p</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.04 (s, 1H), 10.09 (s, 1H), 8.69 (d, <i>J</i> = 2.0 Hz, 1H), 7.96 (d, <i>J</i> = 8.2 Hz, 2H), 7.83 (d, <i>J</i> = 2.1 Hz, 1H), 7.48 (d, <i>J</i> = 8.2 Hz, 2H), 5.44 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.2, 167.0, 166.2, 148.8, 140.5, 131.0, 130.1, 128.4, 128.0, 125.9, 113.4, 59.7. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>10</sub>NO<sub>6</sub> 288.0514 [M – H]<sup>−</sup>, found 288.0515.</div></div><div id="sec4_1_6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-Hydroxy-1-(4-methoxybenzyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10q</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.04 (s, 1H), 8.64 (d, <i>J</i> = 2.1 Hz, 1H), 7.82 (d, <i>J</i> = 2.1 Hz, 1H), 7.40 (d, <i>J</i> = 8.7 Hz, 2H), 6.96 (d, <i>J</i> = 8.7 Hz, 2H), 5.26 (s, 2H), 3.75 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.0, 166.3, 159.7, 148.6, 139.7, 130.0, 127.6, 125.7, 114.5, 113.3, 59.8, 55.4. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>12</sub>NO<sub>5</sub> 274.0721 [M – H]<sup>−</sup>, found 274.0722.</div></div><div id="sec4_1_6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-Hydroxy-1-(naphthalen-1-ylmethyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10r</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.09 (s, 1H), 8.64 (d, <i>J</i> = 1.8 Hz, 1H), 8.07 (d, <i>J</i> = 8.3 Hz, 1H), 8.02 (d, <i>J</i> = 8.3 Hz, 1H), 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.82 (d, <i>J</i> = 1.8 Hz, 1H), 7.64 (t, <i>J</i> = 7.3 Hz, 1H), 7.60 (t, <i>J</i> = 7.3 Hz, 1H), 7.56 (t, <i>J</i> = 7.6 Hz, 1H), 7.39 (d, <i>J</i> = 7.6 Hz, 1H), 5.90 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.3, 166.4, 148.8, 140.4, 133.7, 131.2, 130.7, 129.7, 129.1, 127.4, 127.3, 126.7, 126.1, 126.0, 123.2, 113.5, 58.1. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>12</sub>NO<sub>4</sub> 294.0772 [M – H]<sup>−</sup>, found 294.0776.</div></div><div id="sec4_1_6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-Hydroxy-1-(1-(naphthalen-1-yl)ethyl)-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10s</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.06 (s, 1H), 8.58 (d, <i>J</i> = 1.8 Hz, 1H), 8.05 (d, <i>J</i> = 8.2 Hz, 1H), 8.01 (dd, <i>J</i> = 8.0, 4.0 Hz, 2H), 7.86 (d, <i>J</i> = 7.1 Hz, 1H), 7.82 (d, <i>J</i> = 1.8 Hz, 1H), 7.66 (dd, <i>J</i> = 16.0, 8.3 Hz, 1H), 7.58 (dt, <i>J</i> = 14.7, 6.9 Hz, 2H), 6.59 (q, <i>J</i> = 6.8 Hz, 1H), 1.98 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.2, 166.4, 149.0, 138.4, 133.9, 133.0, 130.7, 130.4, 129.4), 127.6, 126.6, 126.1, 125.8, 124.3, 122.8, 113.6, 62.1, 20.7. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>14</sub>NO<sub>4</sub> 308.0928 [M – H], found 308.0936.</div></div><div id="sec4_1_6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-Hydroxy-4-oxo-1-((1-phenylcyclopentyl)methyl)-1,4-dihydropyridine-3-carboxylic Acid (<b>10t</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.82 (s, 2H), 7.70 (s, 2H), 7.29 (t, <i>J</i> = 7.3 Hz, 5H), 7.21 (dd, <i>J</i> = 15.2, 7.4 Hz, 7H), 7.09 (s, 2H), 4.32 (s, 5H), 1.94 (d, <i>J</i> = 5.1 Hz, 8H), 1.81 (s, 5H), 1.58 (s, 4H). HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>18</sub>NO<sub>4</sub> 312.1241 [M – H]<sup>−</sup>, found 312.1253.</div></div><div id="sec4_1_6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-([1,1′-Biphenyl]-2-ylmethyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10u</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.94 (s, 1H), 8.04 (s, 1H), 7.50–7.44 (m, 2H), 7.44–7.39 (m, 2H), 7.38 (d, <i>J</i> = 6.9 Hz, 1H), 7.28 (dd, <i>J</i> = 14.2, 7.0 Hz, 5H), 5.36 (s, 2H). HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>14</sub>NO<sub>4</sub> 320.0928 [M – H]<sup>−</sup>, found 320.0936.</div></div><div id="sec4_1_6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-([1,1′-Biphenyl]-4-ylmethyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10v</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.71 (s, 1H), 7.88 (s, 1H), 7.70 (d, <i>J</i> = 7.7 Hz, 2H), 7.66 (d, <i>J</i> = 7.3 Hz, 2H), 7.51 (d, <i>J</i> = 7.6 Hz, 2H), 7.46 (t, <i>J</i> = 7.3 Hz, 2H), 7.38 (d, <i>J</i> = 7.2 Hz, 1H), 5.40 (s, 2H). HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>14</sub>NO<sub>4</sub> 320.0928 [M – H]<sup>−</sup>, found 320.0936.</div></div><div id="sec4_1_6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-((4′-(Aminomethyl)-[1,1′-biphenyl]-4-yl)methyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylic Acid (<b>10w</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.10 (s, 1H), 8.71 (d, <i>J</i> = 2.0 Hz, 1H), 8.19 (s, 3H), 7.90 (d, <i>J</i> = 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.2, 4.1 Hz, 4H), 7.54 (dd, <i>J</i> = 8.2, 5.3 Hz, 4H), 5.40 (s, 2H), 4.08 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.6, 166.7, 149.2, 140.7, 140.3, 140.2, 135.7, 134.0, 130.1, 129.5, 127.9, 127.5, 126.4, 113.9, 60.3. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub> 349.1194 [M – H]<sup>−</sup>, found 349.1196.</div></div><div id="sec4_1_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-Hydroxy-4-oxo-1-(4-(quinolin-3-yl)benzyl)-1,4-dihydropyridine-3-carboxylic Acid (<b>10x</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.32 (d, <i>J</i> = 2.1 Hz, 1H), 8.80 (s, 1H), 8.74 (d, <i>J</i> = 2.0 Hz, 1H), 8.10 (t, <i>J</i> = 7.9 Hz, 2H), 7.96 (d, <i>J</i> = 8.2 Hz, 2H), 7.91 (d, <i>J</i> = 2.0 Hz, 1H), 7.84 (t, <i>J</i> = 7.1 Hz, 1H), 7.71 (t, <i>J</i> = 7.4 Hz, 1H), 7.63 (d, <i>J</i> = 8.2 Hz, 2H), 5.44 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 166.0, 148.1, 148.0, 144.2, 139.9, 136.5, 135.7, 135.2, 132.2, 130.7, 128.9, 128.5, 127.7, 127.6, 126.5, 125.6, 113.1, 59.5. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>15</sub>N<sub>2</sub>O<sub>4</sub> 371.1037 [M – H], found 371.1039.</div></div><div id="sec4_1_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Hydroxy-4-oxo-1-((4′-sulfamoyl[1,1′-biphenyl]-4-yl)methyl)-1,4-dihydropyridine-3-carboxylic Acid (<b>10y</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.08 (s, 1H), 8.73 (d, <i>J</i> = 2.0 Hz, 1H), 7.89 (d, <i>J</i> = 2.0 Hz, 1H), 7.88 (d, <i>J</i> = 8.6 Hz, 2H), 7.86 (d, <i>J</i> = 8.6 Hz, 2H), 7.78 (d, <i>J</i> = 8.2 Hz, 2H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.39 (s, 2H), 5.41 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.8, 165.9, 148.2, 142.9, 142.4, 139.9, 138.7, 135.5, 128.7, 127.0, 126.0, 125.5, 113.0, 59.4. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S 399.0656 [M – H], found 399.0667.</div></div><div id="sec4_1_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-Hydroxy-4-oxo-1-(4-(pyridin-3-yl)benzyl)-1,4-dihydropyridine-3-carboxylic Acid (<b>10z</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.01 (s, 1H), 8.73 (d, <i>J</i> = 1.9 Hz, 1H), 8.68 (d, <i>J</i> = 4.9 Hz, 1H), 8.33 (d, <i>J</i> = 7.9 Hz, 1H), 7.90 (d, <i>J</i> = 2.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.2 Hz, 2H), 7.70 (dd, <i>J</i> = 7.8, 5.1 Hz, 1H), 7.59 (d, <i>J</i> = 8.1 Hz, 2H), 5.42 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.1, 166.2, 148.7, 145.3, 144.4, 140.2, 138.3, 136.4, 136.3, 136.0, 129.1, 127.9, 125.8, 125.4, 113.4, 59.7. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>13</sub>N<sub>2</sub>O<sub>4</sub> 321.0881 [M – H], found 321.0887.</div></div><div id="sec4_1_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Ethyl-1-(4-fluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxylate (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): 8.50 (d, <i>J</i> = 1.2 Hz, 1H), 7.58 (d, <i>J</i> = 1.2 Hz, 1H), 7.41 (dd, <i>J</i> = 8.2, 5.4 Hz, 2H), 7.16 (t, <i>J</i> = 8.2 Hz, 2H), 5.25 (s, 2H), 4.34 (q, <i>J</i> = 7.1 Hz, 2H), 1.36 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.2, 156.1, 154.1, 142.5, 133.5, 123.4, 122.1, 113.2, 107.9, 105.7, 52.7, 52.1, 9.3. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>13</sub>FNO<sub>4</sub> 290.0834 [M – H], found 290.0837.</div></div><div id="sec4_1_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-(4-Fluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxamide (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.44 (d, <i>J</i> = 4.2 Hz, 1H), 9.13 (s, 1H), 8.49 (d, <i>J</i> = 2.1 Hz, 1H), 7.65 (d, <i>J</i> = 2.1 Hz, 1H), 7.53–7.39 (m, 3H), 7.23 (t, <i>J</i> = 8.8 Hz, 2H), 5.23 (s, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.7, 165.6, 163.0, 161.4, 149.5, 139.9, 132.6, 130.5, 122.1, 116.0, 58.8. HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>10</sub>FN<sub>2</sub>O<sub>3</sub> 261.0681 [M – H], found 261.0681.</div></div><div id="sec4_1_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-(2,4-Difluorobenzyl)-1-(4-fluorobenzyl)-5-hydroxy-4-oxo-1,4-dihydropyridine-3-carboxamide (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.60 (t, <i>J</i> = 5.7 Hz, 1H), 9.20 (s, 1H), 8.51 (d, <i>J</i> = 1.8 Hz, 1H), 7.67 (d, <i>J</i> = 1.8 Hz, 1H), 7.46 (dd, <i>J</i> = 8.2, 5.8 Hz, 2H), 7.41 (dd, <i>J</i> = 15.5, 8.4 Hz, 1H), 7.23 (dd, <i>J</i> = 14.5, 5.8 Hz, 3H), 7.08–7.03 (m, 1H), 5.25 (s, 2H), 4.53 (d, <i>J</i> = 5.7 Hz, 2H). HRMS-ESI (−) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub> 387.0962 [M – H], found 387.0967.</div></div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Biology. Reagents. Biologicals</h3><div class="NLM_p last">Recombinant HIV-1 reverse transcriptase (RT) was expressed and purified as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The catalytically active RNase H domain fragment of HIV-1 RT was expressed from plasmid pCSR231 (Dr. Daria Hazuda, Merck, West Point, PA) and purified as previously described.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> P4R5 HIV infection indicator cells were obtained from the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH (p4R5.MAGI from Dr. Nathaniel Landau). These cells express CD4, CXCR4, and CCR5 as well as a β-galactosidase reporter gene under the control of an HIV LTR promoter.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Chemicals</h3><div class="NLM_p last">DNA and RNA oligonucleotides for the preparation of RNA/DNA duplexes for assay of RNase H activity were purchased from Trilink (San Diego, CA).</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> RNase H Assay</h3><div class="NLM_p last">RNase H activity was measured essentially as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Three different RNA/DNA duplex substrates were used, each assessing a different mode of RNase H cleavage. HTS-1 (RNA 5′-gaucugagccugggagcu-3′-fluorescein annealed to DNA 3′-CTAGACTCGGACCCTCGA-5′-Dabcyl) is a high sensitivity duplex that assesses nonspecific internal cleavage. HTS-2 (RNA 5′-cugguuagaccagaucugagccugggagcu-3′-fluorescein annealed to DNA 3′-GGTCTAGACTCGGACCCTCGA-5′-Dabcyl) provides a duplex with a recessed DNA 3′-terminus and measures 3′-DNA directed or polymerase directed RNase H cleavage. HTS-3 (RNA 5′-accagaucugagccugggagcu-3-fluorescein annealed to DNA 3′-GACCAATCTGGTCTAGACTCGGACCCTCGA-5′-Dabcyl) measures 5′-RNA-directed RNase H cleavage.</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> RT Polymerase Assay</h3><div class="NLM_p last">HIV RT polymerase activity was determined in the presence and the absence of inhibitor using 10 μM [<sup>3</sup>H]TTP and 40 nM poly(rA)-oligo(dT)16 (both obtained from PerkinElmer, Waltham, MA) in 50 mM Tris-HCl, pH 7.4 (37 °C), containing 60 mM KCl and 5 mM MgCl<sub>2</sub>. Reactions were initiated by the addition of 10 nM WT or mutant RT and carried out for 20 min at 37 °C. Reactions were quenched by 200 μL of ice cold 10% TCA containing 20 mM sodium pyrophosphate and filtered using a 1.2 μm glass fiber filter 96-well plates (Millipore, Billerica, MA) followed by sequential wash with 10% TCA and ethanol. The extent of radionucleotide incorporation was determined by liquid scintillation spectrometry.</div></div><div id="sec4_2_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Order-of-Addition RNase H Inhibition Assays</h3><div class="NLM_p">Order-of-addition RNase H inhibition assays were carried out as previously described with some minor modifications.<a onclick="showRef(event, 'ref21 ref38'); return false;" href="javascript:void(0);" class="ref ref21 ref38">(21, 38)</a> Each reaction contained 100 nM HIV-1 RT, 6 mM MgCl<sub>2</sub>, 250 nM RNA/DNA (HTS-1) substrate, 30 μM inhibitor, and 1% DMSO. HIV-1 RT was preincubated with inhibitor, MgCl<sub>2</sub>, and/or RNA/DNA (HTS-1) substrate in the following conditions at 37 °C for 10 min prior to starting the reaction: RT + inhibitor, RT + inhibitor + MgCl<sub>2</sub>, RT + inhibitor + HTS-1, RT + HTS-1, and RT + HTS-1 + MgCl<sub>2</sub> + DMSO (no inhibitor control). The reactions were initiated by the addition of the missing components and were run at 37 °C for 10 min. A control with only DMSO carrier was used to adjust the fluorescence signal of the samples that contained inhibitor. Values are reported as mean ± standard deviation from two independent experiments.</div><div class="NLM_p last">To mimic conditions similar to those in the virion, order-of-addition reactions containing 300 nM HIV-1 RT, 6 mM MgCl<sub>2</sub>, 50 nM RNA/DNA (HTS-1) substrate, 0.5 mM EDTA, 30 μM inhibitor, and 1% DMSO were also performed. HIV-1 RT was preincubated with inhibitor, MgCl<sub>2</sub>, and/or RNA/DNA (HTS-1) substrate in the following conditions at 37 °C for 10 min prior to starting the reaction: RT + inhibitor, RT + HTS-1, and RT + HTS-1 + MgCl<sub>2</sub> + DMSO (no inhibitor control). The reactions were initiated by the addition of the missing components and were run at 37 °C for 2 min. A control with only DMSO carrier was used to adjust the fluorsecnece signal of the samples that contained inhibitor. Values are reported as the mean ± standard deviation from two independent experiments.</div></div><div id="sec4_2_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> HIV IN Assay</h3><div class="NLM_p last">HIV integrase was expressed and purified as previously reported.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Inhibition assays were performed using a modified protocol of our reported method.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Briefly, 2.1 μL of compound suspended in DMSO was placed in duplicate into a Black 96-well nonbinding plate (Corning 3991). Compounds were plated in duplicate to a final concentration of 0.13–100 μM. To each well of the plate 186.9 μL of reaction mixture without DNA substrate was added (10 mM HEPES, pH 7.5, 10% glycerol w/v, 10 mM MnCl<sub>2</sub>, 1 mM DTT, 1 μM integrase). The enzyme was incubated with inhibitor for 10 min at 25 °C after which the reaction was initiated by the addition of 21 μL of 500 nM oligo (5′ biotin ATGTGGAAAATCTCTAGCA annealed with ACTGCTAGAGATTTTCCACAT 3′ Cy5). Reactions were incubated at 37 °C for 30 min and then quenched by the addition of 5.2 μL of 500 mM EDTA. Each reaction was moved (200 μL) to a MultiScreen HTS PCR plate (Millipore MSSLBPC10) containing 20 μL of streptavidin agarose beads (Life Technologies S951) and incubated with shaking for 30 min. A vacuum manifold was used to remove the reaction mixture and the beads were similarly washed 3 times with wash buffer (0.05% SDS, 1 mM EDTA in PBS). The plates were further washed 3 times with 200 μL of 50 mM NaOH to denature DNA not covalently linked to the biotin modification. For each denaturation step the plate was incubated with shaking at 25 °C for 5 min and the NaOH was removed by centrifugation at 1000<i>g</i> for 1 min. The reaction products were eluted from the beads by the addition of 150 μL of formamide. The plate was incubated at 25 °C for 10 min and read directly at 635/675 in a SpectraMax i3 plate reader (Molecular Devices).</div></div><div id="sec4_2_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Antiviral Assays</h3><div class="NLM_p last">Antiviral assays were carried out using P4R5 indicator cells essentially as previously described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> P4R5 cells were cultured in 96-well microplates (5 × 10<sup>3</sup> cells per well) and maintained in DMEM/10% FBS supplemented with puromycin (0.5 μg/mL). Cells were incubated in the presence or the absence of drug for 16 h and then exposed to HIV followed by an additional incubation period of 48 h. The extent of infection was assessed using a fluorescence-based β-galactosidase detection assay, as previously described.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec4_2_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Modeling and Docking Analysis</h3><div class="NLM_p">Molecular modeling was performed using the Schrodinger small molecule drug discovery suite 2014-3. The crystal structure of HIV-1 RNase H p15 with engineered <i>E. coli</i> loop cocrystallized with pyrimidinol carboxylic acid (<b>5</b>) was extracted from the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HYF">3HYF</a><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>) as reported by Lansdon et.al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The above structure was subjected to analysis and found that the native ligand, pyrimidinolcarboxylic acid was bound to the active site of RNase H. This model was subjected to Protein Preparation Wizard<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> (Schrödinger Inc.) in which missing hydrogens atoms were added, zero-order bonds to metals were created followed by the generation of metal binding states. The structure of protein was minimized using OPLS 2005 force field<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> to optimize hydrogen bonding network and converge heavy atoms to an rmsd of 0.3 Å. The processed model indicates that the interaction between the pyrimidinol carboxylic acid (<b>5</b>) and RNase H is mediated by two metal cations (Mn<sup>2+</sup>) coordinated by the active site residues D443, E478, D498, and D549.</div><div class="NLM_p last">The receptor grid generation tool in Maestro (Schrodinger Inc.) was used to define an active site around the native ligand (<b>5</b>) to cover all the residues within 12 Å from it with both the metal cofactors (Mn<sup>2+</sup>) as a constraint to identify the chelating triad during docking. Compounds <b>10r</b> and <b>10y</b> were drawn using Maestro and subjected to Lig Prep<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> to generate conformers, possible protonation at pH of 7 ± 3, and metal binding states that serve as an input for docking process. All the dockings were performed using Glide XP<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> (Glide, version 6.4) mode with both the Mn<sup>2+</sup> metal cofactors as a constraint. The van der Waals radii of nonpolar atoms for each of the ligands were scaled by a factor of 0.8. The predicted favorable binding mode of compounds <b>10r</b> and <b>10y</b> features the critical interaction between the chelating triad and to the divalent metal cofactors. All the ligands within the active site of RNase H were further refined post docking by minimizing under implicit solvent to account for the local protein flexibility.</div></div><div id="sec4_2_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> HIV-1 RT Crystallization and Data Collection</h3><div class="NLM_p">HIV-1 RT containing C280S mutations in the p66 and p51 subunits was expressed and purified as previously described.<a onclick="showRef(event, 'ref38 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref41">(38, 41)</a> Cocrystallization of HIV-1 RT with <b>10y</b> was achieved by mixing a solution of RT at a final concentration of 10 mg/mL, 50 mM MgCl<sub>2</sub>, 5 mM tris(2-carboxyethyl)phosphine (TCEP) HCl, 0.5% β-octylglucoside, and 1 mM <b>10y</b> in a 1:1 ratio with a solution of 15% PEG 3500, 0.1 M sodium potassium phosphate, 5% ethylene glycol, and 0.1 M MES, pH 6.1. Large, blocky crystals grew by hanging drop vapor diffusion at 18 °C in 2–3 days.</div><div class="NLM_p last">HIV-1 RT/<b>10y</b> cocrystals were additionally soaked with 1.5 mM <b>10y</b>, 5 mM TCEP HCl, 0.6% β-octylglucoside, 8% ethylene glycol, and 50 mM MgCl<sub>2</sub> for 20 min before brief cryoprotection in a solution containing 23% ethylene glycol and 4% trimethylamine <i>N</i>-oxide, followed by fast cryocooling in liquid nitrogen. Four data sets collected at beamline 4.2.2 of the Advanced Light Source at Lawrence Berkeley National Laboratory were processed, scaled, and merged to 2.9 Å resolution using XDS.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The HIV-1 RT/<b>10y</b> crystals were of space group <i>P</i>1 and had unit cell dimensions of <i>a</i> = 69.1 Å, <i>b</i> = 89.3 Å, <i>c</i> = 108.2 Å and α = 105.5°, β = 92.7°, γ = 110.8°. Two RT molecules were present in the asymmetric unit, and the Matthews coefficient was 2.5 Å<sup>3</sup>/Da, corresponding to a solvent content of 51.6%.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Crystal data and statisitcs are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_001.pdf" class="ext-link">Supporting Information Table 1</a>.</div></div><div id="sec4_2_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Phase Determination and Structure Refinement</h3><div class="NLM_p last">The structure was determined by molecular replacement using Phaser.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> A crystal structure of unliganded HIV-1 RT (Protein Data Bank code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DLO">1DLO</a>) was used as an initial search model for a related higher resolution structure (2.28 Å) of an unpublished P1 RT/RNase H inhibitor complex with two molecules in the asymmetric unit. Rigid-body, simulated annealing (to remove bias), atomic displacement parameter (ADP), real-space and restrained refinement were perfomed on this initial model using Phenix.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Several cycles of model building and refinement were carried out using Coot<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and Phenix or Refmac,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> respectively, for the related higher resolution RT/RNase H inhibior complex, and this final model was used as the search model for molecular replacement of the RT/<b>10y</b> complex using the above protocols. The final RT/<b>10y</b> structure was validated using MolProbity.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Final refinement statistics are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_001.pdf" class="ext-link">Supporting Information Table 1</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00465">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00465" class="ext-link">10.1021/acs.jmedchem.6b00465</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemical synthesis, general procedures, spectral data, including <sup>1</sup>H NMR of intermediates (<b>16a</b>–<b>s</b>, <b>17a</b>–<b>s</b>,<b>w</b>-<b>z</b>), and crystallographic data and refinement statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_001.pdf">jm6b00465_si_001.pdf (489.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_002.csv">jm6b00465_si_002.csv (1.98 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J1E">5J1E</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00465" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhengqiang Wang</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97e0f6f9f0efa3a0a5d7e2faf9b9f2f3e2"><span class="__cf_email__" data-cfemail="0275636c657a36353042776f6c2c676677">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayakanth Kankanala</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen A. Kirby</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology and Immunology and Department of Biochemistry, University of Missouri School of Medicine, Christopher
S. Bond Life Sciences Center, Columbia, Missouri 65211, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Liu</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lena Miller</span> - <span class="hlFld-Affiliation affiliation">Department of Microbiology and Molecular
Genetics, University of Pittsburgh School
of Medicine, Pittsburgh, Pennsylvania 15219, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Nagy</span> - <span class="hlFld-Affiliation affiliation">Department of Microbiology and Molecular
Genetics, University of Pittsburgh School
of Medicine, Pittsburgh, Pennsylvania 15219, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Wilson</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Parniak</span> - <span class="hlFld-Affiliation affiliation">Department of Microbiology and Molecular
Genetics, University of Pittsburgh School
of Medicine, Pittsburgh, Pennsylvania 15219, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan G. Sarafianos</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology and Immunology and Department of Biochemistry, University of Missouri School of Medicine, Christopher
S. Bond Life Sciences Center, Columbia, Missouri 65211, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d97e3929-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported in part by the National Institutes of Health (Grant AI100890 to S.G.S., M.A.P., and Z.W.) and by the Research Development and Seed Grant Program of the Center for Drug Design, University of Minnesota. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> Abbreviations Used</h2><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">reverse transcriptase</p></td></tr><tr><td class="NLM_term">RNase H or RNH</td><td class="NLM_def"><p class="first last">ribonuclease H</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">integrase</p></td></tr><tr><td class="NLM_term">NRTI</td><td class="NLM_def"><p class="first last">nucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">NNRTI</td><td class="NLM_def"><p class="first last">non-nucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">INST</td><td class="NLM_def"><p class="first last">integrase strand transfer</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>UNAIDS: AIDS information. <a href="http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/" class="extLink">http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UNAIDS%3A+AIDS+information.+http%3A%2F%2Fwww.unaids.org%2Fen%2Fdataanalysis%2Fdatatools%2Faidsinfo%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Yeni, P.</span><span> </span><span class="NLM_article-title">Update on HAART in HIV</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">S100</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.jhep.2005.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jhep.2005.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=16359748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktl2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2006&pages=S100-103&author=P.+Yeni&title=Update+on+HAART+in+HIV&doi=10.1016%2Fj.jhep.2005.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Update on HAART in HIV</span></div><div class="casAuthors">Yeni, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S100-S103</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral combination therapy (HAART) has been responsible for a dramatic decrease in AIDS mortality since 1996, and has changed the clin. profile of HIV infection from a sub-acute lethal to a chronic ambulatory disease.  HAART consists of a double nucleoside (NRTI) backbone plus either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir pharmacol. enhanced protease inhibitor (PI/r).  Triple NRTI combinations are less potent than 2NRTIs/NNRTI or 2NRTIs/PI/r combinations.  Antiretroviral first-line therapy is rapidly moving towards more convenient and less toxic regimens.  Three double NRTI co-formulations are now available, and the risk of mitochondrial toxicity is low with drugs such as 3TC, FTC and tenofovir.  Similarly, atazanavir, a recently available PI, can be given once daily and is less metabolically toxic than other PIs.  Antiretroviral salvage therapy takes advantage of the development or availability of new drugs, either from existing (tipranavir, TMC 114 as new PIs) or new classes (T20 as a fusion inhibitor), that remain active on many triple-class drug resistant viruses.  More progress is needed in the field of drug discovery, since a significant proportion of patients still die from AIDS with a multi-resistant virus, and since the incidence of primary HIV resistance is increasing in various parts of the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-v9cXc64aqLVg90H21EOLACvtfcHk0ljN_1F6JBvXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktl2ksQ%253D%253D&md5=ec6531565d1b68066aa2efc155caa6fa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2005.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2005.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DYeni%26aufirst%3DP.%26atitle%3DUpdate%2520on%2520HAART%2520in%2520HIV%26jtitle%3DJ.%2520Hepatol.%26date%3D2006%26volume%3D44%26spage%3DS100%26epage%3D103%26doi%3D10.1016%2Fj.jhep.2005.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Tramontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">HIV-1 RT-associated RNase H function inhibitors: recent advances in drug development</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2837</span><span class="NLM_x">–</span> <span class="NLM_lpage">2853</span><span class="refDoi"> DOI: 10.2174/092986710792065045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.2174%2F092986710792065045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20858167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaisrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2837-2853&author=E.+Tramontanoauthor=R.+Di+Santo&title=HIV-1+RT-associated+RNase+H+function+inhibitors%3A+recent+advances+in+drug+development&doi=10.2174%2F092986710792065045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 RT-associated RNase H function inhibitors: recent advances in drug development</span></div><div class="casAuthors">Tramontano, E.; Di Santo, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2837-2853</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The HIV-1 genomic RNA reverse transcription is an essential step in the virus cycle carried out by the viral-coded reverse transcriptase (RT), which has two assocd. functions: the RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) function and the RNase H function.  The RNAse H function catalyzes the selective hydrolysis of the RNA strand of the RNA:DNA heteroduplex replication intermediate.  The RT assocd. activities are both essential for HIV-1 replication and validated targets for drug development, but only the polymerase function has been widely investigated as drug target.  In fact, either nucleoside or non-nucleoside RT inhibitors currently used in therapy act on the polymerase assocd. activity.  In this review, we describe the compds., reported up to today, which inhibit the HIV-1 RNase H function, their chem. structures, the structure-activity relationships and the mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp4M03GSrALbVg90H21EOLACvtfcHk0ljN_1F6JBvXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaisrzJ&md5=b32cef40a7c0938edbf7f35b504e6ccf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986710792065045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792065045%26sid%3Dliteratum%253Aachs%26aulast%3DTramontano%26aufirst%3DE.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DHIV-1%2520RT-associated%2520RNase%2520H%2520function%2520inhibitors%253A%2520recent%2520advances%2520in%2520drug%2520development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2837%26epage%3D2853%26doi%3D10.2174%2F092986710792065045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span><span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jmb.2008.10.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19022262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=693-713&author=S.+G.+Sarafianosauthor=B.+Marchandauthor=K.+Dasauthor=D.+M.+Himmelauthor=M.+A.+Parniakauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structure+and+function+of+HIV-1+reverse+transcriptase%3A+molecular+mechanisms+of+polymerization+and+inhibition&doi=10.1016%2Fj.jmb.2008.10.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition</span></div><div class="casAuthors">Sarafianos, Stefan G.; Marchand, Bruno; Das, Kalyan; Himmel, Daniel M.; Parniak, Michael A.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-713</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The rapid replication of the HIV-1 virus and errors made during viral replication cause the virus to evolve rapidly in patients, making the problems of vaccine development and drug therapy particularly challenging.  In the absence of an effective vaccine, drugs are the only useful treatment.  Anti-HIV drugs work; so far drug therapy has saved more than 3 × 106 yr of life.  Unfortunately, HIV-1 virus develops resistance to all of the available drugs.  Although a no. of useful anti-HIV drugs have been approved for use in patients, the problems assocd. with drug toxicity and the development of resistance means that the search for new drugs is an ongoing process.  The 3 viral enzymes, reverse transcriptase (RT), integrase (IN), and protease (PR) are all good drug targets.  Two distinct types of RT inhibitors, both of which block the polymerase activity of RT, have been approved to treat HIV-1 infections, nucleoside analogs (NRTIs) and non-nucleosides (NNRTIs), and there are promising leads for compds. that either block the RNase H activity or block the polymerase in other ways.  A better understanding of the structure and function(s) of RT and of the mechanism(s) of inhibition can be used to generate better drugs; in particular, drugs that are effective against the current drug-resistant strains of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrnqshyZtC7Vg90H21EOLACvtfcHk0lgNGIgBG46qyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D&md5=e26f178e629a36f6e248a879057021a2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.071%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520and%2520function%2520of%2520HIV-1%2520reverse%2520transcriptase%253A%2520molecular%2520mechanisms%2520of%2520polymerization%2520and%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D693%26epage%3D713%26doi%3D10.1016%2Fj.jmb.2008.10.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span> </span><span class="NLM_article-title">Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2009.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.antiviral.2009.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19887088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFCmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=39-58&author=T.+Cihlarauthor=A.+S.+Ray&title=Nucleoside+and+nucleotide+HIV+reverse+transcriptase+inhibitors%3A+25+years+after+zidovudine&doi=10.1016%2Fj.antiviral.2009.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine</span></div><div class="casAuthors">Cihlar, Tomas; Ray, Adrian S.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-58</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Twenty-five years ago, nucleoside analog 3'-azidothymidine (AZT) was shown to efficiently block the replication of HIV in cell culture.  Subsequent studies demonstrated that AZT acts via the selective inhibition of HIV reverse transcriptase (RT) by its triphosphate metabolite.  These discoveries have established the first class of antiretroviral agents: nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs).  Over the years that followed, NRTIs evolved into the main component of antiretroviral drug combinations that are now used for the treatment of all populations of HIV infected patients.  A total of thirteen NRTI drug products are now available for clin. application: eight individual NRTIs, four fixed-dose combinations of two or three NRTIs, and one complete fixed-dose regimen contg. two NRTIs and one non-nucleoside RT inhibitor.  Multiple NRTIs or their prodrugs are in various stages of clin. development and new potent NRTIs are still being identified through drug discovery efforts.  This article will review basic principles of the in vitro and in vivo pharmacol. of NRTIs, discuss their clin. use including limitations assocd. with long-term NRTI therapy, and describe newly identified NRTIs with promising pharmacol. profiles highlighting those in the development pipeline.  This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-OQhoXyRM_7Vg90H21EOLACvtfcHk0lgNGIgBG46qyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFCmtQ%253D%253D&md5=1a880624a780d1d969809f47497deda4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DRay%26aufirst%3DA.%2BS.%26atitle%3DNucleoside%2520and%2520nucleotide%2520HIV%2520reverse%2520transcriptase%2520inhibitors%253A%252025%2520years%2520after%2520zidovudine%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D39%26epage%3D58%26doi%3D10.1016%2Fj.antiviral.2009.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">de Bethune, M. P.</span><span> </span><span class="NLM_article-title">Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989–2009)</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.antiviral.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19781578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFCmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=75-90&author=M.+P.+de+Bethune&title=Non-nucleoside+reverse+transcriptase+inhibitors+%28NNRTIs%29%2C+their+discovery%2C+development%2C+and+use+in+the+treatment+of+HIV-1+infection%3A+a+review+of+the+last+20+years+%281989%E2%80%932009%29&doi=10.1016%2Fj.antiviral.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)</span></div><div class="casAuthors">de Bethune, Marie-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-90</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It is almost 20 years since NNRTIs were identified as a new class of antiretroviral drugs for the treatment of HIV-1 infection.  Although they belong to different and diverse chem. families, they share a common and unique mechanism of action: their interaction with HIV-1 reverse transcriptase induces conformational changes that inhibit the catalytic activities of the enzyme.  They are characterized by their specificity for HIV-1, which makes them very selective inhibitors of the virus.  First generation NNRTIs nevirapine and efavirenz, in combination with other antiretroviral drugs, have become a cornerstone for the treatment of HIV-1 infection, in patients initiating antiretroviral therapy.  Further research has led to the discovery and development of next generation NNRTIs with an increased genetic barrier to the development of resistance.  Etravirine is the first NNRTI to show sustained virol. efficacy in patients with NNRTI resistant HIV-1.  This review covers the NNRTI class of anti-HIV-1 drugs, from the initial discovery of the class in 1990 to the current compds. in clin. development, i.e. around 20 years of research and development efforts.  It describes the characteristics of the NNRTIs, their mechanisms of action, HIV-1 resistance to the inhibitors, and the drugs that have been approved for the treatment of HIV-1 infection, or are currently in clin. development.  The role of NNRTIs in prevention of HIV transmission is also addressed.  This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3g4c9flBpALVg90H21EOLACvtfcHk0lgNGIgBG46qyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFCmuw%253D%253D&md5=73cd7039f629fd4667dae95a1ea82dd5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBethune%26aufirst%3DM.%2BP.%26atitle%3DNon-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520%2528NNRTIs%2529%252C%2520their%2520discovery%252C%2520development%252C%2520and%2520use%2520in%2520the%2520treatment%2520of%2520HIV-1%2520infection%253A%2520a%2520review%2520of%2520the%2520last%252020%2520years%2520%25281989%25E2%2580%25932009%2529%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D75%26epage%3D90%26doi%3D10.1016%2Fj.antiviral.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span>HIV drugs in development. <a href="http://www.thebody.com/index/treat/newdrugs.html" class="extLink">http://www.thebody.com/index/treat/newdrugs.html</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=HIV+drugs+in+development.+http%3A%2F%2Fwww.thebody.com%2Findex%2Ftreat%2Fnewdrugs.html+%28accessed+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Parniak, M. A.</span> Unpublishd data.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Parniak%2C+M.+A.+Unpublishd+data."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DParniak%26aufirst%3DM.%2BA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent progress in the research of small molecule HIV-1 RNase H inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span><span class="refDoi"> DOI: 10.2174/0929867321666140120121158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.2174%2F0929867321666140120121158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=24438523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1956-1967&author=L.+Caoauthor=W.+Songauthor=E.+De+Clercqauthor=P.+Zhanauthor=X.+Liu&title=Recent+progress+in+the+research+of+small+molecule+HIV-1+RNase+H+inhibitors&doi=10.2174%2F0929867321666140120121158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors</span></div><div class="casAuthors">Cao, Lili; Song, Weiguo; De Clercq, Erik; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reverse transcription of human immunodeficiency virus type 1 (HIV-1) is a crucial step in the life cycle initiated by the viral-coded reverse transcriptase (RT), functioning as RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) and the RNase H (RNase H).  The RNase H functions to degrade the RNA strand of the RNA:DNA heteroduplex, which makes it an attractive target for rational anti-HIV-1 drug design and development.  Although development of drugs targeting the DNA polymerase have been highly successful, the discovery of drugable inhibitors of HIV RNase H is still in its infancy and none of RNase H inhibitors has reached the clin. development stage currently.  This review describes the recent progress in the HIV-1 RNase H inhibitors, focusing on their chem. feature, mechanism and the structure-activity relationship (SAR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1aiiPIvi0xLVg90H21EOLACvtfcHk0lgyXlM1ayWlUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D&md5=b304a792478d2ffcbe8d85405c74f0c1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140120121158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140120121158%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520the%2520research%2520of%2520small%2520molecule%2520HIV-1%2520RNase%2520H%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1956%26epage%3D1967%26doi%3D10.2174%2F0929867321666140120121158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derosier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">In, P. W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, K. E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span> </span><span class="NLM_article-title">Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">6852</span><span class="NLM_x">–</span> <span class="NLM_lpage">6859</span><span class="refDoi"> DOI: 10.1093/nar/gkg881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Fnar%2Fgkg881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=14627818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlyktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=6852-6859&author=K.+Klumppauthor=J.+Q.+Hangauthor=S.+Rajendranauthor=Y.+L.+Yangauthor=A.+Derosierauthor=P.+W.+K.+Inauthor=H.+Overtonauthor=K.+E.+B.+Parkesauthor=N.+Cammackauthor=J.+A.+Martin&title=Two-metal+ion+mechanism+of+RNA+cleavage+by+HIV+RNase+H+and+mechanism-based+design+of+selective+HIV+RNase+H+inhibitors&doi=10.1093%2Fnar%2Fgkg881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors</span></div><div class="casAuthors">Klumpp, Klaus; Hang, Julie Qi; Rajendran, Surendran; Yang, Yanli; Derosier, Andre; In, Philippe Wong Kai; Overton, Hilary; Parkes, Kevin E. B.; Cammack, Nick; Martin, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6852-6859</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV) RNase H activity is essential for the synthesis of viral DNA by HIV reverse transcriptase (HIV-RT).  RNA cleavage by RNase H requires the presence of divalent metal ions, but the role of metal ions in the mechanism of RNA cleavage has not been resolved.  We measured HIV RNase H activity assocd. with HIV-RT protein in the presence of different concns. of either Mg2+, Mn2+, Co2+ or a combination of these divalent metal ions.  Polymerase-independent HIV RNase H was similar to or more active with Mn2+ and Co2+ compared with Mg2+.  Activation of RNase H by these metal ions followed sigmoidal dose-response curves suggesting cooperative metal ion binding.  Titrn. of Mg2+-bound HIV RNase H with Mn2+ or Co2+ ions generated bell-shaped activity dose-response curves.  Higher activity could be achieved through simultaneous binding of more than one divalent metal ion at intermediate Mn2+ and Co2+ concns., and complete replacement of Mg2+ occurred at higher Mn2+ or Co2+ concns.  These results are consistent with a two-metal ion mechanism of RNA cleavage as previously suggested for a no. of polymerase-assocd. nucleases.  In contrast, the structurally highly homologous RNase HI from Escherichia coli is most strongly activated by Mg2+, is significantly inhibited by submillimolar concns. of Mn2+ and most probably cleaves RNA via a one-metal ion mechanism.  Based on this difference in active site structure, a series of small mol. N-hydroxyimides was identified with significant enzyme inhibitory potency and selectivity for HIV RNase H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQleqyPkDZcbVg90H21EOLACvtfcHk0lgyXlM1ayWlUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlyktLo%253D&md5=1cd71b3a891106b81d6a64f5044e3465</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkg881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkg881%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DHang%26aufirst%3DJ.%2BQ.%26aulast%3DRajendran%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%2BL.%26aulast%3DDerosier%26aufirst%3DA.%26aulast%3DIn%26aufirst%3DP.%2BW.%2BK.%26aulast%3DOverton%26aufirst%3DH.%26aulast%3DParkes%26aufirst%3DK.%2BE.%2BB.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26atitle%3DTwo-metal%2520ion%2520mechanism%2520of%2520RNA%2520cleavage%2520by%2520HIV%2520RNase%2520H%2520and%2520mechanism-based%2520design%2520of%2520selective%2520HIV%2520RNase%2520H%2520inhibitors%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D6852%26epage%3D6859%26doi%3D10.1093%2Fnar%2Fgkg881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1625</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1016/j.str.2009.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.str.2009.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20004166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFantbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1625-1635&author=D.+M.+Himmelauthor=K.+A.+Maegleyauthor=T.+A.+Paulyauthor=J.+D.+Baumanauthor=K.+Dasauthor=C.+Dhariaauthor=A.+D.+Clarkauthor=K.+Ryanauthor=M.+J.+Hickeyauthor=R.+A.+Loveauthor=S.+H.+Hughesauthor=S.+Bergqvistauthor=E.+Arnold&title=Structure+of+HIV-1+reverse+transcriptase+with+the+inhibitor+beta-Thujaplicinol+bound+at+the+RNase+H+active+site&doi=10.1016%2Fj.str.2009.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site</span></div><div class="casAuthors">Himmel, Daniel M.; Maegley, Karen A.; Pauly, Tom A.; Bauman, Joseph D.; Das, Kalyan; Dharia, Chhaya; Clark, Arthur D.; Ryan, Kevin; Hickey, Michael J.; Love, Robert A.; Hughes, Stephen H.; Bergqvist, Simon; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1625-1635</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Novel inhibitors are needed to counteract the rapid emergence of drug-resistant HIV variants.  HIV-1 reverse transcriptase (RT) has both DNA polymerase and RNase H (RNH) enzymic activities, but approved drugs that inhibit RT target the polymerase.  Inhibitors that act against new targets, such as RNH, should be effective against all of the current drug-resistant variants.  Here, we present 2.80 Å and 2.04 Å resoln. crystal structures of an RNH inhibitor, β-thujaplicinol, bound at the RNH active site of both HIV-1 RT and an isolated RNH domain.  β-Thujaplicinol chelates two divalent metal ions at the RNH active site.  We provide biochem. evidence that β-thujaplicinol is a slow-binding RNH inhibitor with noncompetitive kinetics and suggest that it forms a tropylium ion that interacts favorably with RT and the RNA:DNA substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmlpF9Bg7bhbVg90H21EOLACvtfcHk0lgyXlM1ayWlUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFantbrJ&md5=12f4e4bd069fce4e8e3e7876373e7ae8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DPauly%26aufirst%3DT.%2BA.%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DDharia%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DLove%26aufirst%3DR.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520of%2520HIV-1%2520reverse%2520transcriptase%2520with%2520the%2520inhibitor%2520beta-Thujaplicinol%2520bound%2520at%2520the%2520RNase%2520H%2520active%2520site%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26spage%3D1625%26epage%3D1635%26doi%3D10.1016%2Fj.str.2009.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myshakina, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">2617</span><span class="NLM_x">–</span> <span class="NLM_lpage">2631</span><span class="refDoi"> DOI: 10.1016/j.jmb.2014.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jmb.2014.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=24840303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslKmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2014&pages=2617-2631&author=D.+M.+Himmelauthor=N.+S.+Myshakinaauthor=T.+Ilinaauthor=A.+Van+Ryauthor=W.+C.+Hoauthor=M.+A.+Parniakauthor=E.+Arnold&title=Structure+of+a+dihydroxycoumarin+active-site+inhibitor+in+complex+with+the+RNase+H+domain+of+HIV-1+reverse+transcriptase+and+structure-activity+analysis+of+inhibitor+analogs&doi=10.1016%2Fj.jmb.2014.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a Dihydroxycoumarin Active-Site Inhibitor in Complex with the RNase H Domain of HIV-1 Reverse Transcriptase and Structure-Activity Analysis of Inhibitor Analogs</span></div><div class="casAuthors">Himmel, Daniel M.; Myshakina, Nataliya S.; Ilina, Tatiana; Van Ry, Alexander; Ho, William C.; Parniak, Michael A.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2617-2631</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV) encodes four essential enzymes: protease, integrase, reverse transcriptase (RT)-assocd. DNA polymerase, and RT-assocd. RNase H.  Current clin. approved anti-AIDS drugs target all HIV enzymic activities except RNase H, which has proven to be a very difficult target for HIV drug discovery.  Our high-throughput screening activities identified the dihydroxycoumarin compd. F3284-8495 as a specific inhibitor of RT RNase H, with low micromolar potency in vitro.  Optimization of inhibitory potency can be facilitated by structural information about inhibitor-target binding.  Here, we report the crystal structure of F3284-8495 bound to the active site of an isolated RNase H domain of HIV-1 RT at a resoln. limit of 1.71 Å.  From predictions based on this structure, compds. were obtained that showed improved inhibitory activity.  Computational anal. suggested structural alterations that could provide addnl. interactions with RT and thus improve inhibitory potency.  These studies established proof of concept that F3284-8495 could be used as a favorable chem. scaffold for development of HIV RNase H inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjcp3p4ztiz7Vg90H21EOLACvtfcHk0lg502Xird38mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslKmurs%253D&md5=f9600de68cd1b531ef8b27c0d8719fee</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2014.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2014.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DMyshakina%26aufirst%3DN.%2BS.%26aulast%3DIlina%26aufirst%3DT.%26aulast%3DVan%2BRy%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520of%2520a%2520dihydroxycoumarin%2520active-site%2520inhibitor%2520in%2520complex%2520with%2520the%2520RNase%2520H%2520domain%2520of%2520HIV-1%2520reverse%2520transcriptase%2520and%2520structure-activity%2520analysis%2520of%2520inhibitor%2520analogs%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D426%26spage%3D2617%26epage%3D2631%26doi%3D10.1016%2Fj.jmb.2014.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Shaw-Reid, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danzeisen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span> </span><span class="NLM_article-title">Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span><span class="refDoi"> DOI: 10.1074/jbc.C200621200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1074%2Fjbc.C200621200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=12480948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=2777-2780&author=C.+A.+Shaw-Reidauthor=V.+Munshiauthor=P.+Grahamauthor=A.+Wolfeauthor=M.+Witmerauthor=R.+Danzeisenauthor=D.+B.+Olsenauthor=S.+S.+Carrollauthor=M.+Embreyauthor=J.+S.+Waiauthor=M.+D.+Millerauthor=J.+L.+Coleauthor=D.+J.+Hazuda&title=Inhibition+of+HIV-1+ribonuclease+H+by+a+novel+diketo+acid%2C+4-%5B5-%28benzoylamino%29thien-2-yl%5D-2%2C4-dioxobutanoic+acid&doi=10.1074%2Fjbc.C200621200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid</span></div><div class="casAuthors">Shaw-Reid, Cathryn A.; Munshi, Vandna; Graham, Pia; Wolfe, Abigail; Witmer, Marc; Danzeisen, Renee; Olsen, David B.; Carroll, Steven S.; Embrey, Mark; Wai, John S.; Miller, Michael D.; Cole, James L.; Hazuda, Daria J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2777-2780</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human immunodeficiency virus-type 1 (HIV-1) reverse transcriptase (RT) coordinates DNA polymn. and RNase H (RNase H) activities using two discrete active sites embedded within a single heterodimeric polyprotein.  We have identified a novel thiophene diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid, that selectively inhibits polymerase-independent RNase H cleavage (IC50 = 3.2 μM) but has no effect on DNA polymn. (IC50 > 50 μM).  The activity profile of the diketo acid is shown to be distinct from previously described compds., including the polymerase inhibitor foscarnet and the putative RNase H inhibitor 4-chlorophenylhydrazone.  Both foscarnet and the hydrazone inhibit RNase H cleavage and DNA polymn. activities of RT, yet neither inhibits the RNase H activity of RT contg. a mutation in the polymerase active site (D185N) or an isolated HIV-1 RNase H domain chimera contg. the α-C helix from Escherichia coli RNase HI, suggesting these compds. affect RNase H indirectly.  In contrast, the diketo acid inhibits the RNase H activity of the isolated RNase H domain as well as full-length RT, and inhibition is not affected by the polymerase active site mutation.  In isothermal titrn. calorimetry studies using the isolated RNase H domain, binding of the diketo acid is independent of nucleic acid but strictly requires Mn2+ implying a direct interaction between the inhibitor and the RNase H active site.  These studies demonstrate that inhibition of HIV-1 RNase H may occur by either direct or indirect mechanisms, and they provide a framework for identifying novel agents such as 4-[5-(benzoylamino)thien- 2-yl]-2,4-dioxobutanoic acid that specifically targets RNase H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEn4xJCxmBvbVg90H21EOLACvtfcHk0lg502Xird38mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1GgsQ%253D%253D&md5=7d0ca6e9cf63c7d8a3632b78ac97ab0c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200621200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200621200%26sid%3Dliteratum%253Aachs%26aulast%3DShaw-Reid%26aufirst%3DC.%2BA.%26aulast%3DMunshi%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DP.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DCole%26aufirst%3DJ.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520HIV-1%2520ribonuclease%2520H%2520by%2520a%2520novel%2520diketo%2520acid%252C%25204-%255B5-%2528benzoylamino%2529thien-2-yl%255D-2%252C4-dioxobutanoic%2520acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D2777%26epage%3D2780%26doi%3D10.1074%2Fjbc.C200621200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kirschberg, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brendza, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liclican, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansdon, E. B.</span><span> </span><span class="NLM_article-title">RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5781</span><span class="NLM_x">–</span> <span class="NLM_lpage">5784</span><span class="refDoi"> DOI: 10.1021/jm900597q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900597q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWqtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5781-5784&author=T.+A.+Kirschbergauthor=M.+Balakrishnanauthor=N.+H.+Squiresauthor=T.+Barnesauthor=K.+M.+Brendzaauthor=X.+Chenauthor=E.+J.+Eisenbergauthor=W.+Jinauthor=N.+Kuttyauthor=S.+Leavittauthor=A.+Liclicanauthor=Q.+Liuauthor=X.+Liuauthor=J.+Makauthor=J.+K.+Perryauthor=M.+Wangauthor=W.+J.+Watkinsauthor=E.+B.+Lansdon&title=RNase+H+active+site+inhibitors+of+human+immunodeficiency+virus+type+1+reverse+transcriptase%3A+design%2C+biochemical+activity%2C+and+structural+information&doi=10.1021%2Fjm900597q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information</span></div><div class="casAuthors">Kirschberg, Thorsten A.; Balakrishnan, Mini; Squires, Neil H.; Barnes, Tiffany; Brendza, Katherine M.; Chen, Xiaowu; Eisenberg, Eugene J.; Jin, Weili; Kutty, Nilima; Leavitt, Stephanie; Liclican, Albert; Liu, Qi; Liu, Xiaohong; Mak, John; Perry, Jason K.; Wang, Michael; Watkins, William J.; Lansdon, Eric B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5781-5784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyrimidinol carboxylic acids were designed as inhibitors of HIV-1 RNase H function.  These mols. can coordinate to two divalent metal ions in the RNase H active site.  Inhibition of enzymic activity was measured in a biochem. assay, but no antiviral effect was obsd.  Binding was demonstrated via a solid state structure of the isolated p15-Ec domain of HIV-1 RT showing inhibitor and two Mn(II) ions bound to the RNase H active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_O-7zroiObVg90H21EOLACvtfcHk0lg_HH_29tz_Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWqtb%252FL&md5=5cf9a05d81ba1af195b933b2bdad99b8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900597q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900597q%26sid%3Dliteratum%253Aachs%26aulast%3DKirschberg%26aufirst%3DT.%2BA.%26aulast%3DBalakrishnan%26aufirst%3DM.%26aulast%3DSquires%26aufirst%3DN.%2BH.%26aulast%3DBarnes%26aufirst%3DT.%26aulast%3DBrendza%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DEisenberg%26aufirst%3DE.%2BJ.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DKutty%26aufirst%3DN.%26aulast%3DLeavitt%26aufirst%3DS.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMak%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26atitle%3DRNase%2520H%2520active%2520site%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%253A%2520design%252C%2520biochemical%2520activity%252C%2520and%2520structural%2520information%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5781%26epage%3D5784%26doi%3D10.1021%2Fjm900597q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzek, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuston, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnck, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelberger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span> </span><span class="NLM_article-title">Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6754</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.08.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.bmcl.2010.08.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20869872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6754-6757&author=P.+D.+Williamsauthor=D.+D.+Staasauthor=S.+Venkatramanauthor=H.+M.+Loughranauthor=R.+D.+Ruzekauthor=T.+M.+Boothauthor=T.+A.+Lyleauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=B.+P.+Feustonauthor=L.+T.+Ectoauthor=J.+A.+Flynnauthor=D.+J.+DiStefanoauthor=D.+J.+Hazudaauthor=C.+M.+Bahnckauthor=A.+L.+Himmelbergerauthor=G.+Dornadulaauthor=R.+C.+Hrinauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=M.+D.+Millerauthor=J.+A.+Grobler&title=Potent+and+selective+HIV-1+ribonuclease+H+inhibitors+based+on+a+1-hydroxy-1%2C8-naphthyridin-2%281H%29-one+scaffold&doi=10.1016%2Fj.bmcl.2010.08.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold</span></div><div class="casAuthors">Williams, Peter D.; Staas, Donnette D.; Venkatraman, Shankar; Loughran, H. Marie; Ruzek, Rowena D.; Booth, Theresa M.; Lyle, Terry A.; Wai, John S.; Vacca, Joseph P.; Feuston, Bradley P.; Ecto, Linda T.; Flynn, Jessica A.; Di Stefano, Daniel J.; Hazuda, Daria J.; Bahnck, Carolyn M.; Himmelberger, Amy L.; Dornadula, Geetha; Hrin, Renee C.; Stillmock, Kara A.; Witmer, Marc V.; Miller, Michael D.; Grobler, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6754-6757</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Optimization studies using an HIV RNase H active site inhibitor contg. a 1-hydroxy-1,8-naphthyridin-2(1H)-one core identified 4-position substituents that provided several potent and selective inhibitors.  The best compd. was potent and selective in biochem. assays (IC50 = 0.045 μM, HIV RT RNase H; 13 μM, HIV RT-polymerase; 24 μM, HIV integrase) and showed antiviral efficacy in a single-cycle viral replication assay in P4-2 cells (IC50 = 0.19 μM) with a modest window with respect to cytotoxicity (CC50 = 3.3 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9suuOSksTb7Vg90H21EOLACvtfcHk0lg_HH_29tz_Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL3L&md5=88515db2a862c3fc2192b08f23e28c32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.135%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DRuzek%26aufirst%3DR.%2BD.%26aulast%3DBooth%26aufirst%3DT.%2BM.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFeuston%26aufirst%3DB.%2BP.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DFlynn%26aufirst%3DJ.%2BA.%26aulast%3DDiStefano%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DBahnck%26aufirst%3DC.%2BM.%26aulast%3DHimmelberger%26aufirst%3DA.%2BL.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DHrin%26aufirst%3DR.%2BC.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520selective%2520HIV-1%2520ribonuclease%2520H%2520inhibitors%2520based%2520on%2520a%25201-hydroxy-1%252C8-naphthyridin-2%25281H%2529-one%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6754%26epage%3D6757%26doi%3D10.1016%2Fj.bmcl.2010.08.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Beilhartz, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deanda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerondelis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotte, M.</span><span> </span><span class="NLM_article-title">Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">16270</span><span class="NLM_x">–</span> <span class="NLM_lpage">16277</span><span class="refDoi"> DOI: 10.1074/jbc.M114.569707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1074%2Fjbc.M114.569707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=24719329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptl2qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=16270-16277&author=G.+L.+Beilhartzauthor=M.+Ngureauthor=B.+A.+Johnsauthor=F.+Deandaauthor=P.+Gerondelisauthor=M.+Gotte&title=Inhibition+of+the+ribonuclease+H+activity+of+HIV-1+reverse+transcriptase+by+GSK5750+correlates+with+slow+enzyme-inhibitor+dissociation&doi=10.1074%2Fjbc.M114.569707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation</span></div><div class="casAuthors">Beilhartz, Greg L.; Ngure, Marianne; Johns, Brian A.; DeAnda, Felix; Gerondelis, Peter; Gotte, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">16270-16277</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Compds. that efficiently inhibit the RNase (RNase) H activity of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have yet to be developed.  Here, we demonstrate that GSK5750, a 1-hydroxy-pyridopyrimidinone analog, binds to the enzyme with an equil. dissocn. const. (Kd) of ∼400 nm.  Inhibition of HIV-1 RNase H is specific, as DNA synthesis is not affected.  Moreover, GSK5750 does not inhibit the activity of Escherichia coli RNase H.  Order-of-addn. expts. show that GSK5750 binds to the free enzyme in an Mg2+-dependent fashion.  However, as reported for other active site inhibitors, binding of GSK5750 to a preformed enzyme-substrate complex is severely compromised.  The bound nucleic acid prevents access to the RNase H active site, which represents a possible biochem. hurdle in the development of potent RNase H inhibitors.  Previous studies suggested that formation of a complex with the prototypic RNase H inhibitor β-thujaplicinol is slow, and, once formed, it dissocs. rapidly.  This unfavorable kinetic behavior can limit the potency of RNase H active site inhibitors.  Although the assocn. kinetics of GSK5750 remains slow, our data show that this compd. forms a long lasting complex with HIV-1 RT.  We conclude that slow dissocn. of the inhibitor and HIV-1 RT improves RNase H active site inhibitors and may circumvent the obstacle posed by the inability of these compds. to bind to a preformed enzyme-substrate complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3jO9fV0KNwrVg90H21EOLACvtfcHk0lixi8zRBtL7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptl2qt74%253D&md5=789145792b14990c5060e47efaef028d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.569707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.569707%26sid%3Dliteratum%253Aachs%26aulast%3DBeilhartz%26aufirst%3DG.%2BL.%26aulast%3DNgure%26aufirst%3DM.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DDeanda%26aufirst%3DF.%26aulast%3DGerondelis%26aufirst%3DP.%26aulast%3DGotte%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520the%2520ribonuclease%2520H%2520activity%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520GSK5750%2520correlates%2520with%2520slow%2520enzyme-inhibitor%2520dissociation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D16270%26epage%3D16277%26doi%3D10.1074%2Fjbc.M114.569707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nowotny, M.</span><span> </span><span class="NLM_article-title">Retroviral integrase superfamily: the structural perspective</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1038/embor.2008.256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1038%2Fembor.2008.256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19165139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=144-151&author=M.+Nowotny&title=Retroviral+integrase+superfamily%3A+the+structural+perspective&doi=10.1038%2Fembor.2008.256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Retroviral integrase superfamily: the structural perspective</span></div><div class="casAuthors">Nowotny, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-151</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The retroviral integrase superfamily (RISF) comprises numerous important nucleic acid-processing enzymes, including transposases, integrases and various nucleases.  These enzymes are involved in a wide range of processes such as transposition, replication and repair of DNA, homologous recombination, and RNA-mediated gene silencing.  Two out of the four enzymes that are encoded by the human immunodeficiency virus, RNase H1 and integrase, are members of this superfamily.  RISF enzymes act on various substrates, and yet show remarkable mechanistic and structural similarities.  All share a common fold of the catalytic core and the active site, which is composed primarily of carboxylate residues.  Here, RISF proteins are presented from a structural perspective, describing the individual members and the common and divergent elements of their structures, as well as the mechanistic insights gained from the structures of RNase H1 enzyme complexes with RNA/DNA hybrids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMYe1c5DixdbVg90H21EOLACvtfcHk0lixi8zRBtL7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVChsg%253D%253D&md5=8e67d5e63bdc6e84a3f7576cd6eaa74c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fembor.2008.256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2008.256%26sid%3Dliteratum%253Aachs%26aulast%3DNowotny%26aufirst%3DM.%26atitle%3DRetroviral%2520integrase%2520superfamily%253A%2520the%2520structural%2520perspective%26jtitle%3DEMBO%2520Rep.%26date%3D2009%26volume%3D10%26spage%3D144%26epage%3D151%26doi%3D10.1038%2Fembor.2008.256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fujishita, T.; Mikamiyama, M.; Kawai, M.; Akiyama, T.</span><span> </span><span class="NLM_article-title">Substituted 3-hydroxy-4-pyridone derivative</span>. WO2010110231,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Fujishita&author=M.+Mikamiyama&author=M.+Kawai&author=T.+Akiyama&title=Substituted+3-hydroxy-4-pyridone+derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFujishita%26aufirst%3DT.%26atitle%3DSubstituted%25203-hydroxy-4-pyridone%2520derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkoff, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5916</span><span class="refDoi"> DOI: 10.1021/jm400645w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29&doi=10.1021%2Fjm400645w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)</span></div><div class="casAuthors">Johns, Brian A.; Kawasuji, Takashi; Weatherhead, Jason G.; Taishi, Teruhiko; Temelkoff, David P.; Yoshida, Hiroshi; Akiyama, Toshiyuki; Taoda, Yoshiyuki; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Jeffrey, Jerry; Foster, Scott A.; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Johnson, Matthew N.; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5901-5916</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572) (3, III) and S/GSK1265744 (4, IV).  These drugs stem from a series of carbamoyl pyridone analogs designed using a two-metal chelation model of the integrase catalytic active site.  Structure-activity studies evolved a tricyclic series of carbamoyl pyridines that demonstrated properties indicative of once-daily dosing and superior potency against resistant viral strains.  An inherent hemiaminal ring fusion stereocenter within the tricyclic carbamoyl pyridone scaffold led to a crit. substrate controlled diastereoselective synthetic strategy whereby chiral information from small readily available amino alcs. was employed to control relative and abs. stereochem. of the final drug candidates.  Modest to extremely high levels of stereochem. control were obsd. depending on ring size and position of the stereocenter.  This approach resulted in the discovery of 3 and 4, which are currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1G_fuC1lAtLVg90H21EOLACvtfcHk0lixi8zRBtL7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK&md5=c44c9e62870c2177b07cdd08d22ea600</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916%26doi%3D10.1021%2Fjm400645w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vernekar, S. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kankanala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span> </span><span class="NLM_article-title">Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1021/jm501132s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501132s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=651-664&author=S.+K.+V.+Vernekarauthor=Z.+Liuauthor=E.+Nagyauthor=L.+Millerauthor=K.+A.+Kirbyauthor=D.+J.+Wilsonauthor=J.+Kankanalaauthor=S.+G.+Sarafianosauthor=M.+A.+Parniakauthor=Z.+Q.+Wang&title=Design%2C+synthesis%2C+biochemical%2C+and+antiviral+evaluations+of+C6+benzyl+and+C6+biarylmethyl+substituted+2-hydroxylisoquinoline-1%2C3-diones%3A+dual+inhibition+against+HIV+reverse+transcriptase-associated+RNase+H+and+polymerase+with+antiviral+activities&doi=10.1021%2Fjm501132s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities</span></div><div class="casAuthors">Vernekar, Sanjeev Kumar V.; Liu, Zheng; Nagy, Eva; Miller, Lena; Kirby, Karen A.; Wilson, Daniel J.; Kankanala, Jayakanth; Sarafianos, Stefan G.; Parniak, Michael A.; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reverse transcriptase (RT) assocd. RNase H (RNase H) remains the only virally encoded enzymic function not targeted by current chemotherapy against human immunodeficiency virus (HIV).  Although numerous chemotypes have been reported to inhibit HIV RNase H biochem., few show significant antiviral activity against HIV.  We report herein the design, synthesis, and biol. evaluations of a novel variant of 2-hydroxyisoquinoline-1,3-dione (HID) scaffold featuring a crucial C-6 benzyl or biarylmethyl moiety, e. g., I.  The synthesis involved a recently reported metal-free direct benzylation between tosylhydrazone and boronic acid, which allowed the generation of structural diversity for the hydrophobic arom. region.  Biochem. studies showed that the C-6 benzyl and biarylmethyl HID analogs, previously unknown chemotypes, consistently inhibited HIV RT-assocd. RNase H and polymerase with IC50s in low to submicromolar range.  The obsd. dual inhibitory activity remained uncompromised against RT mutants resistant to non-nucleoside RT inhibitors (NNRTIs), suggesting the involvement of binding site(s) other than the NNRTI binding pocket.  Intriguingly, these same compds. inhibited the polymerase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia coli RNase H.  Addnl. biochem. testing revealed a substantially reduced level of inhibition against HIV integrase.  Mol. docking corroborates favorable binding of these analogs to the active site of HIV RNase H.  Finally, a no. of these analogs also demonstrated antiviral activity at low micromolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeenALml-35bVg90H21EOLACvtfcHk0lh2luhEFwLQKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO&md5=a4574233b65a5a0efd3634a2011fc94f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501132s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501132s%26sid%3Dliteratum%253Aachs%26aulast%3DVernekar%26aufirst%3DS.%2BK.%2BV.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DKankanala%26aufirst%3DJ.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26atitle%3DDesign%252C%2520synthesis%252C%2520biochemical%252C%2520and%2520antiviral%2520evaluations%2520of%2520C6%2520benzyl%2520and%2520C6%2520biarylmethyl%2520substituted%25202-hydroxylisoquinoline-1%252C3-diones%253A%2520dual%2520inhibition%2520against%2520HIV%2520reverse%2520transcriptase-associated%2520RNase%2520H%2520and%2520polymerase%2520with%2520antiviral%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D651%26epage%3D664%26doi%3D10.1021%2Fjm501132s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budihas, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grice, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beutler, J. A.</span><span> </span><span class="NLM_article-title">A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1016/j.ab.2003.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.ab.2003.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=14705777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Kkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2003&pages=33-39&author=M.+A.+Parniakauthor=K.+L.+Minauthor=S.+R.+Budihasauthor=S.+F.+Le+Griceauthor=J.+A.+Beutler&title=A+fluorescence-based+high-throughput+screening+assay+for+inhibitors+of+human+immunodeficiency+virus-1+reverse+transcriptase-associated+ribonuclease+H+activity&doi=10.1016%2Fj.ab.2003.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity</span></div><div class="casAuthors">Parniak, Michael A.; Min, Kyung-Lyum; Budihas, Scott R.; Le Grice, Stuart F. J.; Beutler, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A fluorescence resonance energy transfer assay readily applicable to 96-well and 384-well microplate formats with robotic operation was developed to enable high-throughput screening for inhibitors of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (RT)-assocd. RNase H activity, an underexplored target for antiretroviral development.  The assay substrate is an 18-nucleotide 3'-fluorescein-labeled RNA annealed to a complementary 18-nucleotide 5'-Dabcyl-modified DNA.  The intact duplex has an extremely low background fluorescent signal and provides up to 50-fold fluorescent signal enhancement following hydrolysis.  The size and sequence of the duplex are such that HIV-1 RT-RNase H cuts the RNA strand close to the 3' end.  The fluorescein-labeled ribonucleotide fragment readily dissocs. from the complementary DNA at room temp. with immediate generation of a fluorescent signal.  This assay is rapid, inexpensive, and robust, providing Z' factors of 0.8 and coeffs. of variation of about 5%.  The assay can be carried out both in real-time (continuous) and in "quench" modes; the latter requires only two addn. steps with no washing and is thus suitable for robotic operation.  Several chem. libraries totaling more than 106,000 compds. were screened with this assay in approx. 1 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzURDybesnbVg90H21EOLACvtfcHk0lh2luhEFwLQKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Kkt7k%253D&md5=4f06c7c5cb1d358b2638234439d547b3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2003.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2003.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DMin%26aufirst%3DK.%2BL.%26aulast%3DBudihas%26aufirst%3DS.%2BR.%26aulast%3DLe%2BGrice%26aufirst%3DS.%2BF.%26aulast%3DBeutler%26aufirst%3DJ.%2BA.%26atitle%3DA%2520fluorescence-based%2520high-throughput%2520screening%2520assay%2520for%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus-1%2520reverse%2520transcriptase-associated%2520ribonuclease%2520H%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D322%26spage%3D33%26epage%3D39%26doi%3D10.1016%2Fj.ab.2003.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Beilhartz, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichoo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotte, M.</span><span> </span><span class="NLM_article-title">HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jmb.2009.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=462-474&author=G.+L.+Beilhartzauthor=M.+Wendelerauthor=N.+Baichooauthor=J.+Rauschauthor=S.+Le+Griceauthor=M.+Gotte&title=HIV-1+reverse+transcriptase+can+simultaneously+engage+its+DNA%2FRNA+substrate+at+both+DNA+polymerase+and+RNase+H+active+sites%3A+implications+for+RNase+H+inhibition&doi=10.1016%2Fj.jmb.2009.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DBeilhartz%26aufirst%3DG.%2BL.%26aulast%3DWendeler%26aufirst%3DM.%26aulast%3DBaichoo%26aufirst%3DN.%26aulast%3DRausch%26aufirst%3DJ.%26aulast%3DLe%2BGrice%26aufirst%3DS.%26aulast%3DGotte%26aufirst%3DM.%26atitle%3DHIV-1%2520reverse%2520transcriptase%2520can%2520simultaneously%2520engage%2520its%2520DNA%252FRNA%2520substrate%2520at%2520both%2520DNA%2520polymerase%2520and%2520RNase%2520H%2520active%2520sites%253A%2520implications%2520for%2520RNase%2520H%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D462%26epage%3D474%26doi%3D10.1016%2Fj.jmb.2009.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sirivolu, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernekar, S. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myshakina, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span> </span><span class="NLM_article-title">Clicking 3 ′-azidothymidine into novel potent inhibitors of human immunodeficiency virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8765</span><span class="NLM_x">–</span> <span class="NLM_lpage">8780</span><span class="refDoi"> DOI: 10.1021/jm401232v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401232v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8765-8780&author=V.+R.+Sirivoluauthor=S.+K.+V.+Vernekarauthor=T.+Ilinaauthor=N.+S.+Myshakinaauthor=M.+A.+Parniakauthor=Z.+Q.+Wang&title=Clicking+3+%E2%80%B2-azidothymidine+into+novel+potent+inhibitors+of+human+immunodeficiency+virus&doi=10.1021%2Fjm401232v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401232v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401232v%26sid%3Dliteratum%253Aachs%26aulast%3DSirivolu%26aufirst%3DV.%2BR.%26aulast%3DVernekar%26aufirst%3DS.%2BK.%2BV.%26aulast%3DIlina%26aufirst%3DT.%26aulast%3DMyshakina%26aufirst%3DN.%2BS.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26atitle%3DClicking%25203%2520%25E2%2580%25B2-azidothymidine%2520into%2520novel%2520potent%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8765%26epage%3D8780%26doi%3D10.1021%2Fjm401232v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>Small-Molecule Drug Discovery Suite 2014-3: Glide, version <span class="NLM_edition">6.4</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Small-Molecule+Drug+Discovery+Suite+2014-3%3A+Glide%2C+version+6.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall-Molecule%2520Drug%2520Discovery%2520Suite%25202014-3%253A%2520Glide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span><span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0li1mXdQbRQKlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdine, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span> </span><span class="NLM_article-title">Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1675</span><span class="refDoi"> DOI: 10.1126/science.282.5394.1669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1126%2Fscience.282.5394.1669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=9831551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1669-1675&author=H.+Huangauthor=R.+Chopraauthor=G.+L.+Verdineauthor=S.+C.+Harrison&title=Structure+of+a+covalently+trapped+catalytic+complex+of+HIV-1+reverse+transcriptase%3A+implications+for+drug+resistance&doi=10.1126%2Fscience.282.5394.1669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance</span></div><div class="casAuthors">Huang, Huifang; Chopra, Rajiv; Verdine, Gregory L.; Harrison, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5394</span>),
    <span class="NLM_cas:pages">1669-1675</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A combinatorial disulfide crosslinking strategy was used to prep. a stalled complex of human immunodeficiency virus-type 1 (HIV-1) reverse transcriptase with a DNA template:primer and a deoxynucleoside triphosphate (dNTP), and the crystal structure of the complex was detd. at a resoln. of 3.2 angstroms.  The presence of a dideoxynucleotide at the 3'-primer terminus allows capture of a state in which the substrates are poised for attack on the dNTP.  Conformational changes that accompany formation of the catalytic complex produce distinct clusters of the residues that are altered in viruses resistant to nucleoside analog drugs.  The positioning of these residues in the neighborhood of the dNTP helps to resolve some long-standing puzzles about the mol. basis of resistance.  The resistance mutations are likely to influence binding or reactivity of the inhibitors, relative to normal dNTPs, and the clustering of the mutations correlates with the chem. structure of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV_rP3C5B_N7Vg90H21EOLACvtfcHk0li1mXdQbRQKlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D&md5=e97c3a69e2aa084beff2ec8dd88af3b4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5394.1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5394.1669%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DStructure%2520of%2520a%2520covalently%2520trapped%2520catalytic%2520complex%2520of%2520HIV-1%2520reverse%2520transcriptase%253A%2520implications%2520for%2520drug%2520resistance%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1669%26epage%3D1675%26doi%3D10.1126%2Fscience.282.5394.1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcomb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1449</span><span class="NLM_x">–</span> <span class="NLM_lpage">1461</span><span class="refDoi"> DOI: 10.1093/emboj/20.6.1449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Femboj%2F20.6.1449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=11250910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVCktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=1449-1461&author=S.+G.+Sarafianosauthor=K.+Dasauthor=C.+Tantilloauthor=A.+D.+Clarkauthor=J.+Dingauthor=J.+M.+Whitcombauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=E.+Arnold&title=Crystal+structure+of+HIV-1+reverse+transcriptase+in+complex+with+a+polypurine+tract+RNA%3ADNA&doi=10.1093%2Femboj%2F20.6.1449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA</span></div><div class="casAuthors">Sarafianos, Stefan G.; Das, Kalyan; Tantillo, Chris; Clark, Arthur D., Jr.; Ding, Jianping; Whitcomb, Jeannette M.; Boyer, Paul L.; Hughes, Stephen H.; Arnold, Edward</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1449-1461</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We have detd. the 3.0 Å resoln. structure of wild-type HIV-1 reverse transcriptase in complex with an RNA:DNA oligonucleotide whose sequence includes a purine-rich segment from the HIV-1 genome called the polypurine tract (PPT).  The PPT is resistant to RNase H cleavage and is used as a primer for second DNA strand synthesis.  The "RNase H primer grip", consisting of amino acids that interact with the DNA primer strand, may contribute to RNase H catalysis and cleavage specificity.  Cleavage specificity is also controlled by the width of the minor groove and the trajectory of the RNA:DNA, both of which are sequence dependent.  An unusual "unzipping" of 7 bp occurs in the adenine stretch of the PPT: an unpaired base on the template strand takes the base pairing out of register and then, following two offset base pairs, an unpaired base on the primer strand re-establishes the normal register.  The structural aberration extends to the RNase H active site and may play a role in the resistance of PPT to RNase H cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKH50BRNF3aLVg90H21EOLACvtfcHk0li1mXdQbRQKlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVCktrs%253D&md5=37213d1688b62adfa5b41b6e4af2e149</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.6.1449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.6.1449%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DTantillo%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DWhitcomb%26aufirst%3DJ.%2BM.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DCrystal%2520structure%2520of%2520HIV-1%2520reverse%2520transcriptase%2520in%2520complex%2520with%2520a%2520polypurine%2520tract%2520RNA%253ADNA%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D1449%26epage%3D1461%26doi%3D10.1093%2Femboj%2F20.6.1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Su, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywickrema, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span> </span><span class="NLM_article-title">Structural Basis for the Inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">7625</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span><span class="refDoi"> DOI: 10.1128/JVI.00353-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FJVI.00353-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20484498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=7625-7633&author=H.-P.+Suauthor=Y.+Yanauthor=G.+S.+Prasadauthor=R.+F.+Smithauthor=C.+L.+Danielsauthor=P.+D.+Abeywickremaauthor=J.+C.+Reidauthor=H.+M.+Loughranauthor=M.+Kornienkoauthor=S.+Sharmaauthor=J.+A.+Groblerauthor=B.+Xuauthor=V.+Sardanaauthor=T.+J.+Allisonauthor=P.+D.+Williamsauthor=P.+L.+Darkeauthor=D.+J.+Hazudaauthor=S.+Munshi&title=Structural+Basis+for+the+Inhibition+of+RNase+H+activity+of+HIV-1+reverse+transcriptase+by+RNase+H+active+site-directed+inhibitors&doi=10.1128%2FJVI.00353-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span></div><div class="casAuthors">Su, Hua-Poo; Yan, Youwei; Prasad, G. Sridhar; Smith, Robert F.; Daniels, Christopher L.; Abeywickrema, Pravien D.; Reid, John C.; Loughran, H. Marie; Kornienko, Maria; Sharma, Sujata; Grobler, Jay A.; Xu, Bei; Sardana, Vinod; Allison, Timothy J.; Williams, Peter D.; Darke, Paul L.; Hazuda, Daria J.; Munshi, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7625-7633</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HIV/AIDS continues to be a menace to public health.  Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients.  However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing therapies.  Currently, approved drugs target three of the four major enzyme activities encoded by the virus that are crit. to the HIV life cycle.  Although a no. of inhibitors of HIV RNase H activity have been reported, few inhibit by directly engaging the RNase H active site.  Here, we describe structures of naphthyridinone-contg. inhibitors bound to the RNase H active site.  This class of compds. binds to the active site via two metal ions that are coordinated by catalytic site residues, D443, E478, D498, and D549.  The directionality of the naphthyridinone pharmacophore is restricted by the ordering of D549 and H539 in the RNase H domain.  In addn., one of the naphthyridinone-based compds. was found to bind at a second site close to the polymerase active site and non-nucleoside/nucleotide inhibitor sites in a metal-independent manner.  Further characterization, using fluorescence-based thermal denaturation and a crystal structure of the isolated RNase H domain reveals that this compd. can also bind the RNase H site and retains the metal-dependent binding mode of this class of mols.  These structures provide a means for structurally guided design of novel RNase H inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofoAtMsynlGbVg90H21EOLACvtfcHk0lj1qCvffkVLLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L&md5=67296baed7573ed339c9fcf985b2ff20</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FJVI.00353-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00353-10%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DH.-P.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DC.%2BL.%26aulast%3DAbeywickrema%26aufirst%3DP.%2BD.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Inhibition%2520of%2520RNase%2520H%2520activity%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520RNase%2520H%2520active%2520site-directed%2520inhibitors%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D7625%26epage%3D7633%26doi%3D10.1128%2FJVI.00353-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lansdon, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster-Moyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschberg, T. A.</span><span> </span><span class="NLM_article-title">Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2905</span><span class="NLM_x">–</span> <span class="NLM_lpage">2915</span><span class="refDoi"> DOI: 10.1128/AAC.01594-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FAAC.01594-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=21464257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Kiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=2905-2915&author=E.+B.+Lansdonauthor=Q.+Liuauthor=S.+A.+Leavittauthor=M.+Balakrishnanauthor=J.+K.+Perryauthor=C.+Lancaster-Moyerauthor=N.+Kuttyauthor=X.+Liuauthor=N.+H.+Squiresauthor=W.+J.+Watkinsauthor=T.+A.+Kirschberg&title=Structural+and+binding+analysis+of+pyrimidinol+carboxylic+acid+and+N-hydroxy+quinazolinedione+HIV-1+RNase+H+inhibitors&doi=10.1128%2FAAC.01594-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors</span></div><div class="casAuthors">Lansdon, Eric B.; Liu, Qi; Leavitt, Stephanie A.; Balakrishnan, Mini; Perry, Jason K.; Lancaster-Moyer, Candra; Kutty, Nilima; Liu, Xiaohong; Squires, Neil H.; Watkins, William J.; Kirschberg, Thorsten A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2905-2915</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HIV-1 RNase H breaks down the intermediate RNA-DNA hybrids during reverse transcription, requiring two divalent metal ions for activity.  Pyrimidinol carboxylic acid and N-hydroxy quinazolinedione inhibitors were designed to coordinate the two metal ions in the active site of RNase H.  High-resoln. (1.4 Å to 2.1 Å) crystal structures were detd. with the isolated RNase H domain and reverse transcriptase (RT), which permit accurate assessment of the metal and water environment at the active site.  The geometry of the metal coordination suggests that the inhibitors mimic a substrate state prior to phosphodiester catalysis.  Surface plasmon resonance studies confirm metal-dependent binding to RNase H and demonstrate that the inhibitors do not bind at the polymerase active site of RT.  Addnl. evaluation of the RNase H site reveals an open protein surface with few addnl. interactions to optimize active-site inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ89ipmZgY9bVg90H21EOLACvtfcHk0lhW6uZ0wthGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Kiu7c%253D&md5=babdbff2785f14cd6f5b1f25890aa583</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FAAC.01594-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01594-10%26sid%3Dliteratum%253Aachs%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DBalakrishnan%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DLancaster-Moyer%26aufirst%3DC.%26aulast%3DKutty%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSquires%26aufirst%3DN.%2BH.%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DKirschberg%26aufirst%3DT.%2BA.%26atitle%3DStructural%2520and%2520binding%2520analysis%2520of%2520pyrimidinol%2520carboxylic%2520acid%2520and%2520N-hydroxy%2520quinazolinedione%2520HIV-1%2520RNase%2520H%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D2905%26epage%3D2915%26doi%3D10.1128%2FAAC.01594-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rodgers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culp, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debouck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span> </span><span class="NLM_article-title">The structure of unliganded reverse-transcriptase from the human-immunodeficiency-virus Type-1</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span><span class="refDoi"> DOI: 10.1073/pnas.92.4.1222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1073%2Fpnas.92.4.1222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=1222-1226&author=D.+W.+Rodgersauthor=S.+J.+Gamblinauthor=B.+A.+Harrisauthor=S.+Rayauthor=J.+S.+Culpauthor=B.+Hellmigauthor=D.+J.+Woolfauthor=C.+Debouckauthor=S.+C.+Harrison&title=The+structure+of+unliganded+reverse-transcriptase+from+the+human-immunodeficiency-virus+Type-1&doi=10.1073%2Fpnas.92.4.1222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.4.1222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.4.1222%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DD.%2BW.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DCulp%26aufirst%3DJ.%2BS.%26aulast%3DHellmig%26aufirst%3DB.%26aulast%3DWoolf%26aufirst%3DD.%2BJ.%26aulast%3DDebouck%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DThe%2520structure%2520of%2520unliganded%2520reverse-transcriptase%2520from%2520the%2520human-immunodeficiency-virus%2520Type-1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D1222%26epage%3D1226%26doi%3D10.1073%2Fpnas.92.4.1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hsiou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure of unliganded HIV-1 reverse transcriptase at 2.7 angstrom resolution: implications of conformational changes for polymerization and inhibition mechanisms</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1016/S0969-2126(96)00091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2FS0969-2126%2896%2900091-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=853-860&author=Y.+Hsiouauthor=J.+Dingauthor=K.+Dasauthor=A.+D.+Clarkauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structure+of+unliganded+HIV-1+reverse+transcriptase+at+2.7+angstrom+resolution%3A+implications+of+conformational+changes+for+polymerization+and+inhibition+mechanisms&doi=10.1016%2FS0969-2126%2896%2900091-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2896%2900091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252896%252900091-3%26sid%3Dliteratum%253Aachs%26aulast%3DHsiou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520of%2520unliganded%2520HIV-1%2520reverse%2520transcriptase%2520at%25202.7%2520angstrom%2520resolution%253A%2520implications%2520of%2520conformational%2520changes%2520for%2520polymerization%2520and%2520inhibition%2520mechanisms%26jtitle%3DStructure%26date%3D1996%26volume%3D4%26spage%3D853%26epage%3D860%26doi%3D10.1016%2FS0969-2126%2896%2900091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">10027</span><span class="NLM_x">–</span> <span class="NLM_lpage">10032</span><span class="refDoi"> DOI: 10.1073/pnas.96.18.10027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1073%2Fpnas.96.18.10027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10468556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFegsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=10027-10032&author=S.+G.+Sarafianosauthor=K.+Dasauthor=A.+D.+Clarkauthor=J.+Dingauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=E.+Arnold&title=Lamivudine+%283TC%29+resistance+in+HIV-1+reverse+transcriptase+involves+steric+hindrance+with+beta-branched+amino+acids&doi=10.1073%2Fpnas.96.18.10027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids</span></div><div class="casAuthors">Sarafianos, Stefan G.; Das, Kalyan; Clark, Arthur D., Jr.; Ding, Jianping; Boyer, Paul L.; Hughes, Stephen H.; Arnold, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10027-10032</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">An important component of triple-drug anti-AIDS therapy is 2',3'-dideoxy-3'-thiacytidine (3TC, lamivudine).  Single mutations at residue 184 of the reverse transcriptase (RT) in HIV cause high-level resistance to 3TC and contribute to the failure of anti-AIDS combination therapy.  We have detd. crystal structures of the 3TC-resistant mutant HIV-1 RT (M184I) in both the presence and absence of a DNA/DNA template-primer.  In the absence of a DNA substrate, the wild-type and mutant structures are very similar.  However, comparison of crystal structures of M184I mutant and wild-type HIV-1 RT with and without DNA reveals repositioning of the template-primer in the M184I/DNA binary complex and other smaller changes in residues in the dNTP-binding site.  On the basis of these structural results, we developed a model that explains the ability of the 3TC-resistant mutant M184I to incorporate dNTPs but not the nucleotide analog 3TCTP.  In this model, steric hindrance is expected for NRTIs with β- or L- ring configurations, as with the enantiomer of 3TC that is used in therapy.  Steric conflict between the oxathiolane ring of 3TCTP and the side chain of β-branched amino acids (Val, Ile, Thr) at position 184 perturbs inhibitor binding, leading to a redn. in incorporation of the analog.  The model can also explain the 3TC resistance of analogous hepatitis B polymerase mutants.  Repositioning of the template-primer as obsd. in the binary complex (M184I/DNA) may also occur in the catalytic ternary complex (M184I/DNA/3TCTP) and contribute to 3TC resistance by interfering with the formation of a catalytically competent closed complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZSQKvs4NyB7Vg90H21EOLACvtfcHk0lhW6uZ0wthGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFegsrg%253D&md5=22ee198411a5c60ba007b19081711485</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.10027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.10027%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DLamivudine%2520%25283TC%2529%2520resistance%2520in%2520HIV-1%2520reverse%2520transcriptase%2520involves%2520steric%2520hindrance%2520with%2520beta-branched%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D10027%26epage%3D10032%26doi%3D10.1073%2Fpnas.96.18.10027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hsiou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleim, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1006/jmbi.2001.4648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1006%2Fjmbi.2001.4648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2001&pages=437-445&author=Y.+Hsiouauthor=J.+P.+Dingauthor=K.+Dasauthor=A.+D.+Clarkauthor=P.+L.+Boyerauthor=P.+Lewiauthor=P.+A.+J.+Janssenauthor=J.+P.+Kleimauthor=M.+Rosnerauthor=S.+H.+Hughesauthor=E.+Arnold&title=The+Lys103Asn+mutation+of+HIV-1+RT%3A+a+novel+mechanism+of+drug+resistance&doi=10.1006%2Fjmbi.2001.4648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2001.4648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2001.4648%26sid%3Dliteratum%253Aachs%26aulast%3DHsiou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%2BP.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DLewi%26aufirst%3DP.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DKleim%26aufirst%3DJ.%2BP.%26aulast%3DRosner%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DThe%2520Lys103Asn%2520mutation%2520of%2520HIV-1%2520RT%253A%2520a%2520novel%2520mechanism%2520of%2520drug%2520resistance%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D309%26spage%3D437%26epage%3D445%26doi%3D10.1006%2Fjmbi.2001.4648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structural basis of HIV-1 resistance to AZT by excision</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span><span class="refDoi"> DOI: 10.1038/nsmb.1908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1038%2Fnsmb.1908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20852643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1202-1209&author=X.+Y.+Tuauthor=K.+Dasauthor=Q.+W.+Hanauthor=J.+D.+Baumanauthor=A.+D.+Clarkauthor=X.+R.+Houauthor=Y.+V.+Frenkelauthor=B.+L.+Gaffneyauthor=R.+A.+Jonesauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=S.+G.+Sarafianosauthor=E.+Arnold&title=Structural+basis+of+HIV-1+resistance+to+AZT+by+excision&doi=10.1038%2Fnsmb.1908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV-1 resistance to AZT by excision</span></div><div class="casAuthors">Tu, Xiongying; Das, Kalyan; Han, Qianwei; Bauman, Joseph D.; Clark, Arthur D.; Hou, Xiaorong; Frenkel, Yulia V.; Gaffney, Barbara L.; Jones, Roger A.; Boyer, Paul L.; Hughes, Stephen H.; Sarafianos, Stefan G.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1202-1209</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV-1) develops resistance to 3'-azido-2',3'-deoxythymidine (AZT, zidovudine) by acquiring mutations in reverse transcriptase that enhance the ATP-mediated excision of AZT monophosphate from the 3' end of the primer.  The excision reaction occurs at the dNTP-binding site, uses ATP as a pyrophosphate donor, unblocks the primer terminus and allows reverse transcriptase to continue viral DNA synthesis.  The excision product is AZT adenosine dinucleoside tetraphosphate (AZTppppA).  We detd. five crystal structures: wild-type reverse transcriptase-double-stranded DNA (RT-dsDNA)-AZTppppA; AZT-resistant (AZTr; M41L D67N K70R T215Y K219Q) RT-dsDNA-AZTppppA; AZTr RT-dsDNA terminated with AZT at dNTP- and primer-binding sites; and AZTr apo reverse transcriptase.  The AMP part of AZTppppA bound differently to wild-type and AZTr reverse transcriptases, whereas the AZT triphosphate part bound the two enzymes similarly.  Thus, the resistance mutations create a high-affinity ATP-binding site.  The structure of the site provides an opportunity to design inhibitors of AZT-monophosphate excision.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGIO2feJMMO7Vg90H21EOLACvtfcHk0lirde7u73CKnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73I&md5=e0394a2d8e947d42534c5c7e8d366ed4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1908%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DX.%2BY.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DQ.%2BW.%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DHou%26aufirst%3DX.%2BR.%26aulast%3DFrenkel%26aufirst%3DY.%2BV.%26aulast%3DGaffney%26aufirst%3DB.%2BL.%26aulast%3DJones%26aufirst%3DR.%2BA.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520of%2520HIV-1%2520resistance%2520to%2520AZT%2520by%2520excision%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1202%26epage%3D1209%26doi%3D10.1038%2Fnsmb.1908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>PyMOL: <a href="http://www.pymol.org" class="extLink">www.pymol.org</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PyMOL%3A+www.pymol.org+%28accessed+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Fletcher, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleschak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borkow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span> </span><span class="NLM_article-title">Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1006/prep.1996.0004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1006%2Fprep.1996.0004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=9172779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK28XhtVCqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=27-32&author=R.+S.+Fletcherauthor=G.+Holleschakauthor=E.+Nagyauthor=D.+Arionauthor=G.+Borkowauthor=Z.+Guauthor=M.+A.+Wainbergauthor=M.+A.+Parniak&title=Single-step+purification+of+recombinant+wild-type+and+mutant+HIV-1+reverse+transcriptase&doi=10.1006%2Fprep.1996.0004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase</span></div><div class="casAuthors">Fletcher, Ronald S.; Holleschak, Gyula; Nagy, Eva; Arion, Dominique; Borkow, Gadi; Gu, Zhengxian; Wainberg, Mark A.; Parniak, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-32</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A single-step method that enables the purifn. of HIV-1 recombinant reverse transcriptase (RT) directly from bacterial lysates in <2 h is described.  Clarified lysates were applied to com. Q- and S-matrix cartridge columns connected in series.  The columns were washed with low-salt buffer to remove unbound protein, then the Q column was removed and RT was eluted from the S column using a salt gradient.  The purifn. was carried out with both medium-pressure and high-pressure chromatog. systems.  The purifns. were carried out at room temp. near neutral pH, providing enzyme with high DNA polymerase specific activity.  A crucial aspect of the procedure was the use of Tris buffer, a buffer that is normally incompatible in cation-exchange methods.  The method was applicable for the purifn. of the p51/p66 heterodimer and the p51 and p66 homodimer forms of RT.  This method was used to purify wild-type RT and several recombinant RT proteins contg. mutations correlated with dideoxynucleoside drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotv6nxVQS-UrVg90H21EOLACvtfcHk0lirde7u73CKnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtVCqu7w%253D&md5=106b9f3b265af0342bed655f2644a5d1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1006%2Fprep.1996.0004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fprep.1996.0004%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DR.%2BS.%26aulast%3DHolleschak%26aufirst%3DG.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DArion%26aufirst%3DD.%26aulast%3DBorkow%26aufirst%3DG.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26atitle%3DSingle-step%2520purification%2520of%2520recombinant%2520wild-type%2520and%2520mutant%2520HIV-1%2520reverse%2520transcriptase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D1996%26volume%3D7%26spage%3D27%26epage%3D32%26doi%3D10.1006%2Fprep.1996.0004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishima, R.</span><span> </span><span class="NLM_article-title">Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2010.01052.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1111%2Fj.1747-0285.2010.01052.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=21114787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2ktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=39-47&author=Q.+Gongauthor=L.+Menonauthor=T.+Ilinaauthor=L.+G.+Millerauthor=J.+Ahnauthor=M.+A.+Parniakauthor=R.+Ishima&title=Interaction+of+HIV-1+reverse+transcriptase+ribonuclease+H+with+an+acylhydrazone+inhibitor&doi=10.1111%2Fj.1747-0285.2010.01052.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor</span></div><div class="casAuthors">Gong, Qingguo; Menon, Lakshmi; Ilina, Tatiana; Miller, Lena G.; Ahn, Jinwoo; Parniak, Michael A.; Ishima, Rieko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">HIV-1 reverse transcriptase is a bifunctional enzyme, having both DNA polymerase (RNA- and DNA-dependent) and RNase H activities.  HIV-1 reverse transcriptase has been an exceptionally important target for antiretroviral therapeutic development, and nearly half of the current clin. used antiretrovirals target reverse transcriptase DNA polymerase.  However, no inhibitors of reverse transcriptase RNase H are on the market or in preclin. development.  Several drug-like small mol. inhibitors of reverse transcriptase RNase H have been described, but little structural information is available about the interactions between reverse transcriptase RNase H and inhibitors that exhibit antiviral activity.  In this report, we describe NMR studies of the interaction of a new RNase H inhibitor, BHMP07, with a catalytically active HIV-1 reverse transcriptase RNase H domain fragment.  We carried out soln. NMR expts. to identify the interaction interface of BHMP07 with the RNase H domain fragment.  Chem. shift changes of backbone amide signals at different BHMP07 concns. clearly demonstrate that BHMP07 mainly recognizes the substrate handle region in the RNase H fragment.  Using RNase H inhibition assays and reverse transcriptase mutants, the binding specificity of BHMP07 was compared with another inhibitor, dihydroxy benzoyl naphthyl hydrazone.  Our results provide a structural characterization of the RNase H inhibitor interaction and are likely to be useful for further improvements of the inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFO6xAt28QU7Vg90H21EOLACvtfcHk0lirde7u73CKnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2ktrs%253D&md5=9d6163932388134057a3d5363c95c9ff</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.01052.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.01052.x%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DMenon%26aufirst%3DL.%26aulast%3DIlina%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DL.%2BG.%26aulast%3DAhn%26aufirst%3DJ.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DIshima%26aufirst%3DR.%26atitle%3DInteraction%2520of%2520HIV-1%2520reverse%2520transcriptase%2520ribonuclease%2520H%2520with%2520an%2520acylhydrazone%2520inhibitor%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D39%26epage%3D47%26doi%3D10.1111%2Fj.1747-0285.2010.01052.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kirby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndongwe, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michailidis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sietsema, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fetterly, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span> </span><span class="NLM_article-title">Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2048</span><span class="NLM_x">–</span> <span class="NLM_lpage">2061</span><span class="refDoi"> DOI: 10.1128/AAC.06000-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FAAC.06000-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=22252812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2qsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=2048-2061&author=K.+A.+Kirbyauthor=B.+Marchandauthor=Y.+T.+Ongauthor=T.+P.+Ndongweauthor=A.+Hachiyaauthor=E.+Michailidisauthor=M.+D.+Leslieauthor=D.+V.+Sietsemaauthor=T.+L.+Fetterlyauthor=C.+A.+Dorstauthor=K.+Singhauthor=Z.+Wangauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Structural+and+inhibition+studies+of+the+RNase+H+function+of+xenotropic+murine+leukemia+virus-related+virus+reverse+transcriptase&doi=10.1128%2FAAC.06000-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase</span></div><div class="casAuthors">Kirby, Karen A.; Marchand, Bruno; Ong, Yee Tsuey; Ndongwe, Tanyaradzwa P.; Hachiya, Atsuko; Michailidis, Eleftherios; Leslie, Maxwell D.; Sietsema, Daniel V.; Fetterly, Tracy L.; Dorst, Christopher A.; Singh, Kamalendra; Wang, Zhengqiang; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2048-2061</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">RNase H inhibitors (RNHIs) have gained attention as potential HIV-1 therapeutics.  Although several RNHIs have been studied in the context of HIV-1 reverse transcriptase (RT) RNase H, there is no information on inhibitors that might affect the RNase H activity of other RTs.  We performed biochem., virol., crystallog., and mol. modeling studies to compare the RNase H function and inhibition profiles of the gammaretroviral xenotropic murine leukemia virus-related virus (XMRV) and Moloney murine leukemia virus (MoMLV) RTs to those of HIV-1 RT.  The RNase H activity of XMRV RT is significantly lower than that of HIV-1 RT and comparable to that of MoMLV RT.  XMRV and MoMLV, but not HIV-1 RT, had optimal RNase H activities in the presence of Mn2+ and not Mg2+.  Using hydroxyl-radical footprinting assays, we demonstrated that the distance between the polymerase and RNase H domains in the MoMLV and XMRV RTs is longer than that in the HIV-1 RT by ∼3.4 Å.  We identified one naphthyridinone and one hydroxyisoquinolinedione as potent inhibitors of HIV-1 and XMRV RT RNases H with 50% inhibitory concns. ranging from ∼0.8 to 0.02 μM.  Two acylhydrazones effective against HIV-1 RT RNase H were less potent against the XMRV enzyme.  We also solved the crystal structure of an XMRV RNase H fragment at high resoln. (1.5 Å) and detd. the mol. details of the XMRV RNase H active site, thus providing a framework that would be useful for the design of antivirals that target RNase H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm1yqV6mSzuLVg90H21EOLACvtfcHk0liqMj05sncETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2qsLc%253D&md5=abf8755f0530c84af47e1ab6464ff9f9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.06000-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06000-11%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DOng%26aufirst%3DY.%2BT.%26aulast%3DNdongwe%26aufirst%3DT.%2BP.%26aulast%3DHachiya%26aufirst%3DA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DLeslie%26aufirst%3DM.%2BD.%26aulast%3DSietsema%26aufirst%3DD.%2BV.%26aulast%3DFetterly%26aufirst%3DT.%2BL.%26aulast%3DDorst%26aufirst%3DC.%2BA.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520and%2520inhibition%2520studies%2520of%2520the%2520RNase%2520H%2520function%2520of%2520xenotropic%2520murine%2520leukemia%2520virus-related%2520virus%2520reverse%2520transcriptase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D2048%26epage%3D2061%26doi%3D10.1128%2FAAC.06000-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span> </span><span class="NLM_article-title">Rationally designed dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3416</span><span class="NLM_x">–</span> <span class="NLM_lpage">3419</span><span class="refDoi"> DOI: 10.1021/jm070512p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070512p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3416-3419&author=Z.+Wangauthor=E.+M.+Bennettauthor=D.+J.+Wilsonauthor=C.+Salomonauthor=R.+Vince&title=Rationally+designed+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1021%2Fjm070512p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase</span></div><div class="casAuthors">Wang, Zhengqiang; Bennett, Eric M.; Wilson, Daniel J.; Salomon, Christine; Vince, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3416-3419</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bifunctional inhibitors were designed and synthesized based on 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) non-nucleoside reverse transcriptase (RT) inhibitors and diketoacid (DKA) integrase (IN) inhibitors.  Biochem. studies revealed activity against RT and IN at low nanomolar and low micromolar concns., resp.  Exceptionally low IC50 values from a cell-based assay were achieved along with remarkably high therapeutic indexes.  Compd. I was identified as the best compd. of the series (IC50: 24 nM against RT, 4.4 μM against IN, and 10 nM against HIV-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKQ5ZDoIQqLVg90H21EOLACvtfcHk0liqMj05sncETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D&md5=021d763f7f62919cc1fe9d010ab56e60</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm070512p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070512p%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DSalomon%26aufirst%3DC.%26aulast%3DVince%26aufirst%3DR.%26atitle%3DRationally%2520designed%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3416%26epage%3D3419%26doi%3D10.1021%2Fjm070512p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Abram, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span> </span><span class="NLM_article-title">Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">11952</span><span class="NLM_x">–</span> <span class="NLM_lpage">11961</span><span class="refDoi"> DOI: 10.1128/JVI.79.18.11952-11961.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FJVI.79.18.11952-11961.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=16140771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWktL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=11952-11961&author=M.+E.+Abramauthor=M.+A.+Parniak&title=Virion+instability+of+human+immunodeficiency+virus+type+1+reverse+transcriptase+%28RT%29+mutated+in+the+protease+cleavage+site+between+RT+p51+and+the+RT+RNase+H+domain&doi=10.1128%2FJVI.79.18.11952-11961.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain</span></div><div class="casAuthors">Abram, Michael E.; Parniak, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11952-11961</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Each of the human immunodeficiency virus type 1 (HIV-1) pol-encoded enzymes, protease (PR), reverse transcriptase (RT), and integrase (IN), is active only as a dimer (or higher-order oligomer in the case of IN), but only RT comprises subunits of different masses.  RT is a heterodimer of 66-kDa and 51-kDa subunits.  The latter is formed by HIV PR-catalyzed cleavage of p66 during virion maturation, resulting in the removal of the RNase H (RNH) domain of a p66 subunit.  In order to study the apparent need for RT heterodimers in the context of the virion, we introduced a variety of mutations in the RT p51-RNH protease cleavage site of an infectious HIV-1 mol. clone.  Surprisingly, rather than leading to virions with increased RT p66 content, most of the mutations resulted in significantly attenuated virus that contained greatly decreased levels of RT that in many cases was primarily p51 RT.  IN levels were also reduced in several mutants.  However, most mutants showed normal levels of the Pr160gag-pol precursor polyprotein, suggesting that reduced virion RT arose from proteolytic instability rather than decreased incorporation.  Mutant virion p24 Gag levels were equiv. to wild type, indicating that Gag incorporation and processing were not affected.  Repeated passage of MT-2 cells exposed to mutant viruses led to the appearance of virus with improved replication capacity; these virions contained normally processed RT at near-wild-type levels.  These results imply that addnl. proteolytic processing of RT to the p66/p51 heterodimer is essential to provide proteolytic stability of RT during HIV-1 maturation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtyy4eriQOP7Vg90H21EOLACvtfcHk0liqMj05sncETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWktL%252FL&md5=e9a14e6bd954b4fea14701bee282fcd7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.18.11952-11961.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.18.11952-11961.2005%26sid%3Dliteratum%253Aachs%26aulast%3DAbram%26aufirst%3DM.%2BE.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26atitle%3DVirion%2520instability%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%2520%2528RT%2529%2520mutated%2520in%2520the%2520protease%2520cleavage%2520site%2520between%2520RT%2520p51%2520and%2520the%2520RT%2520RNase%2520H%2520domain%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D11952%26epage%3D11961%26doi%3D10.1128%2FJVI.79.18.11952-11961.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baweja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oren, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shatkin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5083</span><span class="NLM_x">–</span> <span class="NLM_lpage">5092</span><span class="refDoi"> DOI: 10.1093/nar/gkn464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Fnar%2Fgkn464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=18676450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGkt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=5083-5092&author=J.+D.+Baumanauthor=K.+Dasauthor=W.+C.+Hoauthor=M.+Bawejaauthor=D.+M.+Himmelauthor=A.+D.+Clarkauthor=D.+A.+Orenauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=A.+J.+Shatkinauthor=E.+Arnold&title=Crystal+engineering+of+HIV-1+reverse+transcriptase+for+structure-based+drug+design&doi=10.1093%2Fnar%2Fgkn464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design</span></div><div class="casAuthors">Bauman, Joseph D.; Das, Kalyan; Ho, William C.; Baweja, Mukta; Himmel, Daniel M.; Clark, Arthur D., Jr.; Oren, Deena A.; Boyer, Paul L.; Hughes, Stephen H.; Shatkin, Aaron J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5083-5092</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">HIV-1 reverse transcriptase (RT) is a primary target for anti-AIDS drugs.  Structures of HIV-1 RT, usually detd. at ∼2.5-3.0 Å resoln., are important for understanding enzyme function and mechanisms of drug resistance in addn. to being helpful in the design of RT inhibitors.  Despite hundreds of attempts, it was not possible to obtain the structure of a complex of HIV-1 RT with TMC278, a nonnucleoside RT inhibitor (NNRTI) in advanced clin. trials.  A systematic and iterative protein crystal engineering approach was developed to optimize RT for obtaining crystals in complexes with TMC278 and other NNRTIs that diffract X-rays to 1.8 Å resoln.  Another form of engineered RT was optimized to produce a high-resoln. apo-RT crystal form, reported here at 1.85 Å resoln., with a distinct RT conformation.  Engineered RTs were mutagenized using a new, flexible and cost effective method called methylated overlap-extension ligation independent cloning.  Our anal. suggests that reducing the solvent content, increasing lattice contacts, and stabilizing the internal low-energy conformations of RT are crit. for the growth of crystals that diffract to high resoln.  The new RTs enable rapid crystn. and yield high-resoln. structures that are useful in designing/developing new anti-AIDS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8sHD_iC_LsLVg90H21EOLACvtfcHk0lgGaU59rm3OGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGkt7%252FI&md5=c7957e67c3a017b289e03de94a78cbbd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn464%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DBaweja%26aufirst%3DM.%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DOren%26aufirst%3DD.%2BA.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DShatkin%26aufirst%3DA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DCrystal%2520engineering%2520of%2520HIV-1%2520reverse%2520transcriptase%2520for%2520structure-based%2520drug%2520design%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3D5083%26epage%3D5092%26doi%3D10.1093%2Fnar%2Fgkn464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgGaU59rm3OGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Matthews, B. W.</span><span> </span><span class="NLM_article-title">Determination of Protein Molecular-weight, hydration, and packing from crystal density</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1016/0076-6879(85)14018-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2F0076-6879%2885%2914018-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1985&pages=176-187&author=B.+W.+Matthews&title=Determination+of+Protein+Molecular-weight%2C+hydration%2C+and+packing+from+crystal+density&doi=10.1016%2F0076-6879%2885%2914018-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2885%2914018-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252885%252914018-8%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DB.%2BW.%26atitle%3DDetermination%2520of%2520Protein%2520Molecular-weight%252C%2520hydration%252C%2520and%2520packing%2520from%2520crystal%2520density%26jtitle%3DMethods%2520Enzymol.%26date%3D1985%26volume%3D114%26spage%3D176%26epage%3D187%26doi%3D10.1016%2F0076-6879%2885%2914018-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Mccoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+Mccoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgGaU59rm3OGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMccoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span> </span><span class="NLM_article-title">PHENIX: building new software for automated crystallographic structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1948</span><span class="NLM_x">–</span> <span class="NLM_lpage">1954</span><span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.+W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+building+new+software+for+automated+crystallographic+structure+determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0ljD5yoeptnfSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520building%2520new%2520software%2520for%2520automated%2520crystallographic%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljD5yoeptnfSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljD5yoeptnfSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaver-Fay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snoeyink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">W375</span><span class="NLM_x">–</span> <span class="NLM_lpage">W383</span><span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-W383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eZ241PbazHEhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3DW383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maria E. Cilento, Karen A. Kirby, <span class="NLM_string-name hlFld-ContribAuthor">Stefan G. Sarafianos</span>. </span><span class="cited-content_cbyCitation_article-title">Avoiding Drug Resistance in HIV Reverse Transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3271-3296. <a href="https://doi.org/10.1021/acs.chemrev.0c00967" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00967%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DAvoiding%252BDrug%252BResistance%252Bin%252BHIV%252BReverse%252BTranscriptase%26aulast%3DCilento%26aufirst%3DMaria%2BE.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D06092020%26date%3D28012021%26volume%3D121%26issue%3D6%26spage%3D3271%26epage%3D3296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jing Wu, Jinzhu Zhang, Ruben Soto-Acosta, Lili Mao, Jiahui Lian, Kenny Chen, Guy Pillon, Guoqi Zhang, Robert J. Geraghty, <span class="NLM_string-name hlFld-ContribAuthor">Shengping Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of 1-Hydroxyacridones from para-Quinols and ortho-Methoxycarbonylaryl Isocyanates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (6)
                                     , 4515-4524. <a href="https://doi.org/10.1021/acs.joc.9b03307" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03307%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%252BSynthesis%252Bof%252B1-Hydroxyacridones%252Bfrom%252Bpara-Quinols%252Band%252Bortho-Methoxycarbonylaryl%252BIsocyanates%26aulast%3DWu%26aufirst%3DJing%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D09122019%26date%3D27022020%26date%3D19022020%26volume%3D85%26issue%3D6%26spage%3D4515%26epage%3D4524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Wang, Stefan G. Sarafianos, <span class="NLM_string-name hlFld-ContribAuthor">Zhengqiang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2020,</strong> <em>53 </em>
                                    (1)
                                     , 218-230. <a href="https://doi.org/10.1021/acs.accounts.9b00450" title="DOI URL">https://doi.org/10.1021/acs.accounts.9b00450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.9b00450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.9b00450%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DCutting%252Binto%252Bthe%252BSubstrate%252BDominance%25253A%252BPharmacophore%252Band%252BStructure-Based%252BApproaches%252Btoward%252BInhibiting%252BHuman%252BImmunodeficiency%252BVirus%252BReverse%252BTranscriptase-Associated%252BRibonuclease%252BH%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D23082019%26date%3D27122019%26volume%3D53%26issue%3D1%26spage%3D218%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhaoyong Xi, Zhengqiang Wang, Stefan G. Sarafianos, Nataliya S. Myshakina, <span class="NLM_string-name hlFld-ContribAuthor">Rieko Ishima</span>. </span><span class="cited-content_cbyCitation_article-title">Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (11)
                                     , 1963-1974. <a href="https://doi.org/10.1021/acsinfecdis.9b00300" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00300%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDeterminants%252Bof%252BActive-Site%252BInhibitor%252BInteraction%252Bwith%252BHIV-1%252BRNase%252BH%26aulast%3DXi%26aufirst%3DZhaoyong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13082019%26date%3D02102019%26volume%3D5%26issue%3D11%26spage%3D1963%26epage%3D1974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Allie
Y. Chen, Rebecca N. Adamek, Benjamin L. Dick, Cy V. Credille, Christine N. Morrison, <span class="NLM_string-name hlFld-ContribAuthor">Seth M. Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Metalloenzymes for Therapeutic Intervention. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1323-1455. <a href="https://doi.org/10.1021/acs.chemrev.8b00201" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00201%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTargeting%252BMetalloenzymes%252Bfor%252BTherapeutic%252BIntervention%26aulast%3DChen%26aufirst%3DAllie%2BY.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29032018%26date%3D07092018%26volume%3D119%26issue%3D2%26spage%3D1323%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjeev Kumar V.  Vernekar</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Bulan  Wu</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Nataliya  Myshakina</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, and <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 5045-5056. <a href="https://doi.org/10.1021/acs.jmedchem.7b00440" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00440%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDouble-Winged%252B3-Hydroxypyrimidine-2%25252C4-diones%25253A%252BPotent%252Band%252BSelective%252BInhibition%252Bagainst%252BHIV-1%252BRNase%252BH%252Bwith%252BSignificant%252BAntiviral%252BActivity%26aulast%3DVernekar%26aufirst%3DSanjeev%2BKumar%2BV.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21032017%26date%3D31052017%26date%3D22062017%26date%3D19052017%26volume%3D60%26issue%3D12%26spage%3D5045%26epage%3D5056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Ju</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Bing  Huang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, and <span class="hlFld-ContribAuthor ">Peng  Zhan</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3533-3551. <a href="https://doi.org/10.1021/acs.jmedchem.6b01227" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01227%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BInfluenza%252BVirus%252BPolymerase%252BAcidic%252B%252528PA%252529%252BEndonuclease%25253A%252BContemporary%252BDevelopments%252Band%252BPerspectives%26aulast%3DJu%26aufirst%3DHan%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D13082016%26date%3D07022017%26date%3D11052017%26date%3D24012017%26volume%3D60%26issue%3D9%26spage%3D3533%26epage%3D3551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Meiyan  Fan</span>, <span class="hlFld-ContribAuthor ">Zhiyun  Peng</span>, <span class="hlFld-ContribAuthor ">Guangcheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113546. <a href="https://doi.org/10.1016/j.ejmech.2021.113546" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113546%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bhydroxypyranone%252Band%252Bhydroxypyridinone%252Bas%252Bprivileged%252Bscaffolds%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DHe%26aufirst%3DMin%26date%3D2021%26volume%3D221%26spage%3D113546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Tiffany C.  Edwards</span>, <span class="hlFld-ContribAuthor ">Rajkumar Lalji  Sahani</span>, <span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Hideki  Aihara</span>, <span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complex. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113640. <a href="https://doi.org/10.1016/j.ejmech.2021.113640" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113640%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetal%252Bbinding%252B6-arylthio-3-hydroxypyrimidine-2%25252C4-diones%252Binhibited%252Bhuman%252Bcytomegalovirus%252Bby%252Btargeting%252Bthe%252BpUL89%252Bendonuclease%252Bof%252Bthe%252Bterminase%252Bcomplex%26aulast%3DWang%26aufirst%3DLei%26date%3D2021%26volume%3D222%26spage%3D113640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elke  Bogner</span>, <span class="hlFld-ContribAuthor ">Anna  Egorova</span>, <span class="hlFld-ContribAuthor ">Vadim  Makarov</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecules—Prospective Novel HCMV Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 474. <a href="https://doi.org/10.3390/v13030474" title="DOI URL">https://doi.org/10.3390/v13030474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13030474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13030474%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DSmall%252BMolecules%2525E2%252580%252594Prospective%252BNovel%252BHCMV%252BInhibitors%26aulast%3DBogner%26aufirst%3DElke%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harsha  Kharkwal</span>, <span class="hlFld-ContribAuthor ">Banoth K  Kumar</span>, <span class="hlFld-ContribAuthor ">Sankaranarayanan  Murugesan</span>, <span class="hlFld-ContribAuthor ">Gautam  Singhvi</span>, <span class="hlFld-ContribAuthor ">Preeti  Avasthi</span>, <span class="hlFld-ContribAuthor ">Ankush  Goyal</span>, <span class="hlFld-ContribAuthor ">Joazaizulfazli  Jamalis</span>, <span class="hlFld-ContribAuthor ">Subhash  Chander</span>. </span><span class="cited-content_cbyCitation_article-title">Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 269-286. <a href="https://doi.org/10.4155/fmc-2020-0257" title="DOI URL">https://doi.org/10.4155/fmc-2020-0257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0257%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSearch%252Bfor%252Bnew%252Btherapeutics%252Bagainst%252BHIV-1%252Bvia%252Bdual%252Binhibition%252Bof%252BRNase%252BH%252Band%252Bintegrase%25253A%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bchallenges%26aulast%3DKharkwal%26aufirst%3DHarsha%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D269%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Edeildo Ferreira  da Silva-Júnior</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 and HBV RNase H as Metal-Chelating Inhibitors: Discovery and Medicinal Chemistry Strategies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 585-602. <a href="https://doi.org/10.1007/978-3-030-71165-8_28" title="DOI URL">https://doi.org/10.1007/978-3-030-71165-8_28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-71165-8_28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-71165-8_28%26sid%3Dliteratum%253Aachs%26atitle%3DHIV-1%252Band%252BHBV%252BRNase%252BH%252Bas%252BMetal-Chelating%252BInhibitors%25253A%252BDiscovery%252Band%252BMedicinal%252BChemistry%252BStrategies%26aulast%3DWei%26aufirst%3DFenju%26date%3D2021%26date%3D2021%26spage%3D585%26epage%3D602%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHuman%252BViruses%25253A%252BDiseases%25252C%252BTreatments%252Band%252BVaccines%26aulast%3DAhmad%26aufirst%3DShamim%2BI.%26date%3D2021%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez‐Arias</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Small Molecular HIV‐1 and Hepatitis B Virus RNase H Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 273-292. <a href="https://doi.org/10.1002/9781119640868.ch9" title="DOI URL">https://doi.org/10.1002/9781119640868.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119640868.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119640868.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bin%252BSmall%252BMolecular%252BHIV%2525E2%252580%2525901%252Band%252BHepatitis%252BB%252BVirus%252BRNase%252BH%252BInhibitors%26aulast%3DWei%26aufirst%3DFenju%26date%3D2020%26date%3D2020%26spage%3D273%26epage%3D292%26pub%3DWiley%26atitle%3DAdvances%252Bin%252BMetallodrugs%26aulast%3DShahid%25E2%2580%2590ul%25E2%2580%2590Islam%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malwina  Hyjek</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Figiel</span>, <span class="hlFld-ContribAuthor ">Marcin  Nowotny</span>. </span><span class="cited-content_cbyCitation_article-title">RNases H: Structure and mechanism. </span><span class="cited-content_cbyCitation_journal-name">DNA Repair</span><span> <strong>2019,</strong> <em>84 </em>, 102672. <a href="https://doi.org/10.1016/j.dnarep.2019.102672" title="DOI URL">https://doi.org/10.1016/j.dnarep.2019.102672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dnarep.2019.102672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dnarep.2019.102672%26sid%3Dliteratum%253Aachs%26jtitle%3DDNA%2520Repair%26atitle%3DRNases%252BH%25253A%252BStructure%252Band%252Bmechanism%26aulast%3DHyjek%26aufirst%3DMalwina%26date%3D2019%26volume%3D84%26spage%3D102672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Yanming  Chen</span>, <span class="hlFld-ContribAuthor ">Yafeng  Tian</span>, <span class="hlFld-ContribAuthor ">Yilan  Zhao</span>, <span class="hlFld-ContribAuthor ">Fengshou  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaogang  Luo</span>, <span class="hlFld-ContribAuthor ">Xiulian  Ju</span>, <span class="hlFld-ContribAuthor ">Genyan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              study of 3-hydroxypyrimidine-2,4-diones as inhibitors of HIV RT-associated RNase H using molecular docking, molecular dynamics, 3D-QSAR, and pharmacophore models. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (43)
                                     , 17004-17017. <a href="https://doi.org/10.1039/C9NJ03353J" title="DOI URL">https://doi.org/10.1039/C9NJ03353J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ03353J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ03353J%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DIn%252Bsilico%252Bstudy%252Bof%252B3-hydroxypyrimidine-2%25252C4-diones%252Bas%252Binhibitors%252Bof%252BHIV%252BRT-associated%252BRNase%252BH%252Busing%252Bmolecular%252Bdocking%25252C%252Bmolecular%252Bdynamics%25252C%252B3D-QSAR%25252C%252Band%252Bpharmacophore%252Bmodels%26aulast%3DGao%26aufirst%3DYa%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D43%26spage%3D17004%26epage%3D17017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enzo  Tramontano</span>, <span class="hlFld-ContribAuthor ">Angela  Corona</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>. </span><span class="cited-content_cbyCitation_article-title">Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2019,</strong> <em>171 </em>, 104613. <a href="https://doi.org/10.1016/j.antiviral.2019.104613" title="DOI URL">https://doi.org/10.1016/j.antiviral.2019.104613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2019.104613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2019.104613%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DRibonuclease%252BH%25252C%252Ban%252Bunexploited%252Btarget%252Bfor%252Bantiviral%252Bintervention%252Bagainst%252BHIV%252Band%252Bhepatitis%252BB%252Bvirus%26aulast%3DTramontano%26aufirst%3DEnzo%26date%3D2019%26volume%3D171%26spage%3D104613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Esposito</span>, <span class="hlFld-ContribAuthor ">Francesca Alessandra  Ambrosio</span>, <span class="hlFld-ContribAuthor ">Rita  Maleddu</span>, <span class="hlFld-ContribAuthor ">Giosuè  Costa</span>, <span class="hlFld-ContribAuthor ">Roberta  Rocca</span>, <span class="hlFld-ContribAuthor ">Elias  Maccioni</span>, <span class="hlFld-ContribAuthor ">Raffaella  Catalano</span>, <span class="hlFld-ContribAuthor ">Isabella  Romeo</span>, <span class="hlFld-ContribAuthor ">Phaedra  Eleftheriou</span>, <span class="hlFld-ContribAuthor ">Denish C.  Karia</span>, <span class="hlFld-ContribAuthor ">Petros  Tsirides</span>, <span class="hlFld-ContribAuthor ">Nilesh  Godvani</span>, <span class="hlFld-ContribAuthor ">Hetal  Pandya</span>, <span class="hlFld-ContribAuthor ">Angela  Corona</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Anna  Artese</span>, <span class="hlFld-ContribAuthor ">Athina  Geronikaki</span>, <span class="hlFld-ContribAuthor ">Enzo  Tramontano</span>. </span><span class="cited-content_cbyCitation_article-title">Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111617. <a href="https://doi.org/10.1016/j.ejmech.2019.111617" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111617%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChromenone%252Bderivatives%252Bas%252Ba%252Bversatile%252Bscaffold%252Bwith%252Bdual%252Bmode%252Bof%252Binhibition%252Bof%252BHIV-1%252Breverse%252Btranscriptase-associated%252BRibonuclease%252BH%252Bfunction%252Band%252Bintegrase%252Bactivity%26aulast%3DEsposito%26aufirst%3DFrancesca%26date%3D2019%26volume%3D182%26spage%3D111617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ross D.  Overacker</span>, <span class="hlFld-ContribAuthor ">Somdev  Banerjee</span>, <span class="hlFld-ContribAuthor ">George F.  Neuhaus</span>, <span class="hlFld-ContribAuthor ">Selena  Milicevic Sephton</span>, <span class="hlFld-ContribAuthor ">Alexander  Herrmann</span>, <span class="hlFld-ContribAuthor ">James A.  Strother</span>, <span class="hlFld-ContribAuthor ">Ruth  Brack-Werner</span>, <span class="hlFld-ContribAuthor ">Paul R.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Sandra  Loesgen</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of molecules of the azaBINOL class as antiviral agents: Inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3595-3604. <a href="https://doi.org/10.1016/j.bmc.2019.06.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBiological%252Bevaluation%252Bof%252Bmolecules%252Bof%252Bthe%252BazaBINOL%252Bclass%252Bas%252Bantiviral%252Bagents%25253A%252BInhibition%252Bof%252BHIV-1%252BRNase%252BH%252Bactivity%252Bby%252B7-isopropoxy-8-%252528naphth-1-yl%252529quinoline%26aulast%3DOveracker%26aufirst%3DRoss%2BD.%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3595%26epage%3D3604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Xueshun  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Xiqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Mar  Álvarez</span>, <span class="hlFld-ContribAuthor ">Joanna  Luczkowiak</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Kuo‐Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Chin‐Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Huiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez‐Arias</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biologic evaluation of novel galloyl derivatives as
              HIV
              ‐1
              RN
              ase H inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (4)
                                     , 582-589. <a href="https://doi.org/10.1111/cbdd.13455" title="DOI URL">https://doi.org/10.1111/cbdd.13455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13455%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiologic%252Bevaluation%252Bof%252Bnovel%252Bgalloyl%252Bderivatives%252Bas%252BHIV%252B%2525E2%252580%2525901%252BRN%252Base%252BH%252Binhibitors%26aulast%3DGao%26aufirst%3DPing%26date%3D2019%26date%3D2019%26volume%3D93%26issue%3D4%26spage%3D582%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Ha T.  Do</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 390-399. <a href="https://doi.org/10.1016/j.ejmech.2019.01.081" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.081%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore-based%252Bdesign%252Bof%252Bnovel%252B3-hydroxypyrimidine-2%25252C4-dione%252Bsubtypes%252Bas%252Binhibitors%252Bof%252BHIV%252Breverse%252Btranscriptase-associated%252BRNase%252BH%25253A%252BTolerance%252Bof%252Ba%252Bnonflexible%252Blinker%26aulast%3DTang%26aufirst%3DJing%26date%3D2019%26volume%3D166%26spage%3D390%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Ju</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Designing influenza polymerase acidic endonuclease inhibitors via ‘privileged scaffold’ re-evolution/refining strategy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (4)
                                     , 265-268. <a href="https://doi.org/10.4155/fmc-2018-0489" title="DOI URL">https://doi.org/10.4155/fmc-2018-0489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0489%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Binfluenza%252Bpolymerase%252Bacidic%252Bendonuclease%252Binhibitors%252Bvia%252B%2525E2%252580%252598privileged%252Bscaffold%2525E2%252580%252599%252Bre-evolution%25252Frefining%252Bstrategy%26aulast%3DJu%26aufirst%3DHan%26date%3D2019%26volume%3D11%26issue%3D4%26spage%3D265%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>. </span><span class="cited-content_cbyCitation_article-title">FRET-based assay using a three-way junction DNA substrate to identify inhibitors of human cytomegalovirus pUL89 endonuclease activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2019,</strong> <em>127 </em>, 29-37. <a href="https://doi.org/10.1016/j.ejps.2018.10.016" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DFRET-based%252Bassay%252Busing%252Ba%252Bthree-way%252Bjunction%252BDNA%252Bsubstrate%252Bto%252Bidentify%252Binhibitors%252Bof%252Bhuman%252Bcytomegalovirus%252BpUL89%252Bendonuclease%252Bactivity%26aulast%3DWang%26aufirst%3DYan%26date%3D2019%26volume%3D127%26spage%3D29%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxypyridonecarboxylic Acids as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (16)
                                     , 1658-1663. <a href="https://doi.org/10.1002/cmdc.201800283" title="DOI URL">https://doi.org/10.1002/cmdc.201800283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800283%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHydroxypyridonecarboxylic%252BAcids%252Bas%252BInhibitors%252Bof%252BHuman%252BCytomegalovirus%252BpUL89%252BEndonuclease%26aulast%3DKankanala%26aufirst%3DJayakanth%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D16%26spage%3D1658%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 652-665. <a href="https://doi.org/10.1016/j.ejmech.2018.07.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Arylthio-3-hydroxypyrimidine-2%25252C4-diones%252Bpotently%252Binhibited%252BHIV%252Breverse%252Btranscriptase-associated%252BRNase%252BH%252Bwith%252Bantiviral%252Bactivity%26aulast%3DWang%26aufirst%3DLei%26date%3D2018%26volume%3D156%26spage%3D652%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 680-691. <a href="https://doi.org/10.1016/j.ejmech.2018.07.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Biphenylmethyl-3-hydroxypyrimidine-2%25252C4-diones%252Bpotently%252Band%252Bselectively%252Binhibited%252BHIV%252Breverse%252Btranscriptase-associated%252BRNase%252BH%26aulast%3DWang%26aufirst%3DLei%26date%3D2018%26volume%3D156%26spage%3D680%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Guanyu  Dong</span>, <span class="hlFld-ContribAuthor ">Xujie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Xueshun  Wang</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 714-724. <a href="https://doi.org/10.1016/j.ejmech.2018.06.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.06.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.06.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Hydroxypyrido%25255B2%25252C3-b%25255Dpyrazin-6%2525285H%252529-one%252Bderivatives%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252BHIV-1%252Breverse%252Btranscriptase-associated%252Bribonuclease%252BH%252Band%252Bintegrase%26aulast%3DSun%26aufirst%3DLin%26date%3D2018%26volume%3D155%26spage%3D714%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyrus M.  Lacbay</span>, <span class="hlFld-ContribAuthor ">Michael  Menni</span>, <span class="hlFld-ContribAuthor ">Jean A.  Bernatchez</span>, <span class="hlFld-ContribAuthor ">Matthias  Götte</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore requirements for HIV-1 reverse transcriptase inhibitors that selectively “Freeze” the pre-translocated complex during the polymerization catalytic cycle. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1713-1726. <a href="https://doi.org/10.1016/j.bmc.2018.02.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore%252Brequirements%252Bfor%252BHIV-1%252Breverse%252Btranscriptase%252Binhibitors%252Bthat%252Bselectively%252B%2525E2%252580%25259CFreeze%2525E2%252580%25259D%252Bthe%252Bpre-translocated%252Bcomplex%252Bduring%252Bthe%252Bpolymerization%252Bcatalytic%252Bcycle%26aulast%3DLacbay%26aufirst%3DCyrus%2BM.%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1713%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-chelating 3-hydroxypyrimidine-2,4-diones inhibit human cytomegalovirus pUL89 endonuclease activity and virus replication. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2018,</strong> <em>152 </em>, 10-17. <a href="https://doi.org/10.1016/j.antiviral.2018.01.015" title="DOI URL">https://doi.org/10.1016/j.antiviral.2018.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2018.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DMetal-chelating%252B3-hydroxypyrimidine-2%25252C4-diones%252Binhibit%252Bhuman%252Bcytomegalovirus%252BpUL89%252Bendonuclease%252Bactivity%252Band%252Bvirus%252Breplication%26aulast%3DWang%26aufirst%3DYan%26date%3D2018%26volume%3D152%26spage%3D10%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fengyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Guoxun  Zheng</span>, <span class="hlFld-ContribAuthor ">Tingting  Fu</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Li</span>, <span class="hlFld-ContribAuthor ">Gao  Tu</span>, <span class="hlFld-ContribAuthor ">Ying Hong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Weiwei  Xue</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2018,</strong> <em>20 </em>
                                    (37)
                                     , 23873-23884. <a href="https://doi.org/10.1039/C8CP01843J" title="DOI URL">https://doi.org/10.1039/C8CP01843J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CP01843J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CP01843J%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DPrediction%252Bof%252Bthe%252Bbinding%252Bmode%252Band%252Bresistance%252Bprofile%252Bfor%252Ba%252Bdual-target%252Bpyrrolyl%252Bdiketo%252Bacid%252Bscaffold%252Bagainst%252BHIV-1%252Bintegrase%252Band%252Breverse-transcriptase-associated%252Bribonuclease%252BH%26aulast%3DYang%26aufirst%3DFengyuan%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D37%26spage%3D23873%26epage%3D23884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Łukasz J.  Kiełpiński</span>, <span class="hlFld-ContribAuthor ">Peter H.  Hagedorn</span>, <span class="hlFld-ContribAuthor ">Morten  Lindow</span>, <span class="hlFld-ContribAuthor ">Jeppe  Vinther</span>. </span><span class="cited-content_cbyCitation_article-title">RNase H sequence preferences influence antisense oligonucleotide efficiency. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2017,</strong> <em>45 </em>
                                    (22)
                                     , 12932-12944. <a href="https://doi.org/10.1093/nar/gkx1073" title="DOI URL">https://doi.org/10.1093/nar/gkx1073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkx1073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkx1073%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DRNase%252BH%252Bsequence%252Bpreferences%252Binfluence%252Bantisense%252Boligonucleotide%252Befficiency%26aulast%3DKie%25C5%2582pi%25C5%2584ski%26aufirst%3D%25C5%2581ukasz%2BJ.%26date%3D2017%26date%3D2017%26volume%3D45%26issue%3D22%26spage%3D12932%26epage%3D12944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>141 </em>, 149-161. <a href="https://doi.org/10.1016/j.ejmech.2017.09.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluations%252Bof%252BN-Hydroxy%252Bthienopyrimidine-2%25252C4-diones%252Bas%252Binhibitors%252Bof%252BHIV%252Breverse%252Btranscriptase-associated%252BRNase%252BH%26aulast%3DKankanala%26aufirst%3DJayakanth%26date%3D2017%26volume%3D141%26spage%3D149%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Nataliya A.  Myshakina</span>, <span class="hlFld-ContribAuthor ">Martin T.  Christen</span>, <span class="hlFld-ContribAuthor ">Yue-Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Hilary A.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Zhaoyong  Xi</span>, <span class="hlFld-ContribAuthor ">Seongmi  Kim</span>, <span class="hlFld-ContribAuthor ">Rohit K.  Rao</span>, <span class="hlFld-ContribAuthor ">Skyler T.  Kramer</span>, <span class="hlFld-ContribAuthor ">Qiongying  Yang</span>, <span class="hlFld-ContribAuthor ">Kamalendra  Singh</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Rieko  Ishima</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>. </span><span class="cited-content_cbyCitation_article-title">A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (10)
                                     <a href="https://doi.org/10.1128/AAC.01351-17" title="DOI URL">https://doi.org/10.1128/AAC.01351-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01351-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01351-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DA%252B2-Hydroxyisoquinoline-1%25252C3-Dione%252BActive-Site%252BRNase%252BH%252BInhibitor%252BBinds%252Bin%252BMultiple%252BModes%252Bto%252BHIV-1%252BReverse%252BTranscriptase%26aulast%3DKirby%26aufirst%3DKaren%2BA.%26date%3D2017%26volume%3D61%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wong  Jack Ho</span>, <span class="hlFld-ContribAuthor ">Ng  Tzi Bun</span>, <span class="hlFld-ContribAuthor ">Cheung  Chi Fai</span>, <span class="hlFld-ContribAuthor ">Tam  Chit</span>, <span class="hlFld-ContribAuthor ">C. W. Ng  Charlene</span>, <span class="hlFld-ContribAuthor ">Tse  Ryan</span>, <span class="hlFld-ContribAuthor ">Tse  Tak Fu</span>, <span class="hlFld-ContribAuthor ">Chan  Helen</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HIV Natural Products. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 209-223. <a href="https://doi.org/10.1002/9783527805921.ch8" title="DOI URL">https://doi.org/10.1002/9783527805921.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527805921.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527805921.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DAnti-HIV%252BNatural%252BProducts%26aulast%3DJack%2BHo%26aufirst%3DWong%26date%3D2017%26date%3D2017%26spage%3D209%26epage%3D223%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DNatural%252BProducts%252BTargeting%252BClinically%252BRelevant%252BEnzymes%26aulast%3DAndrade%26aufirst%3DPaula%2BB.%26date%3D2017%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Corona</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>, <span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Giulia  Bianco</span>, <span class="hlFld-ContribAuthor ">Monica  Demurtas</span>, <span class="hlFld-ContribAuthor ">Simona  Distinto</span>, <span class="hlFld-ContribAuthor ">Yung-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Francesca  Esposito</span>, <span class="hlFld-ContribAuthor ">Enzo  Tramontano</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide
          derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP
          functions. </span><span class="cited-content_cbyCitation_journal-name">Pathogens and Disease</span><span> <strong>2017,</strong> <em>75 </em>
                                    (6)
                                     <a href="https://doi.org/10.1093/femspd/ftx078" title="DOI URL">https://doi.org/10.1093/femspd/ftx078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/femspd/ftx078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ffemspd%2Fftx078%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%2520and%2520Disease%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantiviral%252Bevaluation%252Bof%252Bnovel%252Bheteroarylcarbothioamide%252Bderivatives%252Bas%252Bdual%252Binhibitors%252Bof%252BHIV-1%252Breverse%252Btranscriptase-associated%252BRNase%252BH%252Band%252BRDDP%252Bfunctions%26aulast%3DCorona%26aufirst%3DAngela%26date%3D2017%26date%3D2017%26volume%3D75%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Eleftherios  Michailidis</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Maritza N.  Puray-Chavez</span>, <span class="hlFld-ContribAuthor ">Maria  Boftsi</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Wolf</span>, <span class="hlFld-ContribAuthor ">Kelsey N.  Boschert</span>, <span class="hlFld-ContribAuthor ">Megan A.  Sheridan</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Leslie</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Kamalendra  Singh</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Mitsuya</span>, <span class="hlFld-ContribAuthor ">Michael A.  Parniak</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>. </span><span class="cited-content_cbyCitation_article-title">3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00245-17" title="DOI URL">https://doi.org/10.1128/AAC.00245-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00245-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00245-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3D3-Hydroxypyrimidine-2%25252C4-Diones%252Bas%252BNovel%252BHepatitis%252BB%252BVirus%252BAntivirals%252BTargeting%252Bthe%252BViral%252BRibonuclease%252BH%26aulast%3DHuber%26aufirst%3DAndrew%2BD.%26date%3D2017%26volume%3D61%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Mary C.  Casey</span>, <span class="hlFld-ContribAuthor ">Juan  Ji</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>128 </em>, 168-179. <a href="https://doi.org/10.1016/j.ejmech.2017.01.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Cyclohexylmethyl-3-hydroxypyrimidine-2%25252C4-dione%252Bas%252Ban%252Binhibitor%252Bscaffold%252Bof%252BHIV%252Breverase%252Btranscriptase%25253A%252BImpacts%252Bof%252Bthe%252B3-OH%252Bon%252Binhibiting%252BRNase%252BH%252Band%252Bpolymerase%26aulast%3DTang%26aufirst%3DJing%26date%3D2017%26volume%3D128%26spage%3D168%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Lili  Mao</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>, . </span><span class="cited-content_cbyCitation_article-title">Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2017,</strong> <em>91 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/JVI.02152-16" title="DOI URL">https://doi.org/10.1128/JVI.02152-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.02152-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.02152-16%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DInhibition%252Bof%252BHuman%252BCytomegalovirus%252BpUL89%252BTerminase%252BSubunit%252BBlocks%252BVirus%252BReplication%252Band%252BGenome%252BCleavage%26aulast%3DWang%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D91%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nihar  Ranjan</span>, <span class="hlFld-ContribAuthor ">Umesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Sunil K.  Deshmukh</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Targets and Advancements in Drug Discovery: The Case of HIV-AIDS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 419-438. <a href="https://doi.org/10.1007/978-981-10-4284-3_18" title="DOI URL">https://doi.org/10.1007/978-981-10-4284-3_18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-4284-3_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-4284-3_18%26sid%3Dliteratum%253Aachs%26atitle%3DNovel%252BTargets%252Band%252BAdvancements%252Bin%252BDrug%252BDiscovery%25253A%252BThe%252BCase%252Bof%252BHIV-AIDS%26aulast%3DRanjan%26aufirst%3DNihar%26date%3D2017%26date%3D2017%26spage%3D419%26epage%3D438%26pub%3DSpringer%2520Singapore%26atitle%3DBioresources%252Band%252BBioprocess%252Bin%252BBiotechnology%26aulast%3DSugathan%26aufirst%3DShiburaj%26date%3D2017%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of active site RNase H inhibitors. (a) Major chemotypes reported as HIV RNase H active site inhibitors. All chemotypes contain a chelating triad (magenta). Scaffolds <b>4</b>–<b>7</b> also feature an aryl or biaryl moiety (cyan) connected through a methylene or amino linker. (b) Hydroxypyridone carboxylate (blue) is implicated in influenza endonuclease inhibitor <b>8</b> and HIV INSTI <b>9</b>. Active site RNase H inhibitor chemotype <b>10</b> based on the same chelating core (blue) is designed. An N-1 aryl or biaryl methyl group is included to mimick scaffolds <b>5</b>–<b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Hydroxylpyridinonecarboxylic Acids <b>10a</b>–<b>z</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, THF, rt, 16 h, 95% ; (b) DMF DMA, toluene, rt, 30%; (c) ethyl formate, KO<sup><i>t</i></sup>Bu, THF, rt, 75%; (d) R-NH<sub>2</sub>, EtOH, 100 °C, 30–40 min, microwave, 40–85%; (e) 2 N NaOH, EtOH, 90 °C, 4–6 h, 65–95%; (f) ArB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME/H<sub>2</sub>O (4:1), 150 °C, 30–40 min, microwave, 60–80%; (g) TFA, 80 °C, 20 min, microwave, 40–87%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Hydroxylpyridinonecarboxylate Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 7 N NH<sub>3</sub>/ MeOH, rt, 48 h, 70%; (b) TFA, 80 °C, 20 min, microwave, 65—78%; (c) 2 N NaOH, EtOH, 90 °C, 4 h, 87%; (d) benzylamine, HATU, DIPEA, DMF, rt, 12 h, 72%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dose–response antiviral effect of <b>10r</b> against HIV-1. Experiments were done in triplicate with each data point. The antiviral EC<sub>50</sub> is calculated to be 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Molecular modeling of analogues <b>10r</b> and <b>10y</b> at the RNase H active site and comparison to crystal structure of the HIV RNase H domain in complex with pyrimidinol carboxylic acid. (a) Predicted binding mode of <b>10r</b> within active site of RNase H (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HYF">3HYF</a>). Active site residues are highlighted in green sticks with metal ions as spheres. Some chelating and H-bond interactions are depicted as black dotted lines. (b) Overlay of <b>10r</b> (yellow) on the crystal structure of RNase H with pyrimidinol carboxylic acid (magenta). (c) Overlay of <b>10y</b> (yellow) on the crystal structure of RNase H with pyrimidinolcarboxylic acid (magenta).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/medium/jm-2016-00465x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of HIV RT in complex with analogue <b>10y</b>. Cross-eyed stereoview of <b>10y</b> (cyan) bound at the RNase H active site of HIV RT. The RNase H domain of RT is shown in orange, the p51 in light gray. Conserved active site residues are shown as sticks, and Mg<sup>2+</sup> ions are shown as magenta spheres. Chelating and H-bond interactions are indicated by dashed lines. Cartoon was prepared by PyMOL,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and crystallographic coordinates have been submitted to the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J1E">5J1E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-10/acs.jmedchem.6b00465/20160520/images/large/jm-2016-00465x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00465&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>UNAIDS: AIDS information. <a href="http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/" class="extLink">http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UNAIDS%3A+AIDS+information.+http%3A%2F%2Fwww.unaids.org%2Fen%2Fdataanalysis%2Fdatatools%2Faidsinfo%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Yeni, P.</span><span> </span><span class="NLM_article-title">Update on HAART in HIV</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">S100</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.jhep.2005.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jhep.2005.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=16359748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktl2ksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2006&pages=S100-103&author=P.+Yeni&title=Update+on+HAART+in+HIV&doi=10.1016%2Fj.jhep.2005.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Update on HAART in HIV</span></div><div class="casAuthors">Yeni, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S100-S103</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral combination therapy (HAART) has been responsible for a dramatic decrease in AIDS mortality since 1996, and has changed the clin. profile of HIV infection from a sub-acute lethal to a chronic ambulatory disease.  HAART consists of a double nucleoside (NRTI) backbone plus either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir pharmacol. enhanced protease inhibitor (PI/r).  Triple NRTI combinations are less potent than 2NRTIs/NNRTI or 2NRTIs/PI/r combinations.  Antiretroviral first-line therapy is rapidly moving towards more convenient and less toxic regimens.  Three double NRTI co-formulations are now available, and the risk of mitochondrial toxicity is low with drugs such as 3TC, FTC and tenofovir.  Similarly, atazanavir, a recently available PI, can be given once daily and is less metabolically toxic than other PIs.  Antiretroviral salvage therapy takes advantage of the development or availability of new drugs, either from existing (tipranavir, TMC 114 as new PIs) or new classes (T20 as a fusion inhibitor), that remain active on many triple-class drug resistant viruses.  More progress is needed in the field of drug discovery, since a significant proportion of patients still die from AIDS with a multi-resistant virus, and since the incidence of primary HIV resistance is increasing in various parts of the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-v9cXc64aqLVg90H21EOLACvtfcHk0lixBHRFCxtdJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktl2ksQ%253D%253D&md5=ec6531565d1b68066aa2efc155caa6fa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2005.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2005.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DYeni%26aufirst%3DP.%26atitle%3DUpdate%2520on%2520HAART%2520in%2520HIV%26jtitle%3DJ.%2520Hepatol.%26date%3D2006%26volume%3D44%26spage%3DS100%26epage%3D103%26doi%3D10.1016%2Fj.jhep.2005.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Tramontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">HIV-1 RT-associated RNase H function inhibitors: recent advances in drug development</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2837</span><span class="NLM_x">–</span> <span class="NLM_lpage">2853</span><span class="refDoi"> DOI: 10.2174/092986710792065045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.2174%2F092986710792065045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20858167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaisrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2837-2853&author=E.+Tramontanoauthor=R.+Di+Santo&title=HIV-1+RT-associated+RNase+H+function+inhibitors%3A+recent+advances+in+drug+development&doi=10.2174%2F092986710792065045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 RT-associated RNase H function inhibitors: recent advances in drug development</span></div><div class="casAuthors">Tramontano, E.; Di Santo, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2837-2853</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The HIV-1 genomic RNA reverse transcription is an essential step in the virus cycle carried out by the viral-coded reverse transcriptase (RT), which has two assocd. functions: the RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) function and the RNase H function.  The RNAse H function catalyzes the selective hydrolysis of the RNA strand of the RNA:DNA heteroduplex replication intermediate.  The RT assocd. activities are both essential for HIV-1 replication and validated targets for drug development, but only the polymerase function has been widely investigated as drug target.  In fact, either nucleoside or non-nucleoside RT inhibitors currently used in therapy act on the polymerase assocd. activity.  In this review, we describe the compds., reported up to today, which inhibit the HIV-1 RNase H function, their chem. structures, the structure-activity relationships and the mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp4M03GSrALbVg90H21EOLACvtfcHk0lixBHRFCxtdJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaisrzJ&md5=b32cef40a7c0938edbf7f35b504e6ccf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986710792065045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792065045%26sid%3Dliteratum%253Aachs%26aulast%3DTramontano%26aufirst%3DE.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DHIV-1%2520RT-associated%2520RNase%2520H%2520function%2520inhibitors%253A%2520recent%2520advances%2520in%2520drug%2520development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2837%26epage%3D2853%26doi%3D10.2174%2F092986710792065045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span><span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jmb.2008.10.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19022262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=693-713&author=S.+G.+Sarafianosauthor=B.+Marchandauthor=K.+Dasauthor=D.+M.+Himmelauthor=M.+A.+Parniakauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structure+and+function+of+HIV-1+reverse+transcriptase%3A+molecular+mechanisms+of+polymerization+and+inhibition&doi=10.1016%2Fj.jmb.2008.10.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition</span></div><div class="casAuthors">Sarafianos, Stefan G.; Marchand, Bruno; Das, Kalyan; Himmel, Daniel M.; Parniak, Michael A.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-713</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The rapid replication of the HIV-1 virus and errors made during viral replication cause the virus to evolve rapidly in patients, making the problems of vaccine development and drug therapy particularly challenging.  In the absence of an effective vaccine, drugs are the only useful treatment.  Anti-HIV drugs work; so far drug therapy has saved more than 3 × 106 yr of life.  Unfortunately, HIV-1 virus develops resistance to all of the available drugs.  Although a no. of useful anti-HIV drugs have been approved for use in patients, the problems assocd. with drug toxicity and the development of resistance means that the search for new drugs is an ongoing process.  The 3 viral enzymes, reverse transcriptase (RT), integrase (IN), and protease (PR) are all good drug targets.  Two distinct types of RT inhibitors, both of which block the polymerase activity of RT, have been approved to treat HIV-1 infections, nucleoside analogs (NRTIs) and non-nucleosides (NNRTIs), and there are promising leads for compds. that either block the RNase H activity or block the polymerase in other ways.  A better understanding of the structure and function(s) of RT and of the mechanism(s) of inhibition can be used to generate better drugs; in particular, drugs that are effective against the current drug-resistant strains of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrnqshyZtC7Vg90H21EOLACvtfcHk0lixBHRFCxtdJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D&md5=e26f178e629a36f6e248a879057021a2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.071%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520and%2520function%2520of%2520HIV-1%2520reverse%2520transcriptase%253A%2520molecular%2520mechanisms%2520of%2520polymerization%2520and%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D693%26epage%3D713%26doi%3D10.1016%2Fj.jmb.2008.10.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span> </span><span class="NLM_article-title">Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2009.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.antiviral.2009.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19887088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFCmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=39-58&author=T.+Cihlarauthor=A.+S.+Ray&title=Nucleoside+and+nucleotide+HIV+reverse+transcriptase+inhibitors%3A+25+years+after+zidovudine&doi=10.1016%2Fj.antiviral.2009.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine</span></div><div class="casAuthors">Cihlar, Tomas; Ray, Adrian S.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-58</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Twenty-five years ago, nucleoside analog 3'-azidothymidine (AZT) was shown to efficiently block the replication of HIV in cell culture.  Subsequent studies demonstrated that AZT acts via the selective inhibition of HIV reverse transcriptase (RT) by its triphosphate metabolite.  These discoveries have established the first class of antiretroviral agents: nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs).  Over the years that followed, NRTIs evolved into the main component of antiretroviral drug combinations that are now used for the treatment of all populations of HIV infected patients.  A total of thirteen NRTI drug products are now available for clin. application: eight individual NRTIs, four fixed-dose combinations of two or three NRTIs, and one complete fixed-dose regimen contg. two NRTIs and one non-nucleoside RT inhibitor.  Multiple NRTIs or their prodrugs are in various stages of clin. development and new potent NRTIs are still being identified through drug discovery efforts.  This article will review basic principles of the in vitro and in vivo pharmacol. of NRTIs, discuss their clin. use including limitations assocd. with long-term NRTI therapy, and describe newly identified NRTIs with promising pharmacol. profiles highlighting those in the development pipeline.  This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-OQhoXyRM_7Vg90H21EOLACvtfcHk0lg8RssUmliRLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFCmtQ%253D%253D&md5=1a880624a780d1d969809f47497deda4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DRay%26aufirst%3DA.%2BS.%26atitle%3DNucleoside%2520and%2520nucleotide%2520HIV%2520reverse%2520transcriptase%2520inhibitors%253A%252025%2520years%2520after%2520zidovudine%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D39%26epage%3D58%26doi%3D10.1016%2Fj.antiviral.2009.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">de Bethune, M. P.</span><span> </span><span class="NLM_article-title">Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989–2009)</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.antiviral.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19781578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFCmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=75-90&author=M.+P.+de+Bethune&title=Non-nucleoside+reverse+transcriptase+inhibitors+%28NNRTIs%29%2C+their+discovery%2C+development%2C+and+use+in+the+treatment+of+HIV-1+infection%3A+a+review+of+the+last+20+years+%281989%E2%80%932009%29&doi=10.1016%2Fj.antiviral.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)</span></div><div class="casAuthors">de Bethune, Marie-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-90</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It is almost 20 years since NNRTIs were identified as a new class of antiretroviral drugs for the treatment of HIV-1 infection.  Although they belong to different and diverse chem. families, they share a common and unique mechanism of action: their interaction with HIV-1 reverse transcriptase induces conformational changes that inhibit the catalytic activities of the enzyme.  They are characterized by their specificity for HIV-1, which makes them very selective inhibitors of the virus.  First generation NNRTIs nevirapine and efavirenz, in combination with other antiretroviral drugs, have become a cornerstone for the treatment of HIV-1 infection, in patients initiating antiretroviral therapy.  Further research has led to the discovery and development of next generation NNRTIs with an increased genetic barrier to the development of resistance.  Etravirine is the first NNRTI to show sustained virol. efficacy in patients with NNRTI resistant HIV-1.  This review covers the NNRTI class of anti-HIV-1 drugs, from the initial discovery of the class in 1990 to the current compds. in clin. development, i.e. around 20 years of research and development efforts.  It describes the characteristics of the NNRTIs, their mechanisms of action, HIV-1 resistance to the inhibitors, and the drugs that have been approved for the treatment of HIV-1 infection, or are currently in clin. development.  The role of NNRTIs in prevention of HIV transmission is also addressed.  This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3g4c9flBpALVg90H21EOLACvtfcHk0lg8RssUmliRLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFCmuw%253D%253D&md5=73cd7039f629fd4667dae95a1ea82dd5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBethune%26aufirst%3DM.%2BP.%26atitle%3DNon-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520%2528NNRTIs%2529%252C%2520their%2520discovery%252C%2520development%252C%2520and%2520use%2520in%2520the%2520treatment%2520of%2520HIV-1%2520infection%253A%2520a%2520review%2520of%2520the%2520last%252020%2520years%2520%25281989%25E2%2580%25932009%2529%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D75%26epage%3D90%26doi%3D10.1016%2Fj.antiviral.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span>HIV drugs in development. <a href="http://www.thebody.com/index/treat/newdrugs.html" class="extLink">http://www.thebody.com/index/treat/newdrugs.html</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=HIV+drugs+in+development.+http%3A%2F%2Fwww.thebody.com%2Findex%2Ftreat%2Fnewdrugs.html+%28accessed+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Parniak, M. A.</span> Unpublishd data.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Parniak%2C+M.+A.+Unpublishd+data."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DParniak%26aufirst%3DM.%2BA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent progress in the research of small molecule HIV-1 RNase H inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span><span class="refDoi"> DOI: 10.2174/0929867321666140120121158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.2174%2F0929867321666140120121158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=24438523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1956-1967&author=L.+Caoauthor=W.+Songauthor=E.+De+Clercqauthor=P.+Zhanauthor=X.+Liu&title=Recent+progress+in+the+research+of+small+molecule+HIV-1+RNase+H+inhibitors&doi=10.2174%2F0929867321666140120121158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors</span></div><div class="casAuthors">Cao, Lili; Song, Weiguo; De Clercq, Erik; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reverse transcription of human immunodeficiency virus type 1 (HIV-1) is a crucial step in the life cycle initiated by the viral-coded reverse transcriptase (RT), functioning as RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) and the RNase H (RNase H).  The RNase H functions to degrade the RNA strand of the RNA:DNA heteroduplex, which makes it an attractive target for rational anti-HIV-1 drug design and development.  Although development of drugs targeting the DNA polymerase have been highly successful, the discovery of drugable inhibitors of HIV RNase H is still in its infancy and none of RNase H inhibitors has reached the clin. development stage currently.  This review describes the recent progress in the HIV-1 RNase H inhibitors, focusing on their chem. feature, mechanism and the structure-activity relationship (SAR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1aiiPIvi0xLVg90H21EOLACvtfcHk0lg8RssUmliRLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D&md5=b304a792478d2ffcbe8d85405c74f0c1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140120121158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140120121158%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520the%2520research%2520of%2520small%2520molecule%2520HIV-1%2520RNase%2520H%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1956%26epage%3D1967%26doi%3D10.2174%2F0929867321666140120121158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derosier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">In, P. W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, K. E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span> </span><span class="NLM_article-title">Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">6852</span><span class="NLM_x">–</span> <span class="NLM_lpage">6859</span><span class="refDoi"> DOI: 10.1093/nar/gkg881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Fnar%2Fgkg881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=14627818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlyktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=6852-6859&author=K.+Klumppauthor=J.+Q.+Hangauthor=S.+Rajendranauthor=Y.+L.+Yangauthor=A.+Derosierauthor=P.+W.+K.+Inauthor=H.+Overtonauthor=K.+E.+B.+Parkesauthor=N.+Cammackauthor=J.+A.+Martin&title=Two-metal+ion+mechanism+of+RNA+cleavage+by+HIV+RNase+H+and+mechanism-based+design+of+selective+HIV+RNase+H+inhibitors&doi=10.1093%2Fnar%2Fgkg881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors</span></div><div class="casAuthors">Klumpp, Klaus; Hang, Julie Qi; Rajendran, Surendran; Yang, Yanli; Derosier, Andre; In, Philippe Wong Kai; Overton, Hilary; Parkes, Kevin E. B.; Cammack, Nick; Martin, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6852-6859</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV) RNase H activity is essential for the synthesis of viral DNA by HIV reverse transcriptase (HIV-RT).  RNA cleavage by RNase H requires the presence of divalent metal ions, but the role of metal ions in the mechanism of RNA cleavage has not been resolved.  We measured HIV RNase H activity assocd. with HIV-RT protein in the presence of different concns. of either Mg2+, Mn2+, Co2+ or a combination of these divalent metal ions.  Polymerase-independent HIV RNase H was similar to or more active with Mn2+ and Co2+ compared with Mg2+.  Activation of RNase H by these metal ions followed sigmoidal dose-response curves suggesting cooperative metal ion binding.  Titrn. of Mg2+-bound HIV RNase H with Mn2+ or Co2+ ions generated bell-shaped activity dose-response curves.  Higher activity could be achieved through simultaneous binding of more than one divalent metal ion at intermediate Mn2+ and Co2+ concns., and complete replacement of Mg2+ occurred at higher Mn2+ or Co2+ concns.  These results are consistent with a two-metal ion mechanism of RNA cleavage as previously suggested for a no. of polymerase-assocd. nucleases.  In contrast, the structurally highly homologous RNase HI from Escherichia coli is most strongly activated by Mg2+, is significantly inhibited by submillimolar concns. of Mn2+ and most probably cleaves RNA via a one-metal ion mechanism.  Based on this difference in active site structure, a series of small mol. N-hydroxyimides was identified with significant enzyme inhibitory potency and selectivity for HIV RNase H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQleqyPkDZcbVg90H21EOLACvtfcHk0lhPoanPuPzKWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlyktLo%253D&md5=1cd71b3a891106b81d6a64f5044e3465</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkg881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkg881%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DHang%26aufirst%3DJ.%2BQ.%26aulast%3DRajendran%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%2BL.%26aulast%3DDerosier%26aufirst%3DA.%26aulast%3DIn%26aufirst%3DP.%2BW.%2BK.%26aulast%3DOverton%26aufirst%3DH.%26aulast%3DParkes%26aufirst%3DK.%2BE.%2BB.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26atitle%3DTwo-metal%2520ion%2520mechanism%2520of%2520RNA%2520cleavage%2520by%2520HIV%2520RNase%2520H%2520and%2520mechanism-based%2520design%2520of%2520selective%2520HIV%2520RNase%2520H%2520inhibitors%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D6852%26epage%3D6859%26doi%3D10.1093%2Fnar%2Fgkg881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1625</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1016/j.str.2009.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.str.2009.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20004166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFantbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1625-1635&author=D.+M.+Himmelauthor=K.+A.+Maegleyauthor=T.+A.+Paulyauthor=J.+D.+Baumanauthor=K.+Dasauthor=C.+Dhariaauthor=A.+D.+Clarkauthor=K.+Ryanauthor=M.+J.+Hickeyauthor=R.+A.+Loveauthor=S.+H.+Hughesauthor=S.+Bergqvistauthor=E.+Arnold&title=Structure+of+HIV-1+reverse+transcriptase+with+the+inhibitor+beta-Thujaplicinol+bound+at+the+RNase+H+active+site&doi=10.1016%2Fj.str.2009.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site</span></div><div class="casAuthors">Himmel, Daniel M.; Maegley, Karen A.; Pauly, Tom A.; Bauman, Joseph D.; Das, Kalyan; Dharia, Chhaya; Clark, Arthur D.; Ryan, Kevin; Hickey, Michael J.; Love, Robert A.; Hughes, Stephen H.; Bergqvist, Simon; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1625-1635</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Novel inhibitors are needed to counteract the rapid emergence of drug-resistant HIV variants.  HIV-1 reverse transcriptase (RT) has both DNA polymerase and RNase H (RNH) enzymic activities, but approved drugs that inhibit RT target the polymerase.  Inhibitors that act against new targets, such as RNH, should be effective against all of the current drug-resistant variants.  Here, we present 2.80 Å and 2.04 Å resoln. crystal structures of an RNH inhibitor, β-thujaplicinol, bound at the RNH active site of both HIV-1 RT and an isolated RNH domain.  β-Thujaplicinol chelates two divalent metal ions at the RNH active site.  We provide biochem. evidence that β-thujaplicinol is a slow-binding RNH inhibitor with noncompetitive kinetics and suggest that it forms a tropylium ion that interacts favorably with RT and the RNA:DNA substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmlpF9Bg7bhbVg90H21EOLACvtfcHk0lhPoanPuPzKWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFantbrJ&md5=12f4e4bd069fce4e8e3e7876373e7ae8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DPauly%26aufirst%3DT.%2BA.%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DDharia%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DLove%26aufirst%3DR.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520of%2520HIV-1%2520reverse%2520transcriptase%2520with%2520the%2520inhibitor%2520beta-Thujaplicinol%2520bound%2520at%2520the%2520RNase%2520H%2520active%2520site%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26spage%3D1625%26epage%3D1635%26doi%3D10.1016%2Fj.str.2009.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myshakina, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">2617</span><span class="NLM_x">–</span> <span class="NLM_lpage">2631</span><span class="refDoi"> DOI: 10.1016/j.jmb.2014.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jmb.2014.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=24840303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslKmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2014&pages=2617-2631&author=D.+M.+Himmelauthor=N.+S.+Myshakinaauthor=T.+Ilinaauthor=A.+Van+Ryauthor=W.+C.+Hoauthor=M.+A.+Parniakauthor=E.+Arnold&title=Structure+of+a+dihydroxycoumarin+active-site+inhibitor+in+complex+with+the+RNase+H+domain+of+HIV-1+reverse+transcriptase+and+structure-activity+analysis+of+inhibitor+analogs&doi=10.1016%2Fj.jmb.2014.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a Dihydroxycoumarin Active-Site Inhibitor in Complex with the RNase H Domain of HIV-1 Reverse Transcriptase and Structure-Activity Analysis of Inhibitor Analogs</span></div><div class="casAuthors">Himmel, Daniel M.; Myshakina, Nataliya S.; Ilina, Tatiana; Van Ry, Alexander; Ho, William C.; Parniak, Michael A.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2617-2631</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV) encodes four essential enzymes: protease, integrase, reverse transcriptase (RT)-assocd. DNA polymerase, and RT-assocd. RNase H.  Current clin. approved anti-AIDS drugs target all HIV enzymic activities except RNase H, which has proven to be a very difficult target for HIV drug discovery.  Our high-throughput screening activities identified the dihydroxycoumarin compd. F3284-8495 as a specific inhibitor of RT RNase H, with low micromolar potency in vitro.  Optimization of inhibitory potency can be facilitated by structural information about inhibitor-target binding.  Here, we report the crystal structure of F3284-8495 bound to the active site of an isolated RNase H domain of HIV-1 RT at a resoln. limit of 1.71 Å.  From predictions based on this structure, compds. were obtained that showed improved inhibitory activity.  Computational anal. suggested structural alterations that could provide addnl. interactions with RT and thus improve inhibitory potency.  These studies established proof of concept that F3284-8495 could be used as a favorable chem. scaffold for development of HIV RNase H inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjcp3p4ztiz7Vg90H21EOLACvtfcHk0lguEf-8TxYwjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslKmurs%253D&md5=f9600de68cd1b531ef8b27c0d8719fee</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2014.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2014.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DMyshakina%26aufirst%3DN.%2BS.%26aulast%3DIlina%26aufirst%3DT.%26aulast%3DVan%2BRy%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520of%2520a%2520dihydroxycoumarin%2520active-site%2520inhibitor%2520in%2520complex%2520with%2520the%2520RNase%2520H%2520domain%2520of%2520HIV-1%2520reverse%2520transcriptase%2520and%2520structure-activity%2520analysis%2520of%2520inhibitor%2520analogs%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D426%26spage%3D2617%26epage%3D2631%26doi%3D10.1016%2Fj.jmb.2014.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Shaw-Reid, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danzeisen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span> </span><span class="NLM_article-title">Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span><span class="refDoi"> DOI: 10.1074/jbc.C200621200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1074%2Fjbc.C200621200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=12480948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=2777-2780&author=C.+A.+Shaw-Reidauthor=V.+Munshiauthor=P.+Grahamauthor=A.+Wolfeauthor=M.+Witmerauthor=R.+Danzeisenauthor=D.+B.+Olsenauthor=S.+S.+Carrollauthor=M.+Embreyauthor=J.+S.+Waiauthor=M.+D.+Millerauthor=J.+L.+Coleauthor=D.+J.+Hazuda&title=Inhibition+of+HIV-1+ribonuclease+H+by+a+novel+diketo+acid%2C+4-%5B5-%28benzoylamino%29thien-2-yl%5D-2%2C4-dioxobutanoic+acid&doi=10.1074%2Fjbc.C200621200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid</span></div><div class="casAuthors">Shaw-Reid, Cathryn A.; Munshi, Vandna; Graham, Pia; Wolfe, Abigail; Witmer, Marc; Danzeisen, Renee; Olsen, David B.; Carroll, Steven S.; Embrey, Mark; Wai, John S.; Miller, Michael D.; Cole, James L.; Hazuda, Daria J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2777-2780</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human immunodeficiency virus-type 1 (HIV-1) reverse transcriptase (RT) coordinates DNA polymn. and RNase H (RNase H) activities using two discrete active sites embedded within a single heterodimeric polyprotein.  We have identified a novel thiophene diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid, that selectively inhibits polymerase-independent RNase H cleavage (IC50 = 3.2 μM) but has no effect on DNA polymn. (IC50 > 50 μM).  The activity profile of the diketo acid is shown to be distinct from previously described compds., including the polymerase inhibitor foscarnet and the putative RNase H inhibitor 4-chlorophenylhydrazone.  Both foscarnet and the hydrazone inhibit RNase H cleavage and DNA polymn. activities of RT, yet neither inhibits the RNase H activity of RT contg. a mutation in the polymerase active site (D185N) or an isolated HIV-1 RNase H domain chimera contg. the α-C helix from Escherichia coli RNase HI, suggesting these compds. affect RNase H indirectly.  In contrast, the diketo acid inhibits the RNase H activity of the isolated RNase H domain as well as full-length RT, and inhibition is not affected by the polymerase active site mutation.  In isothermal titrn. calorimetry studies using the isolated RNase H domain, binding of the diketo acid is independent of nucleic acid but strictly requires Mn2+ implying a direct interaction between the inhibitor and the RNase H active site.  These studies demonstrate that inhibition of HIV-1 RNase H may occur by either direct or indirect mechanisms, and they provide a framework for identifying novel agents such as 4-[5-(benzoylamino)thien- 2-yl]-2,4-dioxobutanoic acid that specifically targets RNase H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEn4xJCxmBvbVg90H21EOLACvtfcHk0lguEf-8TxYwjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1GgsQ%253D%253D&md5=7d0ca6e9cf63c7d8a3632b78ac97ab0c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200621200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200621200%26sid%3Dliteratum%253Aachs%26aulast%3DShaw-Reid%26aufirst%3DC.%2BA.%26aulast%3DMunshi%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DP.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DCole%26aufirst%3DJ.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520HIV-1%2520ribonuclease%2520H%2520by%2520a%2520novel%2520diketo%2520acid%252C%25204-%255B5-%2528benzoylamino%2529thien-2-yl%255D-2%252C4-dioxobutanoic%2520acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D2777%26epage%3D2780%26doi%3D10.1074%2Fjbc.C200621200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kirschberg, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brendza, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liclican, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansdon, E. B.</span><span> </span><span class="NLM_article-title">RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5781</span><span class="NLM_x">–</span> <span class="NLM_lpage">5784</span><span class="refDoi"> DOI: 10.1021/jm900597q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900597q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWqtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5781-5784&author=T.+A.+Kirschbergauthor=M.+Balakrishnanauthor=N.+H.+Squiresauthor=T.+Barnesauthor=K.+M.+Brendzaauthor=X.+Chenauthor=E.+J.+Eisenbergauthor=W.+Jinauthor=N.+Kuttyauthor=S.+Leavittauthor=A.+Liclicanauthor=Q.+Liuauthor=X.+Liuauthor=J.+Makauthor=J.+K.+Perryauthor=M.+Wangauthor=W.+J.+Watkinsauthor=E.+B.+Lansdon&title=RNase+H+active+site+inhibitors+of+human+immunodeficiency+virus+type+1+reverse+transcriptase%3A+design%2C+biochemical+activity%2C+and+structural+information&doi=10.1021%2Fjm900597q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information</span></div><div class="casAuthors">Kirschberg, Thorsten A.; Balakrishnan, Mini; Squires, Neil H.; Barnes, Tiffany; Brendza, Katherine M.; Chen, Xiaowu; Eisenberg, Eugene J.; Jin, Weili; Kutty, Nilima; Leavitt, Stephanie; Liclican, Albert; Liu, Qi; Liu, Xiaohong; Mak, John; Perry, Jason K.; Wang, Michael; Watkins, William J.; Lansdon, Eric B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5781-5784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyrimidinol carboxylic acids were designed as inhibitors of HIV-1 RNase H function.  These mols. can coordinate to two divalent metal ions in the RNase H active site.  Inhibition of enzymic activity was measured in a biochem. assay, but no antiviral effect was obsd.  Binding was demonstrated via a solid state structure of the isolated p15-Ec domain of HIV-1 RT showing inhibitor and two Mn(II) ions bound to the RNase H active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_O-7zroiObVg90H21EOLACvtfcHk0lguEf-8TxYwjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWqtb%252FL&md5=5cf9a05d81ba1af195b933b2bdad99b8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900597q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900597q%26sid%3Dliteratum%253Aachs%26aulast%3DKirschberg%26aufirst%3DT.%2BA.%26aulast%3DBalakrishnan%26aufirst%3DM.%26aulast%3DSquires%26aufirst%3DN.%2BH.%26aulast%3DBarnes%26aufirst%3DT.%26aulast%3DBrendza%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DEisenberg%26aufirst%3DE.%2BJ.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DKutty%26aufirst%3DN.%26aulast%3DLeavitt%26aufirst%3DS.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMak%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26atitle%3DRNase%2520H%2520active%2520site%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%253A%2520design%252C%2520biochemical%2520activity%252C%2520and%2520structural%2520information%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5781%26epage%3D5784%26doi%3D10.1021%2Fjm900597q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzek, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuston, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiStefano, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnck, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelberger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span> </span><span class="NLM_article-title">Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6754</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.08.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.bmcl.2010.08.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20869872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6754-6757&author=P.+D.+Williamsauthor=D.+D.+Staasauthor=S.+Venkatramanauthor=H.+M.+Loughranauthor=R.+D.+Ruzekauthor=T.+M.+Boothauthor=T.+A.+Lyleauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=B.+P.+Feustonauthor=L.+T.+Ectoauthor=J.+A.+Flynnauthor=D.+J.+DiStefanoauthor=D.+J.+Hazudaauthor=C.+M.+Bahnckauthor=A.+L.+Himmelbergerauthor=G.+Dornadulaauthor=R.+C.+Hrinauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=M.+D.+Millerauthor=J.+A.+Grobler&title=Potent+and+selective+HIV-1+ribonuclease+H+inhibitors+based+on+a+1-hydroxy-1%2C8-naphthyridin-2%281H%29-one+scaffold&doi=10.1016%2Fj.bmcl.2010.08.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold</span></div><div class="casAuthors">Williams, Peter D.; Staas, Donnette D.; Venkatraman, Shankar; Loughran, H. Marie; Ruzek, Rowena D.; Booth, Theresa M.; Lyle, Terry A.; Wai, John S.; Vacca, Joseph P.; Feuston, Bradley P.; Ecto, Linda T.; Flynn, Jessica A.; Di Stefano, Daniel J.; Hazuda, Daria J.; Bahnck, Carolyn M.; Himmelberger, Amy L.; Dornadula, Geetha; Hrin, Renee C.; Stillmock, Kara A.; Witmer, Marc V.; Miller, Michael D.; Grobler, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6754-6757</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Optimization studies using an HIV RNase H active site inhibitor contg. a 1-hydroxy-1,8-naphthyridin-2(1H)-one core identified 4-position substituents that provided several potent and selective inhibitors.  The best compd. was potent and selective in biochem. assays (IC50 = 0.045 μM, HIV RT RNase H; 13 μM, HIV RT-polymerase; 24 μM, HIV integrase) and showed antiviral efficacy in a single-cycle viral replication assay in P4-2 cells (IC50 = 0.19 μM) with a modest window with respect to cytotoxicity (CC50 = 3.3 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9suuOSksTb7Vg90H21EOLACvtfcHk0lhP8C2OE_I81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL3L&md5=88515db2a862c3fc2192b08f23e28c32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.135%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DRuzek%26aufirst%3DR.%2BD.%26aulast%3DBooth%26aufirst%3DT.%2BM.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFeuston%26aufirst%3DB.%2BP.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DFlynn%26aufirst%3DJ.%2BA.%26aulast%3DDiStefano%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DBahnck%26aufirst%3DC.%2BM.%26aulast%3DHimmelberger%26aufirst%3DA.%2BL.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DHrin%26aufirst%3DR.%2BC.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520selective%2520HIV-1%2520ribonuclease%2520H%2520inhibitors%2520based%2520on%2520a%25201-hydroxy-1%252C8-naphthyridin-2%25281H%2529-one%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6754%26epage%3D6757%26doi%3D10.1016%2Fj.bmcl.2010.08.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Beilhartz, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deanda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerondelis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotte, M.</span><span> </span><span class="NLM_article-title">Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">16270</span><span class="NLM_x">–</span> <span class="NLM_lpage">16277</span><span class="refDoi"> DOI: 10.1074/jbc.M114.569707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1074%2Fjbc.M114.569707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=24719329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptl2qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=16270-16277&author=G.+L.+Beilhartzauthor=M.+Ngureauthor=B.+A.+Johnsauthor=F.+Deandaauthor=P.+Gerondelisauthor=M.+Gotte&title=Inhibition+of+the+ribonuclease+H+activity+of+HIV-1+reverse+transcriptase+by+GSK5750+correlates+with+slow+enzyme-inhibitor+dissociation&doi=10.1074%2Fjbc.M114.569707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation</span></div><div class="casAuthors">Beilhartz, Greg L.; Ngure, Marianne; Johns, Brian A.; DeAnda, Felix; Gerondelis, Peter; Gotte, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">16270-16277</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Compds. that efficiently inhibit the RNase (RNase) H activity of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have yet to be developed.  Here, we demonstrate that GSK5750, a 1-hydroxy-pyridopyrimidinone analog, binds to the enzyme with an equil. dissocn. const. (Kd) of ∼400 nm.  Inhibition of HIV-1 RNase H is specific, as DNA synthesis is not affected.  Moreover, GSK5750 does not inhibit the activity of Escherichia coli RNase H.  Order-of-addn. expts. show that GSK5750 binds to the free enzyme in an Mg2+-dependent fashion.  However, as reported for other active site inhibitors, binding of GSK5750 to a preformed enzyme-substrate complex is severely compromised.  The bound nucleic acid prevents access to the RNase H active site, which represents a possible biochem. hurdle in the development of potent RNase H inhibitors.  Previous studies suggested that formation of a complex with the prototypic RNase H inhibitor β-thujaplicinol is slow, and, once formed, it dissocs. rapidly.  This unfavorable kinetic behavior can limit the potency of RNase H active site inhibitors.  Although the assocn. kinetics of GSK5750 remains slow, our data show that this compd. forms a long lasting complex with HIV-1 RT.  We conclude that slow dissocn. of the inhibitor and HIV-1 RT improves RNase H active site inhibitors and may circumvent the obstacle posed by the inability of these compds. to bind to a preformed enzyme-substrate complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3jO9fV0KNwrVg90H21EOLACvtfcHk0lhP8C2OE_I81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptl2qt74%253D&md5=789145792b14990c5060e47efaef028d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.569707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.569707%26sid%3Dliteratum%253Aachs%26aulast%3DBeilhartz%26aufirst%3DG.%2BL.%26aulast%3DNgure%26aufirst%3DM.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DDeanda%26aufirst%3DF.%26aulast%3DGerondelis%26aufirst%3DP.%26aulast%3DGotte%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520the%2520ribonuclease%2520H%2520activity%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520GSK5750%2520correlates%2520with%2520slow%2520enzyme-inhibitor%2520dissociation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D16270%26epage%3D16277%26doi%3D10.1074%2Fjbc.M114.569707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nowotny, M.</span><span> </span><span class="NLM_article-title">Retroviral integrase superfamily: the structural perspective</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1038/embor.2008.256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1038%2Fembor.2008.256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19165139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=144-151&author=M.+Nowotny&title=Retroviral+integrase+superfamily%3A+the+structural+perspective&doi=10.1038%2Fembor.2008.256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Retroviral integrase superfamily: the structural perspective</span></div><div class="casAuthors">Nowotny, Marcin</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-151</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The retroviral integrase superfamily (RISF) comprises numerous important nucleic acid-processing enzymes, including transposases, integrases and various nucleases.  These enzymes are involved in a wide range of processes such as transposition, replication and repair of DNA, homologous recombination, and RNA-mediated gene silencing.  Two out of the four enzymes that are encoded by the human immunodeficiency virus, RNase H1 and integrase, are members of this superfamily.  RISF enzymes act on various substrates, and yet show remarkable mechanistic and structural similarities.  All share a common fold of the catalytic core and the active site, which is composed primarily of carboxylate residues.  Here, RISF proteins are presented from a structural perspective, describing the individual members and the common and divergent elements of their structures, as well as the mechanistic insights gained from the structures of RNase H1 enzyme complexes with RNA/DNA hybrids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMYe1c5DixdbVg90H21EOLACvtfcHk0lhP8C2OE_I81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVChsg%253D%253D&md5=8e67d5e63bdc6e84a3f7576cd6eaa74c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fembor.2008.256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2008.256%26sid%3Dliteratum%253Aachs%26aulast%3DNowotny%26aufirst%3DM.%26atitle%3DRetroviral%2520integrase%2520superfamily%253A%2520the%2520structural%2520perspective%26jtitle%3DEMBO%2520Rep.%26date%3D2009%26volume%3D10%26spage%3D144%26epage%3D151%26doi%3D10.1038%2Fembor.2008.256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fujishita, T.; Mikamiyama, M.; Kawai, M.; Akiyama, T.</span><span> </span><span class="NLM_article-title">Substituted 3-hydroxy-4-pyridone derivative</span>. WO2010110231,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Fujishita&author=M.+Mikamiyama&author=M.+Kawai&author=T.+Akiyama&title=Substituted+3-hydroxy-4-pyridone+derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFujishita%26aufirst%3DT.%26atitle%3DSubstituted%25203-hydroxy-4-pyridone%2520derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkoff, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5916</span><span class="refDoi"> DOI: 10.1021/jm400645w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29&doi=10.1021%2Fjm400645w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)</span></div><div class="casAuthors">Johns, Brian A.; Kawasuji, Takashi; Weatherhead, Jason G.; Taishi, Teruhiko; Temelkoff, David P.; Yoshida, Hiroshi; Akiyama, Toshiyuki; Taoda, Yoshiyuki; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Jeffrey, Jerry; Foster, Scott A.; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Johnson, Matthew N.; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5901-5916</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572) (3, III) and S/GSK1265744 (4, IV).  These drugs stem from a series of carbamoyl pyridone analogs designed using a two-metal chelation model of the integrase catalytic active site.  Structure-activity studies evolved a tricyclic series of carbamoyl pyridines that demonstrated properties indicative of once-daily dosing and superior potency against resistant viral strains.  An inherent hemiaminal ring fusion stereocenter within the tricyclic carbamoyl pyridone scaffold led to a crit. substrate controlled diastereoselective synthetic strategy whereby chiral information from small readily available amino alcs. was employed to control relative and abs. stereochem. of the final drug candidates.  Modest to extremely high levels of stereochem. control were obsd. depending on ring size and position of the stereocenter.  This approach resulted in the discovery of 3 and 4, which are currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1G_fuC1lAtLVg90H21EOLACvtfcHk0lgH38Yta7tP1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWhurfK&md5=c44c9e62870c2177b07cdd08d22ea600</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916%26doi%3D10.1021%2Fjm400645w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vernekar, S. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kankanala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span> </span><span class="NLM_article-title">Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1021/jm501132s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501132s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=651-664&author=S.+K.+V.+Vernekarauthor=Z.+Liuauthor=E.+Nagyauthor=L.+Millerauthor=K.+A.+Kirbyauthor=D.+J.+Wilsonauthor=J.+Kankanalaauthor=S.+G.+Sarafianosauthor=M.+A.+Parniakauthor=Z.+Q.+Wang&title=Design%2C+synthesis%2C+biochemical%2C+and+antiviral+evaluations+of+C6+benzyl+and+C6+biarylmethyl+substituted+2-hydroxylisoquinoline-1%2C3-diones%3A+dual+inhibition+against+HIV+reverse+transcriptase-associated+RNase+H+and+polymerase+with+antiviral+activities&doi=10.1021%2Fjm501132s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities</span></div><div class="casAuthors">Vernekar, Sanjeev Kumar V.; Liu, Zheng; Nagy, Eva; Miller, Lena; Kirby, Karen A.; Wilson, Daniel J.; Kankanala, Jayakanth; Sarafianos, Stefan G.; Parniak, Michael A.; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reverse transcriptase (RT) assocd. RNase H (RNase H) remains the only virally encoded enzymic function not targeted by current chemotherapy against human immunodeficiency virus (HIV).  Although numerous chemotypes have been reported to inhibit HIV RNase H biochem., few show significant antiviral activity against HIV.  We report herein the design, synthesis, and biol. evaluations of a novel variant of 2-hydroxyisoquinoline-1,3-dione (HID) scaffold featuring a crucial C-6 benzyl or biarylmethyl moiety, e. g., I.  The synthesis involved a recently reported metal-free direct benzylation between tosylhydrazone and boronic acid, which allowed the generation of structural diversity for the hydrophobic arom. region.  Biochem. studies showed that the C-6 benzyl and biarylmethyl HID analogs, previously unknown chemotypes, consistently inhibited HIV RT-assocd. RNase H and polymerase with IC50s in low to submicromolar range.  The obsd. dual inhibitory activity remained uncompromised against RT mutants resistant to non-nucleoside RT inhibitors (NNRTIs), suggesting the involvement of binding site(s) other than the NNRTI binding pocket.  Intriguingly, these same compds. inhibited the polymerase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia coli RNase H.  Addnl. biochem. testing revealed a substantially reduced level of inhibition against HIV integrase.  Mol. docking corroborates favorable binding of these analogs to the active site of HIV RNase H.  Finally, a no. of these analogs also demonstrated antiviral activity at low micromolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeenALml-35bVg90H21EOLACvtfcHk0lgH38Yta7tP1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO&md5=a4574233b65a5a0efd3634a2011fc94f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501132s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501132s%26sid%3Dliteratum%253Aachs%26aulast%3DVernekar%26aufirst%3DS.%2BK.%2BV.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DKankanala%26aufirst%3DJ.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26atitle%3DDesign%252C%2520synthesis%252C%2520biochemical%252C%2520and%2520antiviral%2520evaluations%2520of%2520C6%2520benzyl%2520and%2520C6%2520biarylmethyl%2520substituted%25202-hydroxylisoquinoline-1%252C3-diones%253A%2520dual%2520inhibition%2520against%2520HIV%2520reverse%2520transcriptase-associated%2520RNase%2520H%2520and%2520polymerase%2520with%2520antiviral%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D651%26epage%3D664%26doi%3D10.1021%2Fjm501132s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budihas, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grice, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beutler, J. A.</span><span> </span><span class="NLM_article-title">A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1016/j.ab.2003.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.ab.2003.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=14705777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Kkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2003&pages=33-39&author=M.+A.+Parniakauthor=K.+L.+Minauthor=S.+R.+Budihasauthor=S.+F.+Le+Griceauthor=J.+A.+Beutler&title=A+fluorescence-based+high-throughput+screening+assay+for+inhibitors+of+human+immunodeficiency+virus-1+reverse+transcriptase-associated+ribonuclease+H+activity&doi=10.1016%2Fj.ab.2003.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity</span></div><div class="casAuthors">Parniak, Michael A.; Min, Kyung-Lyum; Budihas, Scott R.; Le Grice, Stuart F. J.; Beutler, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A fluorescence resonance energy transfer assay readily applicable to 96-well and 384-well microplate formats with robotic operation was developed to enable high-throughput screening for inhibitors of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (RT)-assocd. RNase H activity, an underexplored target for antiretroviral development.  The assay substrate is an 18-nucleotide 3'-fluorescein-labeled RNA annealed to a complementary 18-nucleotide 5'-Dabcyl-modified DNA.  The intact duplex has an extremely low background fluorescent signal and provides up to 50-fold fluorescent signal enhancement following hydrolysis.  The size and sequence of the duplex are such that HIV-1 RT-RNase H cuts the RNA strand close to the 3' end.  The fluorescein-labeled ribonucleotide fragment readily dissocs. from the complementary DNA at room temp. with immediate generation of a fluorescent signal.  This assay is rapid, inexpensive, and robust, providing Z' factors of 0.8 and coeffs. of variation of about 5%.  The assay can be carried out both in real-time (continuous) and in "quench" modes; the latter requires only two addn. steps with no washing and is thus suitable for robotic operation.  Several chem. libraries totaling more than 106,000 compds. were screened with this assay in approx. 1 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzURDybesnbVg90H21EOLACvtfcHk0lgH38Yta7tP1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Kkt7k%253D&md5=4f06c7c5cb1d358b2638234439d547b3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2003.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2003.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DMin%26aufirst%3DK.%2BL.%26aulast%3DBudihas%26aufirst%3DS.%2BR.%26aulast%3DLe%2BGrice%26aufirst%3DS.%2BF.%26aulast%3DBeutler%26aufirst%3DJ.%2BA.%26atitle%3DA%2520fluorescence-based%2520high-throughput%2520screening%2520assay%2520for%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus-1%2520reverse%2520transcriptase-associated%2520ribonuclease%2520H%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D322%26spage%3D33%26epage%3D39%26doi%3D10.1016%2Fj.ab.2003.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Beilhartz, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichoo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotte, M.</span><span> </span><span class="NLM_article-title">HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2Fj.jmb.2009.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=462-474&author=G.+L.+Beilhartzauthor=M.+Wendelerauthor=N.+Baichooauthor=J.+Rauschauthor=S.+Le+Griceauthor=M.+Gotte&title=HIV-1+reverse+transcriptase+can+simultaneously+engage+its+DNA%2FRNA+substrate+at+both+DNA+polymerase+and+RNase+H+active+sites%3A+implications+for+RNase+H+inhibition&doi=10.1016%2Fj.jmb.2009.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DBeilhartz%26aufirst%3DG.%2BL.%26aulast%3DWendeler%26aufirst%3DM.%26aulast%3DBaichoo%26aufirst%3DN.%26aulast%3DRausch%26aufirst%3DJ.%26aulast%3DLe%2BGrice%26aufirst%3DS.%26aulast%3DGotte%26aufirst%3DM.%26atitle%3DHIV-1%2520reverse%2520transcriptase%2520can%2520simultaneously%2520engage%2520its%2520DNA%252FRNA%2520substrate%2520at%2520both%2520DNA%2520polymerase%2520and%2520RNase%2520H%2520active%2520sites%253A%2520implications%2520for%2520RNase%2520H%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D462%26epage%3D474%26doi%3D10.1016%2Fj.jmb.2009.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sirivolu, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernekar, S. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myshakina, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span> </span><span class="NLM_article-title">Clicking 3 ′-azidothymidine into novel potent inhibitors of human immunodeficiency virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8765</span><span class="NLM_x">–</span> <span class="NLM_lpage">8780</span><span class="refDoi"> DOI: 10.1021/jm401232v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401232v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8765-8780&author=V.+R.+Sirivoluauthor=S.+K.+V.+Vernekarauthor=T.+Ilinaauthor=N.+S.+Myshakinaauthor=M.+A.+Parniakauthor=Z.+Q.+Wang&title=Clicking+3+%E2%80%B2-azidothymidine+into+novel+potent+inhibitors+of+human+immunodeficiency+virus&doi=10.1021%2Fjm401232v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401232v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401232v%26sid%3Dliteratum%253Aachs%26aulast%3DSirivolu%26aufirst%3DV.%2BR.%26aulast%3DVernekar%26aufirst%3DS.%2BK.%2BV.%26aulast%3DIlina%26aufirst%3DT.%26aulast%3DMyshakina%26aufirst%3DN.%2BS.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26atitle%3DClicking%25203%2520%25E2%2580%25B2-azidothymidine%2520into%2520novel%2520potent%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8765%26epage%3D8780%26doi%3D10.1021%2Fjm401232v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>Small-Molecule Drug Discovery Suite 2014-3: Glide, version <span class="NLM_edition">6.4</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Small-Molecule+Drug+Discovery+Suite+2014-3%3A+Glide%2C+version+6.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall-Molecule%2520Drug%2520Discovery%2520Suite%25202014-3%253A%2520Glide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span><span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lgeNLI0EKcolg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdine, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span> </span><span class="NLM_article-title">Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1675</span><span class="refDoi"> DOI: 10.1126/science.282.5394.1669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1126%2Fscience.282.5394.1669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=9831551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1669-1675&author=H.+Huangauthor=R.+Chopraauthor=G.+L.+Verdineauthor=S.+C.+Harrison&title=Structure+of+a+covalently+trapped+catalytic+complex+of+HIV-1+reverse+transcriptase%3A+implications+for+drug+resistance&doi=10.1126%2Fscience.282.5394.1669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance</span></div><div class="casAuthors">Huang, Huifang; Chopra, Rajiv; Verdine, Gregory L.; Harrison, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5394</span>),
    <span class="NLM_cas:pages">1669-1675</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A combinatorial disulfide crosslinking strategy was used to prep. a stalled complex of human immunodeficiency virus-type 1 (HIV-1) reverse transcriptase with a DNA template:primer and a deoxynucleoside triphosphate (dNTP), and the crystal structure of the complex was detd. at a resoln. of 3.2 angstroms.  The presence of a dideoxynucleotide at the 3'-primer terminus allows capture of a state in which the substrates are poised for attack on the dNTP.  Conformational changes that accompany formation of the catalytic complex produce distinct clusters of the residues that are altered in viruses resistant to nucleoside analog drugs.  The positioning of these residues in the neighborhood of the dNTP helps to resolve some long-standing puzzles about the mol. basis of resistance.  The resistance mutations are likely to influence binding or reactivity of the inhibitors, relative to normal dNTPs, and the clustering of the mutations correlates with the chem. structure of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV_rP3C5B_N7Vg90H21EOLACvtfcHk0lgeNLI0EKcolg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D&md5=e97c3a69e2aa084beff2ec8dd88af3b4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5394.1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5394.1669%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DStructure%2520of%2520a%2520covalently%2520trapped%2520catalytic%2520complex%2520of%2520HIV-1%2520reverse%2520transcriptase%253A%2520implications%2520for%2520drug%2520resistance%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1669%26epage%3D1675%26doi%3D10.1126%2Fscience.282.5394.1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcomb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1449</span><span class="NLM_x">–</span> <span class="NLM_lpage">1461</span><span class="refDoi"> DOI: 10.1093/emboj/20.6.1449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Femboj%2F20.6.1449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=11250910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVCktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=1449-1461&author=S.+G.+Sarafianosauthor=K.+Dasauthor=C.+Tantilloauthor=A.+D.+Clarkauthor=J.+Dingauthor=J.+M.+Whitcombauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=E.+Arnold&title=Crystal+structure+of+HIV-1+reverse+transcriptase+in+complex+with+a+polypurine+tract+RNA%3ADNA&doi=10.1093%2Femboj%2F20.6.1449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA</span></div><div class="casAuthors">Sarafianos, Stefan G.; Das, Kalyan; Tantillo, Chris; Clark, Arthur D., Jr.; Ding, Jianping; Whitcomb, Jeannette M.; Boyer, Paul L.; Hughes, Stephen H.; Arnold, Edward</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1449-1461</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We have detd. the 3.0 Å resoln. structure of wild-type HIV-1 reverse transcriptase in complex with an RNA:DNA oligonucleotide whose sequence includes a purine-rich segment from the HIV-1 genome called the polypurine tract (PPT).  The PPT is resistant to RNase H cleavage and is used as a primer for second DNA strand synthesis.  The "RNase H primer grip", consisting of amino acids that interact with the DNA primer strand, may contribute to RNase H catalysis and cleavage specificity.  Cleavage specificity is also controlled by the width of the minor groove and the trajectory of the RNA:DNA, both of which are sequence dependent.  An unusual "unzipping" of 7 bp occurs in the adenine stretch of the PPT: an unpaired base on the template strand takes the base pairing out of register and then, following two offset base pairs, an unpaired base on the primer strand re-establishes the normal register.  The structural aberration extends to the RNase H active site and may play a role in the resistance of PPT to RNase H cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKH50BRNF3aLVg90H21EOLACvtfcHk0li8_h3BNCxbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVCktrs%253D&md5=37213d1688b62adfa5b41b6e4af2e149</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.6.1449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.6.1449%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DTantillo%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DWhitcomb%26aufirst%3DJ.%2BM.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DCrystal%2520structure%2520of%2520HIV-1%2520reverse%2520transcriptase%2520in%2520complex%2520with%2520a%2520polypurine%2520tract%2520RNA%253ADNA%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D1449%26epage%3D1461%26doi%3D10.1093%2Femboj%2F20.6.1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Su, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywickrema, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span> </span><span class="NLM_article-title">Structural Basis for the Inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">7625</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span><span class="refDoi"> DOI: 10.1128/JVI.00353-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FJVI.00353-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20484498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=7625-7633&author=H.-P.+Suauthor=Y.+Yanauthor=G.+S.+Prasadauthor=R.+F.+Smithauthor=C.+L.+Danielsauthor=P.+D.+Abeywickremaauthor=J.+C.+Reidauthor=H.+M.+Loughranauthor=M.+Kornienkoauthor=S.+Sharmaauthor=J.+A.+Groblerauthor=B.+Xuauthor=V.+Sardanaauthor=T.+J.+Allisonauthor=P.+D.+Williamsauthor=P.+L.+Darkeauthor=D.+J.+Hazudaauthor=S.+Munshi&title=Structural+Basis+for+the+Inhibition+of+RNase+H+activity+of+HIV-1+reverse+transcriptase+by+RNase+H+active+site-directed+inhibitors&doi=10.1128%2FJVI.00353-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span></div><div class="casAuthors">Su, Hua-Poo; Yan, Youwei; Prasad, G. Sridhar; Smith, Robert F.; Daniels, Christopher L.; Abeywickrema, Pravien D.; Reid, John C.; Loughran, H. Marie; Kornienko, Maria; Sharma, Sujata; Grobler, Jay A.; Xu, Bei; Sardana, Vinod; Allison, Timothy J.; Williams, Peter D.; Darke, Paul L.; Hazuda, Daria J.; Munshi, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7625-7633</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HIV/AIDS continues to be a menace to public health.  Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients.  However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing therapies.  Currently, approved drugs target three of the four major enzyme activities encoded by the virus that are crit. to the HIV life cycle.  Although a no. of inhibitors of HIV RNase H activity have been reported, few inhibit by directly engaging the RNase H active site.  Here, we describe structures of naphthyridinone-contg. inhibitors bound to the RNase H active site.  This class of compds. binds to the active site via two metal ions that are coordinated by catalytic site residues, D443, E478, D498, and D549.  The directionality of the naphthyridinone pharmacophore is restricted by the ordering of D549 and H539 in the RNase H domain.  In addn., one of the naphthyridinone-based compds. was found to bind at a second site close to the polymerase active site and non-nucleoside/nucleotide inhibitor sites in a metal-independent manner.  Further characterization, using fluorescence-based thermal denaturation and a crystal structure of the isolated RNase H domain reveals that this compd. can also bind the RNase H site and retains the metal-dependent binding mode of this class of mols.  These structures provide a means for structurally guided design of novel RNase H inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofoAtMsynlGbVg90H21EOLACvtfcHk0li8_h3BNCxbwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L&md5=67296baed7573ed339c9fcf985b2ff20</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FJVI.00353-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00353-10%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DH.-P.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DC.%2BL.%26aulast%3DAbeywickrema%26aufirst%3DP.%2BD.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Inhibition%2520of%2520RNase%2520H%2520activity%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520RNase%2520H%2520active%2520site-directed%2520inhibitors%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D7625%26epage%3D7633%26doi%3D10.1128%2FJVI.00353-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lansdon, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster-Moyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschberg, T. A.</span><span> </span><span class="NLM_article-title">Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2905</span><span class="NLM_x">–</span> <span class="NLM_lpage">2915</span><span class="refDoi"> DOI: 10.1128/AAC.01594-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FAAC.01594-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=21464257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Kiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=2905-2915&author=E.+B.+Lansdonauthor=Q.+Liuauthor=S.+A.+Leavittauthor=M.+Balakrishnanauthor=J.+K.+Perryauthor=C.+Lancaster-Moyerauthor=N.+Kuttyauthor=X.+Liuauthor=N.+H.+Squiresauthor=W.+J.+Watkinsauthor=T.+A.+Kirschberg&title=Structural+and+binding+analysis+of+pyrimidinol+carboxylic+acid+and+N-hydroxy+quinazolinedione+HIV-1+RNase+H+inhibitors&doi=10.1128%2FAAC.01594-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors</span></div><div class="casAuthors">Lansdon, Eric B.; Liu, Qi; Leavitt, Stephanie A.; Balakrishnan, Mini; Perry, Jason K.; Lancaster-Moyer, Candra; Kutty, Nilima; Liu, Xiaohong; Squires, Neil H.; Watkins, William J.; Kirschberg, Thorsten A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2905-2915</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HIV-1 RNase H breaks down the intermediate RNA-DNA hybrids during reverse transcription, requiring two divalent metal ions for activity.  Pyrimidinol carboxylic acid and N-hydroxy quinazolinedione inhibitors were designed to coordinate the two metal ions in the active site of RNase H.  High-resoln. (1.4 Å to 2.1 Å) crystal structures were detd. with the isolated RNase H domain and reverse transcriptase (RT), which permit accurate assessment of the metal and water environment at the active site.  The geometry of the metal coordination suggests that the inhibitors mimic a substrate state prior to phosphodiester catalysis.  Surface plasmon resonance studies confirm metal-dependent binding to RNase H and demonstrate that the inhibitors do not bind at the polymerase active site of RT.  Addnl. evaluation of the RNase H site reveals an open protein surface with few addnl. interactions to optimize active-site inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ89ipmZgY9bVg90H21EOLACvtfcHk0ljmcb5wFPVilQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Kiu7c%253D&md5=babdbff2785f14cd6f5b1f25890aa583</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FAAC.01594-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01594-10%26sid%3Dliteratum%253Aachs%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DBalakrishnan%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DLancaster-Moyer%26aufirst%3DC.%26aulast%3DKutty%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSquires%26aufirst%3DN.%2BH.%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DKirschberg%26aufirst%3DT.%2BA.%26atitle%3DStructural%2520and%2520binding%2520analysis%2520of%2520pyrimidinol%2520carboxylic%2520acid%2520and%2520N-hydroxy%2520quinazolinedione%2520HIV-1%2520RNase%2520H%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D2905%26epage%3D2915%26doi%3D10.1128%2FAAC.01594-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rodgers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culp, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debouck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span> </span><span class="NLM_article-title">The structure of unliganded reverse-transcriptase from the human-immunodeficiency-virus Type-1</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span><span class="refDoi"> DOI: 10.1073/pnas.92.4.1222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1073%2Fpnas.92.4.1222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=1222-1226&author=D.+W.+Rodgersauthor=S.+J.+Gamblinauthor=B.+A.+Harrisauthor=S.+Rayauthor=J.+S.+Culpauthor=B.+Hellmigauthor=D.+J.+Woolfauthor=C.+Debouckauthor=S.+C.+Harrison&title=The+structure+of+unliganded+reverse-transcriptase+from+the+human-immunodeficiency-virus+Type-1&doi=10.1073%2Fpnas.92.4.1222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.4.1222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.4.1222%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DD.%2BW.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DCulp%26aufirst%3DJ.%2BS.%26aulast%3DHellmig%26aufirst%3DB.%26aulast%3DWoolf%26aufirst%3DD.%2BJ.%26aulast%3DDebouck%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DThe%2520structure%2520of%2520unliganded%2520reverse-transcriptase%2520from%2520the%2520human-immunodeficiency-virus%2520Type-1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D1222%26epage%3D1226%26doi%3D10.1073%2Fpnas.92.4.1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hsiou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structure of unliganded HIV-1 reverse transcriptase at 2.7 angstrom resolution: implications of conformational changes for polymerization and inhibition mechanisms</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1016/S0969-2126(96)00091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2FS0969-2126%2896%2900091-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=853-860&author=Y.+Hsiouauthor=J.+Dingauthor=K.+Dasauthor=A.+D.+Clarkauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structure+of+unliganded+HIV-1+reverse+transcriptase+at+2.7+angstrom+resolution%3A+implications+of+conformational+changes+for+polymerization+and+inhibition+mechanisms&doi=10.1016%2FS0969-2126%2896%2900091-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2896%2900091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252896%252900091-3%26sid%3Dliteratum%253Aachs%26aulast%3DHsiou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520of%2520unliganded%2520HIV-1%2520reverse%2520transcriptase%2520at%25202.7%2520angstrom%2520resolution%253A%2520implications%2520of%2520conformational%2520changes%2520for%2520polymerization%2520and%2520inhibition%2520mechanisms%26jtitle%3DStructure%26date%3D1996%26volume%3D4%26spage%3D853%26epage%3D860%26doi%3D10.1016%2FS0969-2126%2896%2900091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">10027</span><span class="NLM_x">–</span> <span class="NLM_lpage">10032</span><span class="refDoi"> DOI: 10.1073/pnas.96.18.10027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1073%2Fpnas.96.18.10027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10468556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFegsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=10027-10032&author=S.+G.+Sarafianosauthor=K.+Dasauthor=A.+D.+Clarkauthor=J.+Dingauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=E.+Arnold&title=Lamivudine+%283TC%29+resistance+in+HIV-1+reverse+transcriptase+involves+steric+hindrance+with+beta-branched+amino+acids&doi=10.1073%2Fpnas.96.18.10027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids</span></div><div class="casAuthors">Sarafianos, Stefan G.; Das, Kalyan; Clark, Arthur D., Jr.; Ding, Jianping; Boyer, Paul L.; Hughes, Stephen H.; Arnold, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10027-10032</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">An important component of triple-drug anti-AIDS therapy is 2',3'-dideoxy-3'-thiacytidine (3TC, lamivudine).  Single mutations at residue 184 of the reverse transcriptase (RT) in HIV cause high-level resistance to 3TC and contribute to the failure of anti-AIDS combination therapy.  We have detd. crystal structures of the 3TC-resistant mutant HIV-1 RT (M184I) in both the presence and absence of a DNA/DNA template-primer.  In the absence of a DNA substrate, the wild-type and mutant structures are very similar.  However, comparison of crystal structures of M184I mutant and wild-type HIV-1 RT with and without DNA reveals repositioning of the template-primer in the M184I/DNA binary complex and other smaller changes in residues in the dNTP-binding site.  On the basis of these structural results, we developed a model that explains the ability of the 3TC-resistant mutant M184I to incorporate dNTPs but not the nucleotide analog 3TCTP.  In this model, steric hindrance is expected for NRTIs with β- or L- ring configurations, as with the enantiomer of 3TC that is used in therapy.  Steric conflict between the oxathiolane ring of 3TCTP and the side chain of β-branched amino acids (Val, Ile, Thr) at position 184 perturbs inhibitor binding, leading to a redn. in incorporation of the analog.  The model can also explain the 3TC resistance of analogous hepatitis B polymerase mutants.  Repositioning of the template-primer as obsd. in the binary complex (M184I/DNA) may also occur in the catalytic ternary complex (M184I/DNA/3TCTP) and contribute to 3TC resistance by interfering with the formation of a catalytically competent closed complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZSQKvs4NyB7Vg90H21EOLACvtfcHk0ljmcb5wFPVilQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFegsrg%253D&md5=22ee198411a5c60ba007b19081711485</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.10027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.10027%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DLamivudine%2520%25283TC%2529%2520resistance%2520in%2520HIV-1%2520reverse%2520transcriptase%2520involves%2520steric%2520hindrance%2520with%2520beta-branched%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D10027%26epage%3D10032%26doi%3D10.1073%2Fpnas.96.18.10027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hsiou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleim, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span><span class="refDoi"> DOI: 10.1006/jmbi.2001.4648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1006%2Fjmbi.2001.4648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2001&pages=437-445&author=Y.+Hsiouauthor=J.+P.+Dingauthor=K.+Dasauthor=A.+D.+Clarkauthor=P.+L.+Boyerauthor=P.+Lewiauthor=P.+A.+J.+Janssenauthor=J.+P.+Kleimauthor=M.+Rosnerauthor=S.+H.+Hughesauthor=E.+Arnold&title=The+Lys103Asn+mutation+of+HIV-1+RT%3A+a+novel+mechanism+of+drug+resistance&doi=10.1006%2Fjmbi.2001.4648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2001.4648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2001.4648%26sid%3Dliteratum%253Aachs%26aulast%3DHsiou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%2BP.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DLewi%26aufirst%3DP.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DKleim%26aufirst%3DJ.%2BP.%26aulast%3DRosner%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DThe%2520Lys103Asn%2520mutation%2520of%2520HIV-1%2520RT%253A%2520a%2520novel%2520mechanism%2520of%2520drug%2520resistance%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D309%26spage%3D437%26epage%3D445%26doi%3D10.1006%2Fjmbi.2001.4648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structural basis of HIV-1 resistance to AZT by excision</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span><span class="refDoi"> DOI: 10.1038/nsmb.1908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1038%2Fnsmb.1908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20852643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1202-1209&author=X.+Y.+Tuauthor=K.+Dasauthor=Q.+W.+Hanauthor=J.+D.+Baumanauthor=A.+D.+Clarkauthor=X.+R.+Houauthor=Y.+V.+Frenkelauthor=B.+L.+Gaffneyauthor=R.+A.+Jonesauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=S.+G.+Sarafianosauthor=E.+Arnold&title=Structural+basis+of+HIV-1+resistance+to+AZT+by+excision&doi=10.1038%2Fnsmb.1908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV-1 resistance to AZT by excision</span></div><div class="casAuthors">Tu, Xiongying; Das, Kalyan; Han, Qianwei; Bauman, Joseph D.; Clark, Arthur D.; Hou, Xiaorong; Frenkel, Yulia V.; Gaffney, Barbara L.; Jones, Roger A.; Boyer, Paul L.; Hughes, Stephen H.; Sarafianos, Stefan G.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1202-1209</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV-1) develops resistance to 3'-azido-2',3'-deoxythymidine (AZT, zidovudine) by acquiring mutations in reverse transcriptase that enhance the ATP-mediated excision of AZT monophosphate from the 3' end of the primer.  The excision reaction occurs at the dNTP-binding site, uses ATP as a pyrophosphate donor, unblocks the primer terminus and allows reverse transcriptase to continue viral DNA synthesis.  The excision product is AZT adenosine dinucleoside tetraphosphate (AZTppppA).  We detd. five crystal structures: wild-type reverse transcriptase-double-stranded DNA (RT-dsDNA)-AZTppppA; AZT-resistant (AZTr; M41L D67N K70R T215Y K219Q) RT-dsDNA-AZTppppA; AZTr RT-dsDNA terminated with AZT at dNTP- and primer-binding sites; and AZTr apo reverse transcriptase.  The AMP part of AZTppppA bound differently to wild-type and AZTr reverse transcriptases, whereas the AZT triphosphate part bound the two enzymes similarly.  Thus, the resistance mutations create a high-affinity ATP-binding site.  The structure of the site provides an opportunity to design inhibitors of AZT-monophosphate excision.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGIO2feJMMO7Vg90H21EOLACvtfcHk0lidlw5TrDdc6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73I&md5=e0394a2d8e947d42534c5c7e8d366ed4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1908%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DX.%2BY.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DQ.%2BW.%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DHou%26aufirst%3DX.%2BR.%26aulast%3DFrenkel%26aufirst%3DY.%2BV.%26aulast%3DGaffney%26aufirst%3DB.%2BL.%26aulast%3DJones%26aufirst%3DR.%2BA.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520of%2520HIV-1%2520resistance%2520to%2520AZT%2520by%2520excision%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1202%26epage%3D1209%26doi%3D10.1038%2Fnsmb.1908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>PyMOL: <a href="http://www.pymol.org" class="extLink">www.pymol.org</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PyMOL%3A+www.pymol.org+%28accessed+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Fletcher, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleschak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borkow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span> </span><span class="NLM_article-title">Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1006/prep.1996.0004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1006%2Fprep.1996.0004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=9172779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK28XhtVCqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=27-32&author=R.+S.+Fletcherauthor=G.+Holleschakauthor=E.+Nagyauthor=D.+Arionauthor=G.+Borkowauthor=Z.+Guauthor=M.+A.+Wainbergauthor=M.+A.+Parniak&title=Single-step+purification+of+recombinant+wild-type+and+mutant+HIV-1+reverse+transcriptase&doi=10.1006%2Fprep.1996.0004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase</span></div><div class="casAuthors">Fletcher, Ronald S.; Holleschak, Gyula; Nagy, Eva; Arion, Dominique; Borkow, Gadi; Gu, Zhengxian; Wainberg, Mark A.; Parniak, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-32</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A single-step method that enables the purifn. of HIV-1 recombinant reverse transcriptase (RT) directly from bacterial lysates in <2 h is described.  Clarified lysates were applied to com. Q- and S-matrix cartridge columns connected in series.  The columns were washed with low-salt buffer to remove unbound protein, then the Q column was removed and RT was eluted from the S column using a salt gradient.  The purifn. was carried out with both medium-pressure and high-pressure chromatog. systems.  The purifns. were carried out at room temp. near neutral pH, providing enzyme with high DNA polymerase specific activity.  A crucial aspect of the procedure was the use of Tris buffer, a buffer that is normally incompatible in cation-exchange methods.  The method was applicable for the purifn. of the p51/p66 heterodimer and the p51 and p66 homodimer forms of RT.  This method was used to purify wild-type RT and several recombinant RT proteins contg. mutations correlated with dideoxynucleoside drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotv6nxVQS-UrVg90H21EOLACvtfcHk0lidlw5TrDdc6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtVCqu7w%253D&md5=106b9f3b265af0342bed655f2644a5d1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1006%2Fprep.1996.0004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fprep.1996.0004%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DR.%2BS.%26aulast%3DHolleschak%26aufirst%3DG.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DArion%26aufirst%3DD.%26aulast%3DBorkow%26aufirst%3DG.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26atitle%3DSingle-step%2520purification%2520of%2520recombinant%2520wild-type%2520and%2520mutant%2520HIV-1%2520reverse%2520transcriptase%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D1996%26volume%3D7%26spage%3D27%26epage%3D32%26doi%3D10.1006%2Fprep.1996.0004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishima, R.</span><span> </span><span class="NLM_article-title">Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2010.01052.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1111%2Fj.1747-0285.2010.01052.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=21114787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2ktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=39-47&author=Q.+Gongauthor=L.+Menonauthor=T.+Ilinaauthor=L.+G.+Millerauthor=J.+Ahnauthor=M.+A.+Parniakauthor=R.+Ishima&title=Interaction+of+HIV-1+reverse+transcriptase+ribonuclease+H+with+an+acylhydrazone+inhibitor&doi=10.1111%2Fj.1747-0285.2010.01052.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor</span></div><div class="casAuthors">Gong, Qingguo; Menon, Lakshmi; Ilina, Tatiana; Miller, Lena G.; Ahn, Jinwoo; Parniak, Michael A.; Ishima, Rieko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">HIV-1 reverse transcriptase is a bifunctional enzyme, having both DNA polymerase (RNA- and DNA-dependent) and RNase H activities.  HIV-1 reverse transcriptase has been an exceptionally important target for antiretroviral therapeutic development, and nearly half of the current clin. used antiretrovirals target reverse transcriptase DNA polymerase.  However, no inhibitors of reverse transcriptase RNase H are on the market or in preclin. development.  Several drug-like small mol. inhibitors of reverse transcriptase RNase H have been described, but little structural information is available about the interactions between reverse transcriptase RNase H and inhibitors that exhibit antiviral activity.  In this report, we describe NMR studies of the interaction of a new RNase H inhibitor, BHMP07, with a catalytically active HIV-1 reverse transcriptase RNase H domain fragment.  We carried out soln. NMR expts. to identify the interaction interface of BHMP07 with the RNase H domain fragment.  Chem. shift changes of backbone amide signals at different BHMP07 concns. clearly demonstrate that BHMP07 mainly recognizes the substrate handle region in the RNase H fragment.  Using RNase H inhibition assays and reverse transcriptase mutants, the binding specificity of BHMP07 was compared with another inhibitor, dihydroxy benzoyl naphthyl hydrazone.  Our results provide a structural characterization of the RNase H inhibitor interaction and are likely to be useful for further improvements of the inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFO6xAt28QU7Vg90H21EOLACvtfcHk0li1lgaL35GcFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2ktrs%253D&md5=9d6163932388134057a3d5363c95c9ff</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.01052.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.01052.x%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DMenon%26aufirst%3DL.%26aulast%3DIlina%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DL.%2BG.%26aulast%3DAhn%26aufirst%3DJ.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DIshima%26aufirst%3DR.%26atitle%3DInteraction%2520of%2520HIV-1%2520reverse%2520transcriptase%2520ribonuclease%2520H%2520with%2520an%2520acylhydrazone%2520inhibitor%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D39%26epage%3D47%26doi%3D10.1111%2Fj.1747-0285.2010.01052.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kirby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ndongwe, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michailidis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sietsema, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fetterly, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span> </span><span class="NLM_article-title">Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2048</span><span class="NLM_x">–</span> <span class="NLM_lpage">2061</span><span class="refDoi"> DOI: 10.1128/AAC.06000-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FAAC.06000-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=22252812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2qsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=2048-2061&author=K.+A.+Kirbyauthor=B.+Marchandauthor=Y.+T.+Ongauthor=T.+P.+Ndongweauthor=A.+Hachiyaauthor=E.+Michailidisauthor=M.+D.+Leslieauthor=D.+V.+Sietsemaauthor=T.+L.+Fetterlyauthor=C.+A.+Dorstauthor=K.+Singhauthor=Z.+Wangauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Structural+and+inhibition+studies+of+the+RNase+H+function+of+xenotropic+murine+leukemia+virus-related+virus+reverse+transcriptase&doi=10.1128%2FAAC.06000-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase</span></div><div class="casAuthors">Kirby, Karen A.; Marchand, Bruno; Ong, Yee Tsuey; Ndongwe, Tanyaradzwa P.; Hachiya, Atsuko; Michailidis, Eleftherios; Leslie, Maxwell D.; Sietsema, Daniel V.; Fetterly, Tracy L.; Dorst, Christopher A.; Singh, Kamalendra; Wang, Zhengqiang; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2048-2061</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">RNase H inhibitors (RNHIs) have gained attention as potential HIV-1 therapeutics.  Although several RNHIs have been studied in the context of HIV-1 reverse transcriptase (RT) RNase H, there is no information on inhibitors that might affect the RNase H activity of other RTs.  We performed biochem., virol., crystallog., and mol. modeling studies to compare the RNase H function and inhibition profiles of the gammaretroviral xenotropic murine leukemia virus-related virus (XMRV) and Moloney murine leukemia virus (MoMLV) RTs to those of HIV-1 RT.  The RNase H activity of XMRV RT is significantly lower than that of HIV-1 RT and comparable to that of MoMLV RT.  XMRV and MoMLV, but not HIV-1 RT, had optimal RNase H activities in the presence of Mn2+ and not Mg2+.  Using hydroxyl-radical footprinting assays, we demonstrated that the distance between the polymerase and RNase H domains in the MoMLV and XMRV RTs is longer than that in the HIV-1 RT by ∼3.4 Å.  We identified one naphthyridinone and one hydroxyisoquinolinedione as potent inhibitors of HIV-1 and XMRV RT RNases H with 50% inhibitory concns. ranging from ∼0.8 to 0.02 μM.  Two acylhydrazones effective against HIV-1 RT RNase H were less potent against the XMRV enzyme.  We also solved the crystal structure of an XMRV RNase H fragment at high resoln. (1.5 Å) and detd. the mol. details of the XMRV RNase H active site, thus providing a framework that would be useful for the design of antivirals that target RNase H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm1yqV6mSzuLVg90H21EOLACvtfcHk0li1lgaL35GcFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2qsLc%253D&md5=abf8755f0530c84af47e1ab6464ff9f9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.06000-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06000-11%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DOng%26aufirst%3DY.%2BT.%26aulast%3DNdongwe%26aufirst%3DT.%2BP.%26aulast%3DHachiya%26aufirst%3DA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DLeslie%26aufirst%3DM.%2BD.%26aulast%3DSietsema%26aufirst%3DD.%2BV.%26aulast%3DFetterly%26aufirst%3DT.%2BL.%26aulast%3DDorst%26aufirst%3DC.%2BA.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520and%2520inhibition%2520studies%2520of%2520the%2520RNase%2520H%2520function%2520of%2520xenotropic%2520murine%2520leukemia%2520virus-related%2520virus%2520reverse%2520transcriptase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D2048%26epage%3D2061%26doi%3D10.1128%2FAAC.06000-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span> </span><span class="NLM_article-title">Rationally designed dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3416</span><span class="NLM_x">–</span> <span class="NLM_lpage">3419</span><span class="refDoi"> DOI: 10.1021/jm070512p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070512p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3416-3419&author=Z.+Wangauthor=E.+M.+Bennettauthor=D.+J.+Wilsonauthor=C.+Salomonauthor=R.+Vince&title=Rationally+designed+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1021%2Fjm070512p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase</span></div><div class="casAuthors">Wang, Zhengqiang; Bennett, Eric M.; Wilson, Daniel J.; Salomon, Christine; Vince, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3416-3419</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bifunctional inhibitors were designed and synthesized based on 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) non-nucleoside reverse transcriptase (RT) inhibitors and diketoacid (DKA) integrase (IN) inhibitors.  Biochem. studies revealed activity against RT and IN at low nanomolar and low micromolar concns., resp.  Exceptionally low IC50 values from a cell-based assay were achieved along with remarkably high therapeutic indexes.  Compd. I was identified as the best compd. of the series (IC50: 24 nM against RT, 4.4 μM against IN, and 10 nM against HIV-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKQ5ZDoIQqLVg90H21EOLACvtfcHk0li1lgaL35GcFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D&md5=021d763f7f62919cc1fe9d010ab56e60</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm070512p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070512p%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DSalomon%26aufirst%3DC.%26aulast%3DVince%26aufirst%3DR.%26atitle%3DRationally%2520designed%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3416%26epage%3D3419%26doi%3D10.1021%2Fjm070512p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Abram, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span> </span><span class="NLM_article-title">Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">11952</span><span class="NLM_x">–</span> <span class="NLM_lpage">11961</span><span class="refDoi"> DOI: 10.1128/JVI.79.18.11952-11961.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1128%2FJVI.79.18.11952-11961.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=16140771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWktL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=11952-11961&author=M.+E.+Abramauthor=M.+A.+Parniak&title=Virion+instability+of+human+immunodeficiency+virus+type+1+reverse+transcriptase+%28RT%29+mutated+in+the+protease+cleavage+site+between+RT+p51+and+the+RT+RNase+H+domain&doi=10.1128%2FJVI.79.18.11952-11961.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain</span></div><div class="casAuthors">Abram, Michael E.; Parniak, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11952-11961</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Each of the human immunodeficiency virus type 1 (HIV-1) pol-encoded enzymes, protease (PR), reverse transcriptase (RT), and integrase (IN), is active only as a dimer (or higher-order oligomer in the case of IN), but only RT comprises subunits of different masses.  RT is a heterodimer of 66-kDa and 51-kDa subunits.  The latter is formed by HIV PR-catalyzed cleavage of p66 during virion maturation, resulting in the removal of the RNase H (RNH) domain of a p66 subunit.  In order to study the apparent need for RT heterodimers in the context of the virion, we introduced a variety of mutations in the RT p51-RNH protease cleavage site of an infectious HIV-1 mol. clone.  Surprisingly, rather than leading to virions with increased RT p66 content, most of the mutations resulted in significantly attenuated virus that contained greatly decreased levels of RT that in many cases was primarily p51 RT.  IN levels were also reduced in several mutants.  However, most mutants showed normal levels of the Pr160gag-pol precursor polyprotein, suggesting that reduced virion RT arose from proteolytic instability rather than decreased incorporation.  Mutant virion p24 Gag levels were equiv. to wild type, indicating that Gag incorporation and processing were not affected.  Repeated passage of MT-2 cells exposed to mutant viruses led to the appearance of virus with improved replication capacity; these virions contained normally processed RT at near-wild-type levels.  These results imply that addnl. proteolytic processing of RT to the p66/p51 heterodimer is essential to provide proteolytic stability of RT during HIV-1 maturation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtyy4eriQOP7Vg90H21EOLACvtfcHk0liJsbLaM2EYgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWktL%252FL&md5=e9a14e6bd954b4fea14701bee282fcd7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.18.11952-11961.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.18.11952-11961.2005%26sid%3Dliteratum%253Aachs%26aulast%3DAbram%26aufirst%3DM.%2BE.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26atitle%3DVirion%2520instability%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%2520%2528RT%2529%2520mutated%2520in%2520the%2520protease%2520cleavage%2520site%2520between%2520RT%2520p51%2520and%2520the%2520RT%2520RNase%2520H%2520domain%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D11952%26epage%3D11961%26doi%3D10.1128%2FJVI.79.18.11952-11961.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baweja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmel, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oren, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shatkin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5083</span><span class="NLM_x">–</span> <span class="NLM_lpage">5092</span><span class="refDoi"> DOI: 10.1093/nar/gkn464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Fnar%2Fgkn464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=18676450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGkt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=5083-5092&author=J.+D.+Baumanauthor=K.+Dasauthor=W.+C.+Hoauthor=M.+Bawejaauthor=D.+M.+Himmelauthor=A.+D.+Clarkauthor=D.+A.+Orenauthor=P.+L.+Boyerauthor=S.+H.+Hughesauthor=A.+J.+Shatkinauthor=E.+Arnold&title=Crystal+engineering+of+HIV-1+reverse+transcriptase+for+structure-based+drug+design&doi=10.1093%2Fnar%2Fgkn464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design</span></div><div class="casAuthors">Bauman, Joseph D.; Das, Kalyan; Ho, William C.; Baweja, Mukta; Himmel, Daniel M.; Clark, Arthur D., Jr.; Oren, Deena A.; Boyer, Paul L.; Hughes, Stephen H.; Shatkin, Aaron J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5083-5092</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">HIV-1 reverse transcriptase (RT) is a primary target for anti-AIDS drugs.  Structures of HIV-1 RT, usually detd. at ∼2.5-3.0 Å resoln., are important for understanding enzyme function and mechanisms of drug resistance in addn. to being helpful in the design of RT inhibitors.  Despite hundreds of attempts, it was not possible to obtain the structure of a complex of HIV-1 RT with TMC278, a nonnucleoside RT inhibitor (NNRTI) in advanced clin. trials.  A systematic and iterative protein crystal engineering approach was developed to optimize RT for obtaining crystals in complexes with TMC278 and other NNRTIs that diffract X-rays to 1.8 Å resoln.  Another form of engineered RT was optimized to produce a high-resoln. apo-RT crystal form, reported here at 1.85 Å resoln., with a distinct RT conformation.  Engineered RTs were mutagenized using a new, flexible and cost effective method called methylated overlap-extension ligation independent cloning.  Our anal. suggests that reducing the solvent content, increasing lattice contacts, and stabilizing the internal low-energy conformations of RT are crit. for the growth of crystals that diffract to high resoln.  The new RTs enable rapid crystn. and yield high-resoln. structures that are useful in designing/developing new anti-AIDS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8sHD_iC_LsLVg90H21EOLACvtfcHk0liJsbLaM2EYgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGkt7%252FI&md5=c7957e67c3a017b289e03de94a78cbbd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn464%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DBaweja%26aufirst%3DM.%26aulast%3DHimmel%26aufirst%3DD.%2BM.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DOren%26aufirst%3DD.%2BA.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DShatkin%26aufirst%3DA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DCrystal%2520engineering%2520of%2520HIV-1%2520reverse%2520transcriptase%2520for%2520structure-based%2520drug%2520design%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3D5083%26epage%3D5092%26doi%3D10.1093%2Fnar%2Fgkn464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liJsbLaM2EYgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Matthews, B. W.</span><span> </span><span class="NLM_article-title">Determination of Protein Molecular-weight, hydration, and packing from crystal density</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1016/0076-6879(85)14018-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1016%2F0076-6879%2885%2914018-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1985&pages=176-187&author=B.+W.+Matthews&title=Determination+of+Protein+Molecular-weight%2C+hydration%2C+and+packing+from+crystal+density&doi=10.1016%2F0076-6879%2885%2914018-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2885%2914018-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252885%252914018-8%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DB.%2BW.%26atitle%3DDetermination%2520of%2520Protein%2520Molecular-weight%252C%2520hydration%252C%2520and%2520packing%2520from%2520crystal%2520density%26jtitle%3DMethods%2520Enzymol.%26date%3D1985%26volume%3D114%26spage%3D176%26epage%3D187%26doi%3D10.1016%2F0076-6879%2885%2914018-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Mccoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+Mccoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhuGgAQe7P69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMccoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span> </span><span class="NLM_article-title">PHENIX: building new software for automated crystallographic structure determination</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1948</span><span class="NLM_x">–</span> <span class="NLM_lpage">1954</span><span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.+W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+building+new+software+for+automated+crystallographic+structure+determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lhuGgAQe7P69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520building%2520new%2520software%2520for%2520automated%2520crystallographic%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhuGgAQe7P69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhHUDuicW9ssQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaver-Fay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snoeyink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">W375</span><span class="NLM_x">–</span> <span class="NLM_lpage">W383</span><span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-W383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eaYUK7lrFlXg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3DW383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HYF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HYF','PDB','3HYF'); return false;">PDB: 3HYF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J1E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J1E','PDB','5J1E'); return false;">PDB: 5J1E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DLO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DLO','PDB','1DLO'); return false;">PDB: 1DLO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00465">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50688"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00465">10.1021/acs.jmedchem.6b00465</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemical synthesis, general procedures, spectral data, including <sup>1</sup>H NMR of intermediates (<b>16a</b>–<b>s</b>, <b>17a</b>–<b>s</b>,<b>w</b>-<b>z</b>), and crystallographic data and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_001.pdf">jm6b00465_si_001.pdf (489.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00465/suppl_file/jm6b00465_si_002.csv">jm6b00465_si_002.csv (1.98 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J1E">5J1E</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00465&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-10%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00465%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00465" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679987514e76d1ab","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
